-- phpMyAdmin SQL Dump
-- version 4.9.5deb2
-- https://www.phpmyadmin.net/
--
-- Host: localhost
-- Generation Time: Apr 23, 2023 at 02:22 PM
-- Server version: 10.3.38-MariaDB-0ubuntu0.20.04.1
-- PHP Version: 7.4.3-4ubuntu2.18

SET SQL_MODE = "NO_AUTO_VALUE_ON_ZERO";
SET AUTOCOMMIT = 0;
START TRANSACTION;
SET time_zone = "+00:00";


/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8mb4 */;

--
-- Database: `nickoshy_db`
--

-- --------------------------------------------------------

--
-- Table structure for table `HCP`
--

DROP TABLE IF EXISTS `HCP`;
CREATE TABLE IF NOT EXISTS `HCP` (
  `HCP_ID` varchar(6) NOT NULL,
  `HCP_FULL_NAME` varchar(20) DEFAULT NULL,
  `HCP_FIRST_NAME` varchar(14) DEFAULT NULL,
  `HCP_MIDDLE_NAME` varchar(15) DEFAULT NULL,
  `HCP_LAST_NAME` varchar(14) DEFAULT NULL,
  `HCP_CREDENTIALS` varchar(15) DEFAULT NULL,
  `HCP_PHONENO` varchar(20) DEFAULT NULL,
  `HCP_EMAIL` varchar(35) DEFAULT NULL,
  `HCP_IS_PRINCIPAL_INVESTIGATOR` varchar(29) DEFAULT NULL,
  `HCP_IS_COLLABORATOR` varchar(19) DEFAULT NULL,
  PRIMARY KEY (`HCP_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `HCP`:
--

--
-- Dumping data for table `HCP`
--

INSERT INTO `HCP` (`HCP_ID`, `HCP_FULL_NAME`, `HCP_FIRST_NAME`, `HCP_MIDDLE_NAME`, `HCP_LAST_NAME`, `HCP_CREDENTIALS`, `HCP_PHONENO`, `HCP_EMAIL`, `HCP_IS_PRINCIPAL_INVESTIGATOR`, `HCP_IS_COLLABORATOR`) VALUES
('HCP_01', 'A. Dimitrios Colevas', 'A', 'Dimitrios', 'Colevas', 'MD	', '', '', 'Y', ''),
('HCP_02', 'Alex Chang', 'Alex', '', 'Chang', 'MD	', '', '', 'Y', ''),
('HCP_03', 'Anca-Ligia Grosu', 'Anca-Ligia', '', 'Grosu', 'Prof. ', ' +49 761 270 94610', 'anca.grosu@uniklinik-freiburg.de   ', '', 'Y'),
('HCP_04', 'Annie W Chan', 'Annie', 'W', 'Chan', 'MD	', '', '', 'Y', ''),
('HCP_05', 'Ann-Lii Cheng', 'Ann-Lii', '', 'Cheng', 'MD PhD', '', '', 'Y', ''),
('HCP_06', 'Antoine Serre', 'Antoine', '', 'Serre', 'MD	', '', '', 'Y', ''),
('HCP_07', 'Antonio Jimeno', 'Antonio', '', 'Jimeno', 'MD PhD', '', '', 'Y', ''),
('HCP_08', 'Cathy Kubrak', 'Cathy', '', 'Kubrak', 'PhD', '', '', 'Y', ''),
('HCP_09', 'Chris Nutting', 'Chris', '', 'Nutting', '', '', '', 'Y', ''),
('HCP_10', 'Claus Belka', 'Claus', '', 'Belka', 'Prof. ', '+49 89 7095 4520', 'Claus.Belka@med.uni-muenchen.de', '', 'Y'),
('HCP_11', 'Claus Rödel', 'Claus', '', 'Rödel', 'Prof. ', '', '', '', 'Y'),
('HCP_12', 'Daniel Zips', 'Daniel', '', 'Zips', 'Prof. ', ' +49 7071/29-8 21 65', '', '', 'Y'),
('HCP_13', 'Daniela Kandioler', 'Daniela', '', 'Kandioler', 'Prof.', '', '', 'Y', 'Y'),
('HCP_14', 'David H. Ilson', 'David', 'H', 'Ilson', 'MD PhD', '', '', 'Y', ''),
('HCP_15', 'Dr. Orhan Nalcioglu', 'Orhan', '', 'Nalcioglu', 'Professor Dr', '', '', 'Y', ''),
('HCP_16', 'Everett E. Vokes', 'Everett', 'E', 'Vokes', 'MD	', '', '', 'Y', ''),
('HCP_17', 'Gérard LLEDO', 'Gérard', '', 'LLEDO', 'MD	', '', '', 'Y', ''),
('HCP_18', 'Gilles Calais', 'Gilles', '', 'Calais', 'MD PhD', '', '', 'Y', ''),
('HCP_19', 'Giorgio Cortesina', 'Giorgio', '', 'Cortesina', 'MD	', '', '', 'Y', ''),
('HCP_20', 'Gopal Bajaj', 'Gopal', '', 'Bajaj', 'MD	', '', '', 'Y', ''),
('HCP_21', 'Heinz Schmidberger', 'Heinz', '', 'Schmidberger', 'Prof. ', '', '', '', 'Y'),
('HCP_22', 'Inge Marie Svane', 'Inge', 'Marie', 'Svane', 'Professor MD', '', '', 'Y', 'Y'),
('HCP_23', 'Iris Chan	', 'Iris', '', 'Chan', '', '', '', 'Y', ''),
('HCP_24', 'Isabelle BRINDEL', 'Isabelle', '', 'BRINDEL', '', '', '', '', 'Y'),
('HCP_25', 'J. Michael Hamilton', 'J', 'Michael', 'Hamilton', 'MD	', '', '', 'Y', ''),
('HCP_26', 'Jae Ill Zo', 'Jae', 'Ill', 'Zo', 'MD PhD', '', '', 'Y', ''),
('HCP_27', 'James H. Doroshow', 'James', 'H', 'Doroshow', 'MD	', '', '', 'Y', ''),
('HCP_28', 'Jens Overgaard', 'Jens', '', 'Overgaard', '', '', '', 'Y', ''),
('HCP_29', 'Joaquina C. Baranda', 'Joaquina', 'C', 'Baranda', 'MD	', '', '', 'Y', ''),
('HCP_30', 'Johannes Zacherl', 'Johannes', '', 'Zacherl', 'Prof.', '', '', 'Y', ''),
('HCP_31', 'José Mª Taboada', 'José', 'Mª', 'Taboada', '', '', '', 'Y', ''),
('HCP_32', 'Jürgen Debus', 'Jürgen', '', 'Debus', 'Prof. ', '', '', '', 'Y'),
('HCP_33', 'Karin Haustermans', 'Karin', '', 'Haustermans', 'Dr.', '', '', 'Y', ''),
('HCP_34', 'Lori J. Wirth', 'Lori', 'J', 'Wirth', 'MD	', '', '', 'Y', ''),
('HCP_35', 'MARCO MERLANO', 'MARCO', '', 'MERLANO', 'MD	', '', '', 'Y', 'Y'),
('HCP_36', 'Marianne Nordsmark', 'Marianne', '', 'Nordsmark', 'Dr.', '', '', 'Y', ''),
('HCP_37', 'Marshall R. Posner', 'Marshall', 'R', 'Posner', 'MD', '', '', 'Y', ''),
('HCP_38', 'Martin Stuschke', 'Martin', '', 'Stuschke', 'Prof. ', ' +49 201 / 723-23 20', 'martin.stuschke@uk-essen.de', '', 'Y'),
('HCP_39', 'Mechthild Krause', 'Mechthild', '', 'Krause', 'Prof. ', '493514582238', 'str.studien@uniklinikum-dresden.de', 'Y', 'Y'),
('HCP_40', 'Mererid Evans', 'Mererid', '', 'Evans', 'MBBch PhD', '', '', 'Y', ''),
('HCP_41', 'Michael Hejna', 'Michael', '', 'Hejna', 'Prof.', '', '', 'Y', ''),
('HCP_42', 'Mohan Suntharalingam', 'Mohan', '', 'Suntharalingam', 'MD	', '', '', 'Y', ''),
('HCP_43', 'Natalie Moryl', 'Natalie', '', 'Moryl', 'MD	', '', '', 'Y', 'Y'),
('HCP_44', 'Philippe Maingon', 'Philippe', '', 'Maingon', 'MD PhD', '', '', 'Y', ''),
('HCP_45', 'Ramesh Ramanathan', 'Ramesh', '', 'Ramanathan', '', '', '', 'Y', ''),
('HCP_46', 'Robert I. Haddad', 'Robert', 'I', 'Haddad', 'MD	', '', '', 'Y', 'Y'),
('HCP_47', 'Sandra Nuyts', 'Sandra', '', 'Nuyts', 'MD	', '', '', 'Y', ''),
('HCP_48', 'Stephanie Combs', 'Stephanie', '', 'Combs', 'Prof. ', ' +49 89 41 40-45 02', 'radonk@lrz.tum.de', '', 'Y'),
('HCP_49', 'Susan Urba', 'Susan', '', 'Urba', 'MD', '', '', 'Y', ''),
('HCP_50', 'Terrence Jones', 'Terrence', '', 'Jones', 'MBBS MD', '', '', 'Y', ''),
('HCP_51', 'Vincent Grégoire', 'Vincent', '', 'Grégoire', 'Professor MD', '', '', 'Y', ''),
('HCP_52', 'Volker Budach', 'Volker', '', 'Budach', 'MD PhD', '', '', 'Y', 'Y');

-- --------------------------------------------------------

--
-- Table structure for table `HCP_INS`
--

DROP TABLE IF EXISTS `HCP_INS`;
CREATE TABLE IF NOT EXISTS `HCP_INS` (
  `HCP_ID` varchar(6) NOT NULL,
  `INS_ID` varchar(7) NOT NULL,
  PRIMARY KEY (`HCP_ID`,`INS_ID`),
  KEY `INS_ID` (`INS_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `HCP_INS`:
--   `HCP_ID`
--       `HCP` -> `HCP_ID`
--   `INS_ID`
--       `INSTITUTIONS` -> `INS_ID`
--

--
-- Dumping data for table `HCP_INS`
--

INSERT INTO `HCP_INS` (`HCP_ID`, `INS_ID`) VALUES
('HCP_01', 'INS_63'),
('HCP_02', 'INS_45'),
('HCP_03', 'INS_100'),
('HCP_04', 'INS_54'),
('HCP_05', 'INS_01'),
('HCP_06', 'INS_19'),
('HCP_07', 'INS_92'),
('HCP_08', 'INS_89'),
('HCP_09', 'INS_71'),
('HCP_10', 'INS_102'),
('HCP_11', 'INS_104'),
('HCP_12', 'INS_101'),
('HCP_13', 'INS_55'),
('HCP_13', 'INS_56'),
('HCP_14', 'INS_58'),
('HCP_15', 'INS_90'),
('HCP_16', 'INS_91'),
('HCP_17', 'INS_10'),
('HCP_18', 'INS_21'),
('HCP_19', 'INS_82'),
('HCP_20', 'INS_46'),
('HCP_21', 'INS_108'),
('HCP_22', 'INS_27'),
('HCP_22', 'INS_39'),
('HCP_23', 'INS_72'),
('HCP_25', 'INS_61'),
('HCP_26', 'INS_60'),
('HCP_27', 'INS_22'),
('HCP_28', 'INS_02'),
('HCP_29', 'INS_48'),
('HCP_30', 'INS_55'),
('HCP_31', 'INS_72'),
('HCP_32', 'INS_107'),
('HCP_33', 'INS_49'),
('HCP_34', 'INS_29'),
('HCP_35', 'INS_09'),
('HCP_35', 'INS_38'),
('HCP_36', 'INS_88'),
('HCP_37', 'INS_29'),
('HCP_38', 'INS_105'),
('HCP_39', 'INS_86'),
('HCP_40', 'INS_99'),
('HCP_41', 'INS_55'),
('HCP_42', 'INS_95'),
('HCP_43', 'INS_58'),
('HCP_44', 'INS_17'),
('HCP_45', 'INS_74'),
('HCP_46', 'INS_29'),
('HCP_47', 'INS_87'),
('HCP_48', 'INS_103'),
('HCP_49', 'INS_97'),
('HCP_50', 'INS_07'),
('HCP_51', 'INS_24'),
('HCP_51', 'INS_76'),
('HCP_51', 'INS_83'),
('HCP_52', 'INS_106'),
('HCP_52', 'INS_20');

-- --------------------------------------------------------

--
-- Table structure for table `INSTITUTIONS`
--

DROP TABLE IF EXISTS `INSTITUTIONS`;
CREATE TABLE IF NOT EXISTS `INSTITUTIONS` (
  `INS_ID` varchar(7) NOT NULL,
  `INSTITUTION_NAME` varchar(69) DEFAULT NULL,
  `INS_STREET_ADDRESS` varchar(55) DEFAULT NULL,
  `INS_CITY` varchar(26) DEFAULT NULL,
  `INS_STATE_REGION` varchar(16) DEFAULT NULL,
  `INS_ZIPCODE` varchar(11) DEFAULT NULL,
  `INS_COUNTRY` varchar(14) DEFAULT NULL,
  `INS_IS_SPONSOR` varchar(14) DEFAULT NULL,
  `INS_IS_COLLABORATOR` varchar(19) DEFAULT NULL,
  PRIMARY KEY (`INS_ID`),
  KEY `INS_IS_SPONSOR` (`INS_IS_SPONSOR`),
  KEY `INS_IS_COLLABORATOR` (`INS_IS_COLLABORATOR`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `INSTITUTIONS`:
--

--
-- Dumping data for table `INSTITUTIONS`
--

INSERT INTO `INSTITUTIONS` (`INS_ID`, `INSTITUTION_NAME`, `INS_STREET_ADDRESS`, `INS_CITY`, `INS_STATE_REGION`, `INS_ZIPCODE`, `INS_COUNTRY`, `INS_IS_SPONSOR`, `INS_IS_COLLABORATOR`) VALUES
('INS_01', 'National Taiwan University hospital', 'No. 7  Zhongshan S Rd,  Zhongzheng District', 'Taipei City', '', '100', 'Taiwan', 'Y', ''),
('INS_02', 'Aarhus University Hospital', 'Palle Juul-Jensens Blvd. 161', 'Aarhus', '', '8200', 'Denmark', 'Y', 'Y'),
('INS_03', 'Academisch Ziekenhuis Groningen', 'Hanzeplein 1', 'Groningen', '', '9713GZ', 'Netherlands', '', 'Y'),
('INS_04', 'AdventHealth', '601 E Rollins St Suite 400', 'Orlando', 'FL', '32803', 'United States', '', 'Y'),
('INS_05', 'Agenzia Nazionale per i Servizi Sanitari Regionali', 'Via Puglie, 23', 'Roma', '', '187', 'Italy', '', 'Y'),
('INS_06', 'AHS Cancer Control Alberta', '2210 2 St SW', 'Calgary', '', 'T2S3C3', 'Canada', 'Y', ''),
('INS_07', 'Aintree University Hospital', 'Lower Ln  Fazakerley', 'Liverpool', '', 'L97AL', 'United Kingdom', '', ''),
('INS_08', 'Alliance for Clinical Trials in Oncology', '221 Longwood Avenue, Room 108', 'Boston', 'MA', '2115', 'United States', 'Y', ''),
('INS_09', 'ASCO, ESMO, AIOM, G.O.N.O.', '', '', '', '', '', '', ''),
('INS_10', 'Assistance Publique - Hôpitaux de Paris', '55 Bd Diderot CS 22305', 'Paris', '', '75610', 'France', 'Y', ''),
('INS_100', 'Universitätsklinikum Freiburg', 'Hauptstraße 5', 'Freiburg im Breisgau', '', '79104', 'Germany', '', ''),
('INS_101', 'University of Tuebingen', 'Geschwister-Scholl-Platz', 'Tübingen', '', '72074', 'Germany', '', ''),
('INS_102', 'LMU Klinikum - Campus Großhadern', 'Marchioninistraße 15', 'München', '', '81377', 'Germany', '', ''),
('INS_103', 'Technical University of Munich', 'Arcisstraße 21', 'München', '', '80333', 'Germany', '', ''),
('INS_104', 'Frankfurt University Hospital', 'Theodor-Stern-Kai 7', 'Frankfurt am Main', '', '60590', 'Germany', '', ''),
('INS_105', 'University Hospital Essen', 'Hufelandstraße 55', 'Essen', '', '45147', 'Germany', '', ''),
('INS_106', 'Charité Campus Virchow Clinic', 'Augustenburger Pl. 1', 'Berlin', '', '13353', 'Germany', '', ''),
('INS_107', 'NCT Heidelberg', 'Im Neuenheimer Feld 460', 'Heidelberg', '', '69120', 'Germany', '', ''),
('INS_108', 'Johannes Gutenberg-Universität Mainz', 'Langenbeckstraße 1', 'Mainz', '', '55131', 'Germany', '', ''),
('INS_11', 'Astellas Co.', '5 Waterside Citywest Business Campus', 'Dublin', '', '24', 'Ireland', 'Y', ''),
('INS_12', 'AstraZeneca plc', '4601 IN-62', 'Mt Vernon', 'IN', '47620', 'United States', '', 'Y'),
('INS_13', 'Austrian Society Of Surgical Oncology', '9525 W Bryn Mawr Ave # 870', 'Rosemont', 'IL', '60018', 'United States', '', 'Y'),
('INS_14', 'Brigham and Women\'s Hospital', '75 Francis St', 'Boston', 'MA', '2115', 'United States', '', 'Y'),
('INS_15', 'Bristol-Myers Squibb Inc', '100 Binney St', 'Cambridge', 'MA', '2142', 'United States', 'Y', 'Y'),
('INS_16', 'Centre Antoine Lacassagne', '33 Av. de Valombrose', 'Nice', '', '6100', 'France', '', 'Y'),
('INS_17', 'Centre George-François Leclerc Dijon', '1 Rue du Professeur Marion', 'Dijon', '', '21000', 'France', '', ''),
('INS_18', 'Centre Leon Berard', '28 Prom. Léa et Napoléon Bullukian', 'Lyon', '', '69008', 'France', '', 'Y'),
('INS_19', 'Centre Val d\'Aurelle', '31 Rue de la Croix Verte', 'Montpellier', '', '34090', 'France', '', ''),
('INS_20', 'Charité Universitaetsmedizin Berlin', 'Charitépl. 1', 'Berlin', '', '10117', 'Germany', 'Y', ''),
('INS_21', 'CHU de Tours', '2 Bd Tonnellé', 'Tours', '', '37000', 'France', '', ''),
('INS_22', 'City of Hope Comprehensive Cancer Center', '1500 E Duarte Rd', 'Duarte', 'CA', '91010', 'United States', '', ''),
('INS_23', 'City of Hope Medical Center', '1500 E Duarte Rd', 'Duarte', 'CA', '91010', 'United States', 'Y', ''),
('INS_24', 'Cliniques universitaires Saint Luc', 'Av. Hippocrate 10', 'Bruxelles', '', '1200', 'Belgium', 'Y', ''),
('INS_25', 'CNAO National Center of Oncological Hadrontherapy', 'Str. Campeggi 53', 'Pavia', 'PV', '27100', 'Italy', '', 'Y'),
('INS_26', 'cooperative Group', 'Av. Gaston Phoebus', 'Lescar', '', '64231', 'France', '', 'Y'),
('INS_27', 'Copenhagen University Hospital', 'Blegdamsvej 9', 'København', '', '2100', 'Denmark', '', ''),
('INS_28', 'Cross Cancer Institute', '11560 University Ave', 'Edmonton', '', 'T6G1Z2', 'Canada', '', 'Y'),
('INS_29', 'Dana-Farber Cancer Institute', '450 Brookline Ave', 'Boston', 'MA', '2215', 'United States', 'Y', 'Y'),
('INS_30', 'Danish Head and Neck Cancer Group', 'First Hotel Grand, Jernbanegade 18', 'Odense', '', '5000', 'Denmark', '', 'Y'),
('INS_31', 'Deutsche Krebsgesellschaft e.V.', 'Kuno-Fischer-Straße 8', 'Berlin', '', '14057', 'Germany', '', 'Y'),
('INS_32', 'Dresden University of Technology', '', 'Dresden', '', '1069', 'Germany', 'Y', ''),
('INS_33', 'Enzon Pharmaceuticals, Inc.', '8925 Guion Rd', 'Indianapolis', 'IN', '46268', 'United States', 'Y', ''),
('INS_34', 'European Organisation for Research and Treatment of Cancer', 'Avenue Emmanuel Mounier 83/11', 'Brussel', '', '1200', 'Belgium', 'Y', ''),
('INS_35', 'Francois Leclerc Hospital', '45 Rue Leclerc', 'Québec', '', 'G1L2E8', 'Canada', '', 'Y'),
('INS_36', 'Genmab A/S', 'Kalvebod Brygge 43', 'København', '', '1560', 'Denmark', 'Y', ''),
('INS_37', 'German Cancer Research Center', 'Im Neuenheimer Feld 280', 'Heidelberg', '', '69120', 'Germany', '', 'Y'),
('INS_38', 'Gruppo Oncologico del Nord-Ovest', 'Via Goffredo Mameli  3/1', 'Genova', '', '16122', 'Italy', 'Y', ''),
('INS_39', 'Herlev Hospital', 'Borgmester Ib Juuls Vej 1', 'Herlev', '', '2730', 'Denmark', 'Y', ''),
('INS_40', 'HollandPTC', 'Huismansingel 4 JH ', 'Delft', '', '2629', 'Netherlands', '', 'Y'),
('INS_41', 'IBA worldwide', 'Chem. du Cyclotron 3', 'Ottignies-Louvain-la-Neuve', '', '1348', 'Belgium', '', 'Y'),
('INS_42', 'Institut Curie', '26 Rue d\'Ulm', 'Paris', '', '75005', 'France', '', 'Y'),
('INS_43', 'Institute of Cancer Research - Clinical Trials & Statistics Unit', '15 Cotswold Rd', 'Sutton', '', 'SM25NG', 'United Kingdom', 'Y', ''),
('INS_44', 'Istituto Europeo di Oncologia', 'Via Giuseppe Ripamonti 435', 'Milano', '', '20141', 'Italy', 'Y', ''),
('INS_45', 'Johns Hopkins Singapore', '11 Jln Tan Tock Seng', 'Singapore', '', '308433', 'Singapore', '', ''),
('INS_46', 'Johns Hopkins University', '', 'Baltimore', 'MD', '21218', 'United States', '', ''),
('INS_48', 'Kansas City Veteran Affairs Medical Center', '4801 Linwood Blvd', 'Kansas City', 'MO', '64128', 'United States', 'Y', ''),
('INS_49', 'KU Leuven', 'Oude Markt 13', 'Leuven', '', '3000', 'Belgium', '', 'Y'),
('INS_50', 'Life Molecular Imaging SA', 'Tegeler Str. 7', 'Berlin', '', '13353', 'Germany', 'Y', ''),
('INS_52', 'Loyola University Chicago', '1032 W Sheridan Rd', 'Chicago', 'IL', '60660', 'United States', '', 'Y'),
('INS_53', 'Maastro Clinic, The Netherlands', 'Doctor Tanslaan 12', 'Maastricht', '', '6229', 'Netherlands', '', 'Y'),
('INS_54', 'Massachusetts General Hospital', '55 Fruit St', 'Boston', 'MA', '2114', 'United States', 'Y', 'Y'),
('INS_55', 'Medical University of Vienna', 'Spitalgasse 23', 'Wien', '', '1090', 'Austria', 'Y', ''),
('INS_56', 'Medical University of Vienna -  Austrian Society Of Surgical Oncology', 'Spitalgasse 23', 'Wien', '', '1090', 'Austria', '', ''),
('INS_57', 'MedImmune Inc', '', 'Cambridge', '', 'CB216GH', 'United Kingdom', '', 'Y'),
('INS_58', 'Memorial Sloan Kettering Cancer Center', '1275 York Ave', 'New York', 'NY', '10065', 'United States', 'Y', ''),
('INS_59', 'Medical University of Vienna', 'Spitalgasse 23', 'Wien', '', '1090', 'Austria', '', ''),
('INS_60', 'National Cancer Center of Korea', '323 Ilsan-ro  Ilsandong-gu', 'Goyang-si Gyeonggi-do', '', '', 'South Korea', 'Y', ''),
('INS_61', 'National Cancer Institute', '37 Convent Dr', 'Bethesda', 'MD', '20814', 'United States', 'Y', 'Y'),
('INS_63', 'NCI-Investigational Drug Branch', '9000 Rockville Pike', 'Bethesda', 'MD', '20892', 'United States', '', ''),
('INS_64', 'NHS Velindre Hospital', 'Unit 2 Charnwood Court Heol Billingsley, Parc, Nantgarw', 'Cardiff', '', 'CF157QZ', 'United Kingdom', 'Y', ''),
('INS_65', 'NRG Oncology', 'Four Penn Center, 1600 JFK Blvd, Suite 1020', 'Philadelphia', 'PA', '19103', 'United States', '', 'Y'),
('INS_66', 'Paul Scherrer Institut, Center for Proton Therapy', 'PSI CH Forschungsstrasse 111', 'Villigen', '', '5232', 'Switzerland', '', 'Y'),
('INS_67', 'Princess Alexandra Hospital, Brisbane, Australia', '199 Ipswich Rd', 'Woolloongabba', 'QLD', '4102', 'Australia', '', 'Y'),
('INS_68', 'Radiation Therapy Oncology Group', '50 South 16th Street', 'Philadelphia', 'PA', '19102', 'United States', 'Y', ''),
('INS_69', 'Robert H. Lurie Comprehensive Cancer Center', '675 N St Clair St Fl 21 Ste 100', 'Chicago', 'IL', '60611', 'United States', 'Y', ''),
('INS_70', 'Roche SA', '9115 Hague Rd', 'Indianapolis', 'IN', '46256', 'United States', '', 'Y'),
('INS_71', 'Royal Marsden NHS Foundation', 'Fulham Road ', 'London', '', 'SW36JJ', 'United Kingdom', '', ''),
('INS_72', 'Sanofi SA', 'Sanofi Building D,  Corporate Dr', 'Bridgewater Township', 'NJ', '8807', 'United States', 'Y', 'Y'),
('INS_73', 'Sidney Kimmel Comprehensive Cancer Center', '401 N Broadway', 'Baltimore', 'MD', '21231', 'United States', 'Y', ''),
('INS_74', 'Southwest Oncology Group', '14980 Omicron Dr', 'SanAntonio', 'TX', '', 'United States', '', ''),
('INS_75', 'Stanford University', '450 Serra Mall', 'Stanford', 'CA', '94305', 'United States', '', 'Y'),
('INS_76', 'St-Luc University Hospital', 'Av. Hippocrate 10', 'Bruxelles', '', '1200', 'Belgium', '', ''),
('INS_77', 'Technische Universität Dresden', 'Tatzberg 47-51', 'Dresden', '', '1307', 'Germany', '', 'Y'),
('INS_78', 'The Christie NHS Foundation Trust', 'Wilmslow Rd', 'Manchester', '', 'M204BX', 'United Kingdom', '', 'Y'),
('INS_79', 'UC Irvine', '', 'Irvine', 'CA', '92697', 'United States', 'Y', ''),
('INS_80', 'KU Leuven', 'Oude Markt 13', 'Leuven', '', '3000', 'Belgium', '', ''),
('INS_81', 'UNICANCER', '101 Rue de Tolbiac', 'Paris', '', '75013', 'France', '', 'Y'),
('INS_82', 'Universita Degli Studi di Turin', 'Via Sant\'Ottavio 20', 'Torino', 'TO', '10124', 'Italy', '', ''),
('INS_83', 'Université catholique de Louvain -  St-Luc University Hospital', 'Av. Hippocrate 10', 'Bruxelles', '', '1200', 'Belgium', '', ''),
('INS_84', 'University College London Hospitals', '12 Queen Square', 'London', '', 'WC1N3BG', 'United Kingdom', '', 'Y'),
('INS_85', 'University College, London', 'Gower St', 'London', '', 'WC1E6BT', 'United Kingdom', '', 'Y'),
('INS_86', 'University Hospital Carl Gustav Carus', 'Fetscherstraße 74', 'Dresden', '', '1307', 'Germany', '', ''),
('INS_87', 'University hospital Gasthuisberg - Katholiek universiteit van Leuven', 'Oude Markt 13', 'Leuven', '', '3000', 'Belgium', '', ''),
('INS_88', 'University of Aarhus', 'Nordre Ringgade 1', 'Aarhus', '', '8000', 'Denmark', '', 'Y'),
('INS_89', 'University of Alberta', '116 St & 85 Ave', 'Edmonton', ' AB ', 'T6G2R3', 'Canada', '', ''),
('INS_90', 'University of California - Irvine', '', 'Irvine', 'CA', '92697', 'United States', '', ''),
('INS_91', 'University of Chicago', '5801 S Ellis Ave', 'Chicago', 'IL', '60637', 'United States', '', ''),
('INS_92', 'University of Colorado - Denver', '1201 Larimer St', 'Denver', 'CO', '80204', 'United States', 'Y', ''),
('INS_93', 'University of Leeds', 'Woodhouse', 'Leeds', '', 'LS29JT', 'United Kingdom', '', 'Y'),
('INS_94', 'University of Leipzig', 'Augustuspl. 10', 'Leipzig', '', '4109', 'Germany', '', 'Y'),
('INS_95', 'University of Maryland Greenebaum Cancer Center', '22 S Greene St', 'Baltimore', 'MD', '21201', 'United States', '', ''),
('INS_96', 'University of Michigan', '400 4th St', 'Ann Arbor', 'MI', '48103', 'United States', 'Y', ''),
('INS_97', 'University of Michigan Rogel Cancer Center', '1500 E Medical Center Dr', 'Ann Arbor', 'MI', '48109', 'United States', '', ''),
('INS_98', 'Varian- A Siemens Healthineer Company', '400 W Morgan Rd', 'Ann Arbor', 'MI', '48108', 'United States', '', 'Y'),
('INS_99', 'Velindre NHS Trust', 'Unit 2 Charnwood Court Heol Billingsley, Parc, Nantgarw', 'Cardiff', '', 'CF157QZ', 'United Kingdom', '', '');

-- --------------------------------------------------------

--
-- Table structure for table `MESH_TERMS`
--

DROP TABLE IF EXISTS `MESH_TERMS`;
CREATE TABLE IF NOT EXISTS `MESH_TERMS` (
  `MESH_ID` varchar(8) NOT NULL,
  `MESH_TERM` varchar(75) DEFAULT NULL,
  `CANCER_STAGE` varchar(12) DEFAULT NULL,
  `TREATMENTS` varchar(10) DEFAULT NULL,
  `DISEASE_TYPE` varchar(16) DEFAULT NULL,
  `TUMOR_CLASSIFICATION` varchar(20) DEFAULT NULL,
  PRIMARY KEY (`MESH_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `MESH_TERMS`:
--

--
-- Dumping data for table `MESH_TERMS`
--

INSERT INTO `MESH_TERMS` (`MESH_ID`, `MESH_TERM`, `CANCER_STAGE`, `TREATMENTS`, `DISEASE_TYPE`, `TUMOR_CLASSIFICATION`) VALUES
('MESH_001', 'stage III squamous cell carcinoma of the lip and oral cavity', 'stage III', '', 'Neoplasms', ''),
('MESH_002', 'stage IV squamous cell carcinoma of the lip and oral cavity', 'stage IV', '', 'Neoplasms', ''),
('MESH_003', 'stage III squamous cell carcinoma of the oropharynx', 'stage III', '', 'Neoplasms', ''),
('MESH_004', 'stage III lymphoepithelioma of the oropharynx', 'stage III', '', 'Neoplasms', ''),
('MESH_005', 'stage IV squamous cell carcinoma of the oropharynx', 'stage IV', '', 'Neoplasms', ''),
('MESH_006', 'stage IV lymphoepithelioma of the oropharynx', 'stage IV', '', 'Neoplasms', ''),
('MESH_007', 'stage III squamous cell carcinoma of the nasopharynx', 'stage III', '', 'Neoplasms', ''),
('MESH_008', 'stage III lymphoepithelioma of the nasopharynx', 'stage III', '', 'Neoplasms', ''),
('MESH_009', 'stage IV squamous cell carcinoma of the nasopharynx', 'stage IV', '', 'Neoplasms', ''),
('MESH_010', 'stage IV lymphoepithelioma of the nasopharynx', 'stage IV', '', 'Neoplasms', ''),
('MESH_011', 'stage III squamous cell carcinoma of the hypopharynx', 'stage III', '', 'Neoplasms', ''),
('MESH_012', 'stage IV squamous cell carcinoma of the hypopharynx', 'stage IV', '', 'Neoplasms', ''),
('MESH_013', 'stage III squamous cell carcinoma of the larynx', 'stage III', '', 'Neoplasms', ''),
('MESH_014', 'stage IV squamous cell carcinoma of the larynx', 'stage IV', '', 'Neoplasms', ''),
('MESH_015', 'stage III squamous cell carcinoma of the paranasal sinus and nasal cavity', 'stage III', '', 'Neoplasms', ''),
('MESH_016', 'stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity', 'stage IV', '', 'Neoplasms', ''),
('MESH_017', 'Esophageal Neoplasms', '', '', 'Neoplasms', ''),
('MESH_018', 'Gastrointestinal Neoplasms', '', '', 'Neoplasms', ''),
('MESH_019', 'Digestive System Neoplasms', '', '', 'Neoplasms', ''),
('MESH_020', 'Neoplasms by Site', '', '', 'Neoplasms', ''),
('MESH_021', 'Neoplasms', '', '', 'Neoplasms', ''),
('MESH_022', 'Head and Neck Neoplasms', '', '', 'Neoplasms', ''),
('MESH_023', 'Digestive System Diseases', '', '', 'Digestive', ''),
('MESH_024', 'Esophageal Diseases', '', '', 'ENT', ''),
('MESH_025', 'Gastrointestinal Diseases', '', '', 'Gastrointestinal', ''),
('MESH_026', 'Paclitaxel', '', 'Y', '', ''),
('MESH_027', 'Antineoplastic Agents, Phytogenic', '', 'Y', '', ''),
('MESH_028', 'Antineoplastic Agents', '', 'Y', '', ''),
('MESH_029', 'Tubulin Modulators', '', 'Y', '', ''),
('MESH_030', 'Antimitotic Agents', '', 'Y', '', ''),
('MESH_031', 'Mitosis Modulators', '', 'Y', '', ''),
('MESH_032', 'Molecular Mechanisms of Pharmacological Action', '', '', '', ''),
('MESH_033', 'Folic Acid', '', 'Y', '', ''),
('MESH_034', 'Cisplatin', '', 'Y', '', ''),
('MESH_035', 'Hematinics', '', 'Y', '', ''),
('MESH_036', 'Vitamin B Complex', '', 'Y', '', ''),
('MESH_037', 'Vitamins', '', 'Y', '', ''),
('MESH_038', 'Micronutrients', '', 'Y', '', ''),
('MESH_039', 'Physiological Effects of Drugs', '', '', '', ''),
('MESH_040', 'Carcinoma', '', '', 'Neoplasms', ''),
('MESH_041', 'Neoplasms, Glandular and Epithelial', '', '', 'Neoplasms', ''),
('MESH_042', 'Neoplasms by Histologic Type', '', '', 'Neoplasms', ''),
('MESH_043', 'Tetrathiomolybdate', '', 'Y', '', ''),
('MESH_044', 'Chelating Agents', '', 'Y', '', ''),
('MESH_045', 'Sequestering Agents', '', 'Y', '', ''),
('MESH_046', 'Enzyme Inhibitors', '', 'Y', '', ''),
('MESH_047', 'Angiogenesis Inhibitors', '', 'Y', '', ''),
('MESH_048', 'Angiogenesis Modulating Agents', '', 'Y', '', ''),
('MESH_049', 'Growth Substances', '', 'Y', '', ''),
('MESH_050', 'Growth Inhibitors', '', 'Y', '', ''),
('MESH_051', 'Nasopharyngeal Carcinoma', '', '', 'Neoplasms', ''),
('MESH_052', 'Nasopharyngeal Neoplasms', '', '', 'Neoplasms', ''),
('MESH_053', 'Pharyngeal Neoplasms', '', '', 'Neoplasms', ''),
('MESH_054', 'Otorhinolaryngologic Neoplasms', '', '', 'Neoplasms', ''),
('MESH_055', 'Nasopharyngeal Diseases', '', '', 'ENT', ''),
('MESH_056', 'Pharyngeal Diseases', '', '', 'ENT', ''),
('MESH_057', 'Stomatognathic Diseases', '', '', 'Other', ''),
('MESH_058', 'Otorhinolaryngologic Diseases', '', '', 'ENT', ''),
('MESH_059', 'Gemcitabine', '', 'Y', '', ''),
('MESH_060', 'Oxaliplatin', '', 'Y', '', ''),
('MESH_061', 'Antimetabolites, Antineoplastic', '', 'Y', '', ''),
('MESH_062', 'Antimetabolites', '', 'Y', '', ''),
('MESH_063', 'Antiviral Agents', '', 'Y', '', ''),
('MESH_064', 'Anti-Infective Agents', '', 'Y', '', ''),
('MESH_065', 'Immunosuppressive Agents', '', 'Y', '', ''),
('MESH_066', 'Immunologic Factors', '', '', '', ''),
('MESH_067', 'Docetaxel', '', 'Y', '', ''),
('MESH_068', 'Fluorouracil', '', 'Y', '', ''),
('MESH_069', 'Barrett Esophagus', '', '', 'ENT', ''),
('MESH_070', 'Precancerous Conditions', '', '', '', ''),
('MESH_071', 'Erlotinib Hydrochloride', '', 'Y', '', ''),
('MESH_072', 'Protein Kinase Inhibitors', '', 'Y', '', ''),
('MESH_073', 'Carcinoma, Squamous Cell', '', '', 'Neoplasms', ''),
('MESH_074', 'Neoplasms, Squamous Cell', '', '', 'Neoplasms', ''),
('MESH_075', 'Vidarabine', '', 'Y', '', ''),
('MESH_076', 'Cyclophosphamide', '', 'Y', '', ''),
('MESH_077', 'Fludarabine', '', 'Y', '', ''),
('MESH_078', 'Fludarabine phosphate', '', 'Y', '', ''),
('MESH_079', 'Interleukin-2', '', 'Y', '', ''),
('MESH_080', 'Antirheumatic Agents', '', 'Y', '', ''),
('MESH_081', 'Antineoplastic Agents, Alkylating', '', 'Y', '', ''),
('MESH_082', 'Alkylating Agents', '', 'Y', '', ''),
('MESH_083', 'Myeloablative Agonists', '', 'Y', '', ''),
('MESH_084', 'Analgesics, Non-Narcotic', '', 'Y', '', ''),
('MESH_085', 'Analgesics', '', 'Y', '', ''),
('MESH_086', 'Sensory System Agents', '', 'Y', '', ''),
('MESH_087', 'Peripheral Nervous System Agents', '', 'Y', '', ''),
('MESH_088', 'Squamous Cell Carcinoma of Head and Neck', '', '', 'Neoplasms', ''),
('MESH_089', 'Cetuximab', '', 'Y', '', ''),
('MESH_090', 'Antineoplastic Agents, Immunological', '', 'Y', '', ''),
('MESH_091', 'Fatigue', '', '', '', ''),
('MESH_092', 'Methylphenidate', '', 'Y', '', ''),
('MESH_093', 'Central Nervous System Stimulants', '', 'Y', '', ''),
('MESH_094', 'Dopamine Uptake Inhibitors', '', 'Y', '', ''),
('MESH_095', 'Neurotransmitter Uptake Inhibitors', '', 'Y', '', ''),
('MESH_096', 'Membrane Transport Modulators', '', 'Y', '', ''),
('MESH_097', 'Dopamine Agents', '', 'Y', '', ''),
('MESH_098', 'Neurotransmitter Agents', '', 'Y', '', ''),
('MESH_099', 'Ototoxicity', '', '', '', ''),
('MESH_100', 'Radiation Injuries', '', 'Y', '', ''),
('MESH_101', 'Wounds and Injuries', '', '', '', ''),
('MESH_102', 'Ear Diseases', '', '', 'ENT', ''),
('MESH_103', 'Pathologic Processes', '', '', '', ''),
('MESH_104', 'Drug-Related Side Effects and Adverse Reactions', '', '', '', ''),
('MESH_105', 'Chemically-Induced Disorders', '', 'Y', '', ''),
('MESH_106', 'Recurrence', '', '', '', ''),
('MESH_107', 'Disease Attributes', '', '', '', ''),
('MESH_108', 'stage IV breast cancer', 'stage IV', '', 'Neoplasms', ''),
('MESH_109', 'stage IIIA breast cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_110', 'recurrent breast cancer', '', '', 'Neoplasms', ''),
('MESH_111', 'stage IIIB breast cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_112', 'recurrent non-small cell lung cancer', '', '', 'Neoplasms', ''),
('MESH_113', 'stage III ovarian epithelial cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_114', 'stage IV ovarian epithelial cancer', 'stage IV', '', 'Neoplasms', ''),
('MESH_115', 'recurrent ovarian epithelial cancer', '', '', 'Neoplasms', ''),
('MESH_116', 'stage IV nasopharyngeal cancer', 'stage IV', '', 'Neoplasms', ''),
('MESH_117', 'stage IIIA non-small cell lung cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_118', 'stage IIIB non-small cell lung cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_119', 'stage IV non-small cell lung cancer', 'stage IV', '', 'Neoplasms', ''),
('MESH_120', 'unspecified adult solid tumor, protocol specific', '', '', '', 'Y'),
('MESH_121', 'recurrent metastatic squamous neck cancer with occult primary', '', '', 'Neoplasms', ''),
('MESH_122', 'ovarian stromal cancer', '', '', 'Neoplasms', ''),
('MESH_123', 'stage III ovarian germ cell tumor', 'stage III', '', 'Neoplasms', ''),
('MESH_124', 'stage IV ovarian germ cell tumor', 'stage IV', '', 'Neoplasms', ''),
('MESH_125', 'recurrent ovarian germ cell tumor', '', '', '', 'Y'),
('MESH_126', 'stage III basal cell carcinoma of the lip', 'stage III', '', 'Neoplasms', ''),
('MESH_127', 'stage III verrucous carcinoma of the oral cavity', 'stage III', '', 'Neoplasms', ''),
('MESH_128', 'stage III mucoepidermoid carcinoma of the oral cavity', 'stage III', '', 'Neoplasms', ''),
('MESH_129', 'stage III adenoid cystic carcinoma of the oral cavity', 'stage III', '', 'Neoplasms', ''),
('MESH_130', 'stage IV basal cell carcinoma of the lip', 'stage IV', '', 'Neoplasms', ''),
('MESH_131', 'stage IV verrucous carcinoma of the oral cavity', 'stage IV', '', 'Neoplasms', ''),
('MESH_132', 'stage IV mucoepidermoid carcinoma of the oral cavity', 'stage IV', '', 'Neoplasms', ''),
('MESH_133', 'stage IV adenoid cystic carcinoma of the oral cavity', 'stage IV', '', 'Neoplasms', ''),
('MESH_134', 'recurrent squamous cell carcinoma of the lip and oral cavity', '', '', 'Neoplasms', ''),
('MESH_135', 'recurrent basal cell carcinoma of the lip', '', '', 'Neoplasms', ''),
('MESH_136', 'stage IV hypopharyngeal cancer', 'stage IV', '', 'Neoplasms', ''),
('MESH_137', 'recurrent hypopharyngeal cancer', '', '', 'Neoplasms', ''),
('MESH_138', 'recurrent verrucous carcinoma of the oral cavity', '', '', 'Neoplasms', ''),
('MESH_139', 'recurrent mucoepidermoid carcinoma of the oral cavity', '', '', 'Neoplasms', ''),
('MESH_140', 'recurrent adenoid cystic carcinoma of the oral cavity', '', '', 'Neoplasms', ''),
('MESH_141', 'recurrent squamous cell carcinoma of the oropharynx', '', '', 'Neoplasms', ''),
('MESH_142', 'recurrent lymphoepithelioma of the oropharynx', '', '', 'Neoplasms', ''),
('MESH_143', 'recurrent squamous cell carcinoma of the nasopharynx', '', '', 'Neoplasms', ''),
('MESH_144', 'recurrent lymphoepithelioma of the nasopharynx', '', '', 'Neoplasms', ''),
('MESH_145', 'recurrent squamous cell carcinoma of the hypopharynx', '', '', 'Neoplasms', ''),
('MESH_146', 'stage IV verrucous carcinoma of the larynx', 'stage IV', '', 'Neoplasms', ''),
('MESH_147', 'recurrent squamous cell carcinoma of the larynx', '', '', 'Neoplasms', ''),
('MESH_148', 'recurrent verrucous carcinoma of the larynx', '', '', 'Neoplasms', ''),
('MESH_149', 'stage I non-small cell lung cancer', 'stage I', '', 'Neoplasms', ''),
('MESH_150', 'stage II non-small cell lung cancer', 'stage II', '', 'Neoplasms', ''),
('MESH_151', 'stage III non-small cell lung cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_152', 'limited stage small cell lung cancer', '', '', 'Neoplasms', ''),
('MESH_153', 'stage I nasopharyngeal cancer', 'stage I', '', 'Neoplasms', ''),
('MESH_154', 'stage II nasopharyngeal cancer', 'stage II', '', 'Neoplasms', ''),
('MESH_155', 'stage III nasopharyngeal cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_156', 'stage I lip and oral cavity cancer', 'stage I', '', 'Neoplasms', ''),
('MESH_157', 'stage II lip and oral cavity cancer', 'stage II', '', 'Neoplasms', ''),
('MESH_158', 'stage III lip and oral cavity cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_159', 'stage I hypopharyngeal cancer', 'stage I', '', 'Neoplasms', ''),
('MESH_160', 'stage II hypopharyngeal cancer', 'stage II', '', 'Neoplasms', ''),
('MESH_161', 'stage III hypopharyngeal cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_162', 'stage I laryngeal cancer', 'stage I', '', 'Neoplasms', ''),
('MESH_163', 'stage II laryngeal cancer', 'stage II', '', 'Neoplasms', ''),
('MESH_164', 'stage III laryngeal cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_165', 'stage I paranasal sinus and nasal cavity cancer', 'stage I', '', 'Neoplasms', ''),
('MESH_166', 'stage II paranasal sinus and nasal cavity cancer', 'stage II', '', 'Neoplasms', ''),
('MESH_167', 'stage III paranasal sinus and nasal cavity cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_168', 'stage I oropharyngeal cancer', 'stage I', '', 'Neoplasms', ''),
('MESH_169', 'stage II oropharyngeal cancer', 'stage II', '', 'Neoplasms', ''),
('MESH_170', 'stage III oropharyngeal cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_171', 'Capecitabine', '', 'Y', '', ''),
('MESH_172', 'Zalutumumab', '', 'Y', '', ''),
('MESH_173', 'Doxorubicin', '', 'Y', '', ''),
('MESH_174', 'Ifosfamide', '', 'Y', '', ''),
('MESH_175', 'Antibiotics, Antineoplastic', '', 'Y', '', ''),
('MESH_176', 'Topoisomerase II Inhibitors', '', 'Y', '', ''),
('MESH_177', 'Topoisomerase Inhibitors', '', 'Y', '', ''),
('MESH_178', 'Prostatic Neoplasms', '', '', 'Neoplasms', ''),
('MESH_179', 'Colorectal Neoplasms', '', '', 'Neoplasms', ''),
('MESH_180', 'Melanoma', '', '', 'Neoplasms', ''),
('MESH_181', 'Neoplasm Metastasis', '', '', 'Neoplasms', ''),
('MESH_182', 'Adenocarcinoma', '', '', 'Neoplasms', ''),
('MESH_183', 'Stomach Neoplasms', '', '', 'Neoplasms', ''),
('MESH_184', 'Stomach Diseases', '', '', 'Gastrointestinal', ''),
('MESH_185', 'stage II squamous cell carcinoma of the lip and oral cavity', 'stage II', '', 'Neoplasms', ''),
('MESH_186', 'stage II squamous cell carcinoma of the oropharynx', 'stage II', '', 'Neoplasms', ''),
('MESH_187', 'tongue cancer', '', '', 'Neoplasms', ''),
('MESH_188', 'Cancer', '', '', 'Neoplasms', ''),
('MESH_189', 'Gastric', '', '', '', ''),
('MESH_190', 'Gastroesophageal Junction', '', '', '', ''),
('MESH_191', 'Gastric Cancer', '', '', 'Neoplasms', ''),
('MESH_192', 'Gastric Neoplasms', '', '', 'Neoplasms', ''),
('MESH_193', 'Acute respiratory distress syndrome', '', '', 'ENT', ''),
('MESH_194', 'corticosteroids', '', 'Y', '', ''),
('MESH_195', 'postoperative complications', '', '', '', ''),
('MESH_196', 'cytokines', '', '', '', ''),
('MESH_197', 'Mucositis', '', '', 'ENT', ''),
('MESH_198', 'Gastroenteritis', '', '', 'Gastrointestinal', ''),
('MESH_199', 'Mouth Diseases', '', '', 'ENT', ''),
('MESH_200', 'radiation toxicity', '', 'Y', '', ''),
('MESH_201', 'chemotherapeutic agent toxicity', '', 'Y', '', ''),
('MESH_202', 'xerostomia', '', 'Y', '', ''),
('MESH_203', 'stage II squamous cell carcinoma of the hypopharynx', 'stage II', '', 'Neoplasms', ''),
('MESH_204', 'stage II squamous cell carcinoma of the larynx', 'stage II', '', 'Neoplasms', ''),
('MESH_205', 'stage II squamous cell carcinoma of the paranasal sinus and nasal cavity', 'stage II', '', 'Neoplasms', ''),
('MESH_206', 'untreated metastatic squamous neck cancer with occult primary', '', '', 'Neoplasms', ''),
('MESH_207', 'metastatic squamous neck cancer with occult primary squamous cell carcinoma', '', '', 'Neoplasms', ''),
('MESH_208', 'recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity', '', '', 'Neoplasms', ''),
('MESH_209', 'Hypopharyngeal Neoplasms', '', '', 'Neoplasms', ''),
('MESH_210', 'Nivolumab', '', 'Y', '', ''),
('MESH_211', 'Immune Checkpoint Inhibitors', '', 'Y', '', ''),
('MESH_212', 'Papilloma', '', '', 'Neoplasms', ''),
('MESH_213', 'Carboplatin', '', 'Y', '', ''),
('MESH_214', 'stage III salivary gland cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_215', 'stage IV salivary gland cancer', 'stage IV', '', 'Neoplasms', ''),
('MESH_216', 'recurrent salivary gland cancer', '', '', 'Neoplasms', ''),
('MESH_217', 'salivary gland squamous cell carcinoma', '', '', 'Neoplasms', ''),
('MESH_218', 'salivary gland acinic cell tumor', '', '', '', 'Y'),
('MESH_219', 'low-grade salivary gland mucoepidermoid carcinoma', '', '', 'Neoplasms', ''),
('MESH_220', 'high-grade salivary gland mucoepidermoid carcinoma', '', '', 'Neoplasms', ''),
('MESH_221', 'salivary gland adenocarcinoma', '', '', 'Neoplasms', ''),
('MESH_222', 'salivary gland poorly differentiated carcinoma', '', '', 'Neoplasms', ''),
('MESH_223', 'salivary gland malignant mixed cell type tumor', '', '', '', 'Y'),
('MESH_224', 'salivary gland adenoid cystic carcinoma', '', '', 'Neoplasms', ''),
('MESH_225', 'salivary gland anaplastic carcinoma', '', '', 'Neoplasms', ''),
('MESH_226', 'squamous cell carcinoma of the esophagus', '', '', 'Neoplasms', ''),
('MESH_227', 'adenocarcinoma of the esophagus', '', '', 'Neoplasms', ''),
('MESH_228', 'stage II esophageal cancer', 'stage II', '', 'Neoplasms', ''),
('MESH_229', 'stage III esophageal cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_230', 'stage IV esophageal cancer', 'stage IV', '', 'Neoplasms', ''),
('MESH_231', 'recurrent esophageal cancer', '', '', 'Neoplasms', ''),
('MESH_232', 'recurrent gastric cancer', '', '', 'Neoplasms', ''),
('MESH_233', 'adenocarcinoma of the stomach', '', '', 'Neoplasms', ''),
('MESH_234', 'stage IV gastric cancer', 'stage IV', '', 'Neoplasms', ''),
('MESH_235', 'stage III gastric cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_236', 'Irinotecan', '', 'Y', '', ''),
('MESH_237', 'Topoisomerase I Inhibitors', '', 'Y', '', ''),
('MESH_238', 'stage II gastric cancer', 'stage II', '', 'Neoplasms', ''),
('MESH_239', 'stage IIA esophageal cancer', '', '', 'Neoplasms', ''),
('MESH_240', 'stage IIB esophageal cancer', '', '', 'Neoplasms', ''),
('MESH_241', 'stage IIIA esophageal cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_242', 'stage IIIB esophageal cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_243', 'stage IIIC esophageal cancer', 'stage III', '', 'Neoplasms', ''),
('MESH_244', 'Head and neck cancer', '', '', 'Neoplasms', ''),
('MESH_245', 'Oropharyngeal cancer', '', '', 'Neoplasms', ''),
('MESH_246', 'postoperative', '', '', '', ''),
('MESH_247', 'radiotherapy', '', 'Y', '', ''),
('MESH_248', 'radiochemotherapy', '', 'Y', '', ''),
('MESH_249', 'de-intensification', '', '', '', ''),
('MESH_250', 'HPV', '', '', 'Hepatic', ''),
('MESH_252', 'Hypoxia', '', '', '', ''),
('MESH_253', 'Signs and Symptoms, Respiratory', '', '', '', ''),
('MESH_254', 'Nimorazole', '', 'Y', '', ''),
('MESH_255', 'Antitrichomonal Agents', '', 'Y', '', ''),
('MESH_256', 'Antiprotozoal Agents', '', 'Y', '', ''),
('MESH_257', 'Antiparasitic Agents', '', 'Y', '', ''),
('MESH_258', 'Oropharyngeal Neoplasms', '', '', 'Neoplasms', '');

-- --------------------------------------------------------

--
-- Table structure for table `PUBLICATION`
--

DROP TABLE IF EXISTS `PUBLICATION`;
CREATE TABLE IF NOT EXISTS `PUBLICATION` (
  `PUB_ID` varchar(7) NOT NULL,
  `PUBLICATION` varchar(519) DEFAULT NULL,
  `PUB_AUTHORS` varchar(513) DEFAULT NULL,
  `PUB_TITLE` varchar(216) DEFAULT NULL,
  `PUB_JOURNAL` varchar(58) DEFAULT NULL,
  `PUB_CITE` varchar(549) DEFAULT NULL,
  `PUB_PMID` varchar(8) DEFAULT NULL,
  `PUB_JRNL_ISSN` varchar(13) DEFAULT NULL,
  PRIMARY KEY (`PUB_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `PUBLICATION`:
--

--
-- Dumping data for table `PUBLICATION`
--

INSERT INTO `PUBLICATION` (`PUB_ID`, `PUBLICATION`, `PUB_AUTHORS`, `PUB_TITLE`, `PUB_JOURNAL`, `PUB_CITE`, `PUB_PMID`, `PUB_JRNL_ISSN`) VALUES
('PUB_001', 'Kandioler D et al. p53 adapted neoadjuvant therapy for esophageal cancer: pilot study. JCO, vol 25, 18S: 206s', 'D. Kandioler , M. Hejna , R. Zwrtek , S. Kappel , C. Bichler , F. WrbaA. Ba-Ssalamah , C. Zielinski , R. Jakesz , J. Zacherl , p Research Group Study', 'p53 adapted neoadjuvant therapy for esophageal cancer: Pilot study', 'Journal of Clinical Oncology', 'DOI: 10.1200/jco.2007.25.18_suppl.4535 Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007) 4535-4535.', '', '1527-7755'),
('PUB_002', 'Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med. 2001 Dec 27;345(26):1890-900. Review. Erratum in: N Engl J Med 2002 Mar 7;346(10):788', 'A Forastiere , W Koch, A Trotti, D Sidransky', 'Head and neck cancer', 'The New England Journal of Medicine', 'Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med. 2001 Dec 27;345(26):1890-900. doi: 10.1056/NEJMra001375. Erratum in: N Engl J Med 2002 Mar 7;346(10):788. PMID: 11756581.', '11756581', '0028-4793'),
('PUB_003', 'Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, Schuller DE, Forastiere AA. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003 Jan 1;21(1):92-8. doi: 10.1200/JCO.2003.01.008. PMID: 12506176', 'Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, Schuller DE, Forastiere AA', 'An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer', '\nJournal of Clinical Oncology\nJournal of Clinical Oncology', 'Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, Schuller DE, Forastiere AA. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003 Jan 1;21(1):92-8. doi: 10.1200/JCO.2003.01.008. PMID: 12506176.', '12506176', '1527-7755'),
('PUB_004', 'Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006 Feb 9;354(6):567-78', 'James A Bonner , Paul M Harari, Jordi Giralt, Nozar Azarnia, Dong M Shin, Roger B Cohen, Christopher U Jones, Ranjan Sur, David Raben, Jacek Jassem, Roger Ove, Merrill S Kies, Jose Baselga, Hagop Youssoufian, Nadia Amellal, Eric K Rowinsky, K Kian Ang', 'Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck', 'The New England Journal of Medicine', 'Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006 Feb 9;354(6):567-78. doi: 10.1056/NEJMoa053422. PMID: 16467544.', '16467544', '0028-4793'),
('PUB_005', 'Merlano M. Alternating chemotherapy and radiotherapy in locally advanced head and neck cancer: an alternative? Oncologist. 2006 Feb;11(2):146-51. Review', 'Marco Merlano', 'Alternating chemotherapy and radiotherapy in locally advanced head and neck cancer: an alternative?', 'Oncologist', 'Merlano M. Alternating chemotherapy and radiotherapy in locally advanced head and neck cancer: an alternative? Oncologist. 2006 Feb;11(2):146-51. doi: 10.1634/theoncologist.11-2-146. PMID: 16476835.', '16476835', '1083-7159'),
('PUB_006', 'Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM Jr, Haddad RI; TAX 324 Study Group. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007 Oct 25;357(17):1705-15. doi: 10.1056/NEJMoa070956. PMID: 17960013', 'Marshall R Posner , Diane M Hershock, Cesar R Blajman, Elizabeth Mickiewicz, Eric Winquist, Vera Gorbounova, Sergei Tjulandin, Dong M Shin, Kevin Cullen, Thomas J Ervin, Barbara A Murphy, Luis E Raez, Roger B Cohen, Monica Spaulding, Roy B Tishler, Berta Roth, Rosana del Carmen Viroglio, Varagur Venkatesan, Ilya Romanov, Sanjiv Agarwala, K William Harter, Matthew Dugan, Anthony Cmelak, Arnold M Markoe, Paul W Read, Lynn Steinbrenner, A Dimitrios Colevas, Charles M Norris Jr, Robert I Haddad, TAX  Study Group', 'Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer', 'The New England Journal of Medicine', 'Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM Jr, Haddad RI; TAX 324 Study Group. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007 Oct 25;357(17):1705-15. doi: 10.1056/NEJMoa070956. PMID: 17960013.', '17960013', '0028-4793'),
('PUB_007', 'Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL; EORTC 24971/TAX 323 Study Group. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007 Oct 25;357(17):1695-704. doi: 10.1056/NEJMoa071028. PMID: 17960012', 'Jan B Vermorken , Eva Remenar, Carla van Herpen, Thierry Gorlia, Ricard Mesia, Marian Degardin, John S Stewart, Svetislav Jelic, Jan Betka, Joachim H Preiss, Danielle van den Weyngaert, Ahmad Awada, Didier Cupissol, Heinz R Kienzer, Augustin Rey, Isabelle Desaunois, Jacques Bernier, Jean-Louis Lefebvre, EORTC /TAX  Study Group', 'Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer', 'The New England Journal of Medicine', 'Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL; EORTC 24971/TAX 323 Study Group. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007 Oct 25;357(17):1695-704. doi: 10.1056/NEJMoa071028. PMID: 17960012.', '17960012', '0028-4793'),
('PUB_008', 'Lo Nigro C, Maffi M, Fischel JL, Monteverde M, Catarsi P, Tonissi F, Lattanzio L, Riba M, Etienne-Grimaldi MC, Formento P, Milano G, Merlano M. Impact of erythropoietin on the effects of irradiation under hypoxia. J Cancer Res Clin Oncol. 2009 Nov;135(11):1615-23. doi: 10.1007/s00432-009-0609-1. Epub 2009 Jun 5. PMID: 19499245', 'Cristiana Lo Nigro , Monica Maffi, Jean Louis Fischel, Martino Monteverde, Paolo Catarsi, Federica Tonissi, Laura Lattanzio, Michela Riba, Marie-Christine Etienne-Grimaldi, Patricia Formento, Gerard Milano, Marco Merlano', 'Impact of erythropoietin on the effects of irradiation under hypoxia', 'The New England Journal of Medicine', 'Lo Nigro C, Maffi M, Fischel JL, Monteverde M, Catarsi P, Tonissi F, Lattanzio L, Riba M, Etienne-Grimaldi MC, Formento P, Milano G, Merlano M. Impact of erythropoietin on the effects of irradiation under hypoxia. J Cancer Res Clin Oncol. 2009 Nov;135(11):1615-23. doi: 10.1007/s00432-009-0609-1. Epub 2009 Jun 5. PMID: 19499245', '19499245', '0028-4793'),
('PUB_009', 'Merlano M, Marchetti G. Radiochemotherapy in head and neck cancer. Cancer Treat Rev. 2003 Aug;29(4):291-6', 'Marco Merlano , Giuseppe Marchetti', 'Radiochemotherapy in head and neck cancer', 'Cancer Treatment Reviews', 'Merlano M, Marchetti G. Radiochemotherapy in head and neck cancer. Cancer Treat Rev. 2003 Aug;29(4):291-6. doi: 10.1016/s0305-7372(03)00022-7. PMID: 12927569', '12927569', '0305-7372'),
('PUB_010', 'Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, Norris CM, Lake-Willcutt B, Case MA, Costello R, Posner M. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience. Cancer. 2003 Jan 15;97(2):412-8', 'Robert Haddad , A Dimitrios Colevas, Roy Tishler, Paul Busse, Laura Goguen, Christopher Sullivan, Charles M Norris, Bernadette Lake-Willcutt, Mary Ann Case, Rosemary Costello, Marshall Posner', 'Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience', 'Cancer', 'Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, Norris CM, Lake-Willcutt B, Case MA, Costello R, Posner M. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience. Cancer. 2003 Jan 15;97(2):412-8. doi: 10.1002/cncr.11063. PMID: 12518365.', '12518365', '1528-9117'),
('PUB_011', 'Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, Youssoufian H, Rowinsky EK, Ang KK. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2010 Jan;11(1):21-8. doi: 10.1016/S1470-2045(09)70311-0. Epub 2009 Nov 10. Erratum in: Lancet Oncol. 2010 Jan;11(1):14', 'James A Bonner , Paul M Harari, Jordi Giralt, Roger B Cohen, Christopher U Jones, Ranjan K Sur, David Raben, Jose Baselga, Sharon A Spencer, Junming Zhu, Hagop Youssoufian, Eric K Rowinsky, K Kian Ang', 'Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival', 'Lancet Oncology', 'Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, Youssoufian H, Rowinsky EK, Ang KK. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2010 Jan;11(1):21-8. doi: 10.1016/S1470-2045(09)70311-0. Epub 2009 Nov 10. Erratum in: Lancet Oncol. 2010 Jan;11(1):14. PMID: 19897418.', '19897418', '1470-2045'),
('PUB_012', 'Park SY, Na SJ, Kumar M, Mosci C, Wardak M, Koglin N, Bullich S, Mueller A, Berndt M, Stephens AW, Cho YM, Ahn H, Chae SY, Kim HO, Moon DH, Gambhir SS, Mittra ES. Clinical Evaluation of (4S)-4-(3-[(18)F]Fluoropropyl)-L-glutamate ((18)F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer. Clin Cancer Res. 2020 Oct 15;26(20):5380-5387. doi: 10.1158/1078-0432.CCR-20-0644. Epub 2020 Jul 21.', 'Sonya Youngju Park #  , Sae Jung Na #  , Meena Kumar , Camila Mosci , Mirwais Wardak , Norman Koglin , Santiago Bullich , Andre Mueller , Mathias Berndt , Andrew W Stephens , Yong Mee Cho , Hanjong Ahn , Sun Young Chae , Hye Ok Kim  , Dae Hyuk Moon , Sanjiv S Gambhir  , Erik S Mittra  ', 'Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-glutamate (18F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer', 'Clinical Cancer Research', 'Park SY, Na SJ, Kumar M, Mosci C, Wardak M, Koglin N, Bullich S, Mueller A, Berndt M, Stephens AW, Cho YM, Ahn H, Chae SY, Kim HO, Moon DH, Gambhir SS, Mittra ES. Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-glutamate (18F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer. Clin Cancer Res. 2020 Oct 15;26(20):5380-5387. doi: 10.1158/1078-0432.CCR-20-0644. Epub 2020 Jul 21. PMID: 32694158.', '32694158', '1557-3265'),
('PUB_013', 'Ramanathan RK, McDonough SL, Kennecke HF, Iqbal S, Baranda JC, Seery TE, Lim HJ, Hezel AF, Vaccaro GM, Blanke CD. Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005). Cancer. 2015 Jul 1;121(13):2193-7. doi: 10.1002/cncr.29363. Epub 2015 Mar 30.', 'Ramesh K Ramanathan  , Shannon L McDonough , Hagen F Kennecke , Syma Iqbal , Joaquina C Baranda , Tara E Seery , Howard J Lim , Aram F Hezel , Gina M Vaccaro , Charles D Blanke  ', 'Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)', 'Cancer', 'Ramanathan RK, McDonough SL, Kennecke HF, Iqbal S, Baranda JC, Seery TE, Lim HJ, Hezel AF, Vaccaro GM, Blanke CD. Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005). Cancer. 2015 Jul 1;121(13):2193-7. doi: 10.1002/cncr.29363. Epub 2015 Mar 30. PMID: 25827820; PMCID: PMC4589423.', '25827820', '1528-9117'),
('PUB_014', 'Lee HS, Lee JM, Kim MS, Kim HY, Hwangbo B, Zo JI. Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome. Ann Thorac Surg. 2005 Feb;79(2):405-10.', 'Hyun-Sung Lee , Jong Mog Lee, Moon Soo Kim, Hyae Young Kim, Bin Hwangbo, Jae Ill Zo', 'Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome', 'The Annals of Thoracic Surgery', 'Lee HS, Lee JM, Kim MS, Kim HY, Hwangbo B, Zo JI. Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome. Ann Thorac Surg. 2005 Feb;79(2):405-10. doi: 10.1016/j.athoracsur.2004.07.079. PMID: 15680804', '15680804', '0003-4975'),
('PUB_015', 'Annane D, Sébille V, Bellissant E; Ger-Inf-05 Study Group. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med. 2006 Jan;34(1):22-30.', 'Djillali Annane , Véronique Sébille, Eric Bellissant, Ger-Inf- Study Group', 'Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome', '\nCritical Care Medicine', 'Annane D, Sébille V, Bellissant E; Ger-Inf-05 Study Group. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med. 2006 Jan;34(1):22-30. doi: 10.1097/01.ccm.0000194723.78632.62. PMID: 16374152', '16374152', '1530-0293'),
('PUB_016', 'Haddad R, Sonis S, Posner M, Wirth L, Costello R, Braschayko P, Allen A, Mahadevan A, Flynn J, Burke E, Li Y, Tishler RB. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer. Cancer. 2009 Oct 1;115(19):4514-23. doi: 10.1002/cncr.24525.', 'Robert Haddad , Stephen Sonis, Marshall Posner, Lori Wirth, Rosemary Costello, Patricia Braschayko, Aaron Allen, Anand Mahadevan, Jayme Flynn, Elaine Burke, Yi Li, Roy B Tishler', 'Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer', 'Cancer', 'Haddad R, Sonis S, Posner M, Wirth L, Costello R, Braschayko P, Allen A, Mahadevan A, Flynn J, Burke E, Li Y, Tishler RB. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer. Cancer. 2009 Oct 1;115(19):4514-23. doi: 10.1002/cncr.24525. PMID: 19634161', '19634161', '1528-9117'),
('PUB_017', 'Haddad R, O\'Neill A, Rabinowits G, Tishler R, Khuri F, Adkins D, Clark J, Sarlis N, Lorch J, Beitler JJ, Limaye S, Riley S, Posner M. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol. 2013 Mar;14(3):257-64. doi: 10.1016/S1470-2045(13)70011-1. Epub 2013 Feb 13.', 'Robert Haddad , Anne O\'Neill, Guilherme Rabinowits, Roy Tishler, Fadlo Khuri, Douglas Adkins, Joseph Clark, Nicholas Sarlis, Jochen Lorch, Jonathan J Beitler, Sewanti Limaye, Sarah Riley, Marshall Posner', 'Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial', 'Lancet Oncology', 'Haddad R, O\'Neill A, Rabinowits G, Tishler R, Khuri F, Adkins D, Clark J, Sarlis N, Lorch J, Beitler JJ, Limaye S, Riley S, Posner M. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol. 2013 Mar;14(3):257-64. doi: 10.1016/S1470-2045(13)70011-1. Epub 2013 Feb 13. PMID: 23414589', '23414589', '1470-2045'),
('PUB_018', 'Bains MS, Stojadinovic A, Minsky B, Rusch V, Turnbull A, Korst R, Ginsberg R, Kelsen DP, Ilson DH. A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results. J Thorac Cardiovasc Surg. 2002 Aug;124(2):270-7.', 'Manjit S Bains , Alexander Stojadinovic, Bruce Minsky, Valerie Rusch, Alan Turnbull, Robert Korst, Robert Ginsberg, David P Kelsen, David H Ilson', 'A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results', 'The Journal of Thoracic and Cardiovascular Surgery', 'Bains MS, Stojadinovic A, Minsky B, Rusch V, Turnbull A, Korst R, Ginsberg R, Kelsen DP, Ilson DH. A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results. J Thorac Cardiovasc Surg. 2002 Aug;124(2):270-7. doi: 10.1067/mtc.2002.122545. PMID: 12167786', '12167786', '0022-5223'),
('PUB_019', 'Enzinger E, Ilson D, Minsky B, et al.: Phase I/II neoadjuvant concurrent 96 hour taxol, cisplatin, and radiation therapy: promising toxicity profile and response in localized esophageal cancer. [Abstract] Proceedings of the American Society of Clinical Oncology 18: A1038, 1999', 'Enzinger E, Ilson D, Minsky B, et al.', 'Phase I/II neoadjuvant concurrent 96 hour taxol, cisplatin, and radiation therapy: promising toxicity profile and response in localized esophageal cancer.', 'Proceedings of the American Society of Clinical Oncology', 'Enzinger E, Ilson D, Minsky B, et al.: Phase I/II neoadjuvant concurrent 96 hour taxol, cisplatin, and radiation therapy: promising toxicity profile and response in localized esophageal cancer. [Abstract] Proceedings of the American Society of Clinical Oncology 18: A1038, 1999', '', ''),
('PUB_020', 'Ilson DH, Bains M, Kelsen DP, O\'Reilly E, Karpeh M, Coit D, Rusch V, Gonen M, Wilson K, Minsky BD. Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. J Clin Oncol. 2003 Aug 1;21(15):2926-32.', 'David H. Ilson , Manjit Bains , David P. Kelsen , Eileen O’Reilly , Martin Karpeh , Daniel CoitValerie Rusch , Mithat Gonen , Katie Wilson , Bruce D. Minsky', 'Phase I Trial of Escalating-Dose Irinotecan Given Weekly With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Cancer', '\nJournal of Clinical Oncology', 'Ilson DH, Bains M, Kelsen DP, O\'Reilly E, Karpeh M, Coit D, Rusch V, Gonen M, Wilson K, Minsky BD. Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. J Clin Oncol. 2003 Aug 1;21(15):2926-32. doi: 10.1200/JCO.2003.02.147. PMID: 12885811', '12885811', '1527-7755'),
('PUB_021', 'Suntharalingam M, Winter K, Ilson D, Dicker AP, Kachnic L, Konski A, Chakravarthy AB, Anker CJ, Thakrar H, Horiba N, Dubey A, Greenberger JS, Raben A, Giguere J, Roof K, Videtic G, Pollock J, Safran H, Crane CH. Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2017 Nov 1;3(11):1520-1528. doi: 10.1001/jamaoncol.2017.1598. Erratum in: JAMA Oncol. 2017 Nov 1;3(11):1589.', 'Mohan Suntharalingam , Kathryn Winter , David Ilson , Adam P Dicker , Lisa Kachnic , André Konski , A Bapsi Chakravarthy , Christopher J Anker , Harish Thakrar , Naomi Horiba  , Ajay Dubey , Joel S Greenberger , Adam Raben , Jeffrey Giguere , Kevin Roof , Gregory Videtic , Jondavid Pollock , Howard Safran , Christopher H Crane  ', 'Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial', '\nJAMA Oncology', 'Suntharalingam M, Winter K, Ilson D, Dicker AP, Kachnic L, Konski A, Chakravarthy AB, Anker CJ, Thakrar H, Horiba N, Dubey A, Greenberger JS, Raben A, Giguere J, Roof K, Videtic G, Pollock J, Safran H, Crane CH. Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2017 Nov 1;3(11):1520-1528. doi: 10.1001/jamaoncol.2017.1598. Erratum in: JAMA Oncol. 2017 Nov 1;3(11):1589. PMID: 28687830; PMCID: PMC5710193', '28687830', '2374-2445'),
('PUB_022', 'Owadally W, Hurt C, Timmins H, Parsons E, Townsend S, Patterson J, Hutcheson K, Powell N, Beasley M, Palaniappan N, Robinson M, Jones TM, Evans M. PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer. 2015 Aug 27;15:602. doi: 10.1186/s12885-015-1598-x.', 'Waheeda Owadally , Chris Hurt , Hayley Timmins , Emma Parsons , Sarah Townsend , Joanne Patterson , Katherine Hutcheson , Ned Powell , Matthew Beasley , Nachi Palaniappan , Max Robinson , Terence M Jones , Mererid Evans ', 'PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer', 'BMC Cancer', 'Owadally W, Hurt C, Timmins H, Parsons E, Townsend S, Patterson J, Hutcheson K, Powell N, Beasley M, Palaniappan N, Robinson M, Jones TM, Evans M. PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer. 2015 Aug 27;15:602. doi: 10.1186/s12885-015-1598-x. PMID: 26311526; PMCID: PMC4549836', '26311526', '1471-2407'),
('PUB_023', 'Mittra ES, Koglin N, Mosci C, Kumar M, Hoehne A, Keu KV, Iagaru AH, Mueller A, Berndt M, Bullich S, Friebe M, Schmitt-Willich H, Gekeler V, Fels LM, Bacher-Stier C, Moon DH, Chin FT, Stephens AW, Dinkelborg LM, Gambhir SS. Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies. PLoS One. 2016 Feb 18;11(2):e0148628. doi: 10.1371/journal.pone.0148628. eCollection 2016.', 'Erik S Mittra , Norman Koglin , Camila Mosci , Meena Kumar , Aileen Hoehne , Khun Visith Keu , Andrei H Iagaru , Andre Mueller , Mathias Berndt , Santiago Bullich , Matthias Friebe , Heribert Schmitt-Willich , Volker Gekeler , Lüder M Fels , Claudia Bacher-Stier , Dae Hyuk Moon , Frederick T Chin , Andrew W Stephens , Ludger M Dinkelborg , Sanjiv S Gambhir  ', 'Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies', 'PLoS One', 'Mittra ES, Koglin N, Mosci C, Kumar M, Hoehne A, Keu KV, Iagaru AH, Mueller A, Berndt M, Bullich S, Friebe M, Schmitt-Willich H, Gekeler V, Fels LM, Bacher-Stier C, Moon DH, Chin FT, Stephens AW, Dinkelborg LM, Gambhir SS. Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies. PLoS One. 2016 Feb 18;11(2):e0148628. doi: 10.1371/journal.pone.0148628. PMID: 26890637; PMCID: PMC4758607', '26890637', '1932-6203');

-- --------------------------------------------------------

--
-- Table structure for table `SITES`
--

DROP TABLE IF EXISTS `SITES`;
CREATE TABLE IF NOT EXISTS `SITES` (
  `SITE_ID` varchar(9) NOT NULL,
  `SITE_NAME` varchar(125) DEFAULT NULL,
  `SITE_CITY` varchar(18) DEFAULT NULL,
  `SITE_STATE` varchar(18) DEFAULT NULL,
  `SITE_COUNTRY` varchar(17) DEFAULT NULL,
  `SITE_ZIPCODE` varchar(12) DEFAULT NULL,
  PRIMARY KEY (`SITE_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `SITES`:
--

--
-- Dumping data for table `SITES`
--

INSERT INTO `SITES` (`SITE_ID`, `SITE_NAME`, `SITE_CITY`, `SITE_STATE`, `SITE_COUNTRY`, `SITE_ZIPCODE`) VALUES
('SITE_01', 'A.O. Universitaria S. Giovanni Battista-Molinette Di Torino', 'Turin', '', 'Italy', ''),
('SITE_02', 'A.S.O. S. Croce E Carle', 'Cuneo', '', 'Italy', '12100'),
('SITE_03', 'Aarhus University Hospital (AUH)', 'Aarhus', '', 'Denmark', '8000'),
('SITE_04', 'Academisch Ziekenhuis Groningen (UMCG)', 'Groningen', '', 'Netherlands', ''),
('SITE_05', 'Advent Health', 'Orlando', 'Florida', 'United States', '32803'),
('SITE_06', 'Albert Einstein Cancer Center at Albert Einstein College of Medicine', 'Bronx', 'New York', 'United States', '10461'),
('SITE_07', 'Albert-Ludwigs-Universität Freiburg', 'Freiburg', 'Baden-Wuerttemberg', 'Germany', '79106'),
('SITE_08', 'Arcispedale S. Maria Nuova', 'Reggio Emilia', '', 'Italy', ''),
('SITE_09', 'Arizona Oncology - Tucson', 'Tucson', 'Arizona', 'United States', '85704'),
('SITE_10', 'Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center', 'Columbus', 'Ohio', 'United States', ' 43210-1240'),
('SITE_100', 'Hays Medical Center', 'Hays', 'Kansas', 'United States', '67601'),
('SITE_101', 'Heidelberg University Medical School', 'Heidelberg', 'Baden-Wuerttemberg', 'Germany', '69120'),
('SITE_102', 'Hematology/Oncology Associates', 'Port Saint Lucie', 'Florida', 'United States', '34952'),
('SITE_103', 'Holden Comprehensive Cancer Center at University of Iowa', 'Iowa City', 'Iowa', 'United States', ' 52242-1002'),
('SITE_104', 'Hopital Bretonneau Clinique d\'Oncologie et Radiothérapie', 'Tours', '', 'France', ''),
('SITE_105', 'Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet', 'Brussels', '', 'Belgium', '1000'),
('SITE_106', 'Hôpitaux universitaires de Genève - HUG - site de Cluse-Roseraie', 'Geneva', '', 'Switzerland', '1211'),
('SITE_107', 'Howard Community Hospital', 'Kokomo', 'Indiana', 'United States', '46904'),
('SITE_108', 'HPV Research Group Section of Pathology Cardiff University ', 'Cardiff', '', 'United Kingdom', ' CF14 4XN'),
('SITE_109', 'Hudner Oncology Center at Saint Anne\'s Hospital - Fall River', 'Fall River', 'Massachusetts', 'United States', '2721'),
('SITE_11', 'Asl 3 Genovese', 'Genova', '', 'Italy', ''),
('SITE_110', 'Hurley Medical Center', 'Flint', 'Michigan', 'United States', '48502'),
('SITE_111', 'Hutchinson Regional Medical Center', 'Hutchinson', 'Kansas', 'United States', '67502'),
('SITE_112', 'ICRF Medical Oncology Unit', 'Oxford', 'Oxfordshire', 'United Kingdom', ' OX3 7LJ'),
('SITE_113', 'Institut Curie', 'Paris', '', 'France', ''),
('SITE_114', 'Institut Gustave Roussy', 'Villejuif', '', 'France', '94805'),
('SITE_115', 'Irccs - Aou S. Martino - Oncology', 'Genoa', '', 'Italy', ''),
('SITE_116', 'Irccs - Aou San Martino - Radiotherapy', 'Genoa', '', 'Italy', ''),
('SITE_117', 'Irccs Centro Di Riferimento Oncologico Di Basilicata (Crob)', 'Rionero in Vulture', '', 'Italy', ''),
('SITE_118', 'Istituto Nazionale Dei Tumori', 'Milano', '', 'Italy', ''),
('SITE_119', 'James Graham Brown Cancer Center at University of Louisville', 'Louisville', 'Kentucky', 'United States', '40202'),
('SITE_12', 'Asl 8 - Ospedale Businco', 'Cagliari', '', 'Italy', ''),
('SITE_120', 'John B. Amos Cancer Center', 'Columbus', 'Georgia', 'United States', '31904'),
('SITE_121', 'Johns Hopkins Singapore International Medical Center', 'Singapore', '', 'Singapore', '308433'),
('SITE_122', 'Kaiser Franz Josef Spital', 'Vienna', '', 'Austria', '1100'),
('SITE_123', 'Kansas City Cancer Center-Shawnee Mission', 'Shawnee Mission', 'Kansas', 'United States', '66204'),
('SITE_124', 'Kansas City Cancer Centers-Southwest', 'Overland Park', 'Kansas', 'United States', '66210'),
('SITE_125', 'Kapiolani Medical Center for Women and Children', 'Honolulu', 'Hawaii', 'United States', '96826'),
('SITE_126', 'Karol-Marcinkowski Medical University of Poznan', 'Poznań', '', 'Poland', ' 61-866'),
('SITE_127', 'Klinikum der J.W. Goethe Universitaet', 'Frankfurt', '', 'Germany', ' D-60590'),
('SITE_128', 'Krankenhaus der Barmherzigen Brüder', 'Stankt Veit', '', 'Austria', '9300'),
('SITE_129', 'Krankenhaus der Elisabethinen', 'Linz', '', 'Austria', '4020'),
('SITE_13', 'Associates In Womens Health', 'Wichita', 'Kansas', 'United States', '67208'),
('SITE_130', 'Kuakini Medical Center', 'Honolulu', 'Hawaii', 'United States', '96817'),
('SITE_131', 'Lahey Clinic', 'Burlington', 'Massachusetts', 'United States', '1805'),
('SITE_132', 'Lakeland Regional Cancer Care Center - St. Joseph', 'Saint Joseph', 'Michigan', 'United States', '49085'),
('SITE_133', 'Lakes Region General Hospital', 'Laconia', 'New Hampshire', 'United States', '3246'),
('SITE_134', 'Landesklinikum Feldkirch', 'Feldkirch', 'Vorarlberg', 'Austria', ''),
('SITE_135', 'Landesklinikum St. Pölten	', 'St. Polten', 'Lower Austria', 'Austria', '3100'),
('SITE_136', 'Landesklinikum Wiener Neustadt', 'Wiener Neustadt', 'Lower Austria', 'Austria', '2700'),
('SITE_137', 'Landeskrankenhaus Leoben', 'Leoben', '', 'Austria', '8790'),
('SITE_138', 'Lawrence Memorial Hospital', 'Lawrence', 'Kansas', 'United States', '66044'),
('SITE_139', 'Liverpool Head and Neck Centre', 'Liverpool', '', 'United Kingdom', ' L3 9TA'),
('SITE_14', 'Ausl Della Valle D\' Aosta', 'Aosta', '', 'Italy', ''),
('SITE_140', 'Lourdes Regional Cancer Center', 'Binghamton', 'NewYork', 'United States', '13905'),
('SITE_141', 'Lowell General Hospital', 'Lowell', 'Massachusetts', 'United States', '1854'),
('SITE_142', 'Lower Silesian Oncology Centre', 'Wrocław', '', 'Poland', ''),
('SITE_143', 'Loyola University Medical Center', 'Maywood', 'Illinois', 'United States', '60153'),
('SITE_144', 'Loyola University Medical Center/Cardinal Bernadin Cancer Center', 'Maywood', 'Illinois', 'United States', '60153'),
('SITE_145', 'Ludwig-Maximilians-Universitaet Muenchen - Klinikum der Universitaet Muenchen - Campus Grosshadern', 'Muenchen', '', 'Germany', '81377'),
('SITE_146', 'Ludwig-Maximilian-Universität  Klinikum Großhadern', 'München', '', 'Germany', '81377'),
('SITE_147', 'Lund University Hospital', 'Lund', '', 'Sweden', ''),
('SITE_148', 'Maine Center for Cancer Medicine and Blood Disorders - Scarborough', 'Scarborough', 'Maine', 'United States', '4074'),
('SITE_149', 'Maria Sklodowska-Curie Memorial Cancer Centre', 'Warsaw', '', 'Poland', ''),
('SITE_15', 'Azienda Ospedaliera Ospedali Riuniti Di Fano', 'Pesaro', '', 'Italy', ''),
('SITE_150', 'Mary Bird Perkins Cancer Center - Baton Rouge', 'Baton Rouge', 'Louisiana', 'United States', '70809'),
('SITE_151', 'Mass General/North Shore Cancer Center', 'Danvers', 'Massachusetts', 'United States', '1923'),
('SITE_152', 'Massachusetts General Hospital Cancer Center', 'Boston', 'Massachusetts', 'United States', '2114'),
('SITE_153', 'McFarland Clinic PC', 'Ames', 'Iowa', 'United States', '50010'),
('SITE_154', 'McGill Cancer Centre at McGill University', 'Montreal', 'Quebec', 'Canada', ' H2W 1S6'),
('SITE_155', 'MD Anderson Cancer Centre', 'Houston', 'Texas', 'United States', '77030'),
('SITE_156', 'Mechthild Krause', 'Dresden', 'Saxony', 'Germany', '1307'),
('SITE_157', 'Medical University Innsbruck', 'Innsbruck', 'Tirol', 'Austria', ''),
('SITE_158', 'Medical University Of Gdansk', 'Gdansk', '', 'Poland', ' 80 211'),
('SITE_159', 'Medical University of Vienna', 'Vienna', '', 'Austria', '1090'),
('SITE_16', 'Azienda Ospedaliera Villa Scassi - Asl3', 'Genova', '', 'Italy', ''),
('SITE_160', 'Medical University of Vienna -  Vienna General Hospital (AKH)', 'Vienna', '', 'Austria', '1090'),
('SITE_161', 'Medizinische Hochschule Hannover', 'Hannover', '', 'Germany', '30625'),
('SITE_162', 'Memorial Hospital of South Bend', 'South Bend', 'Indiana', 'United States', '46601'),
('SITE_163', 'Memorial Sloan Kettering Cancer Center', 'New York', 'New York', 'United States', '10021'),
('SITE_164', 'Memorial University Medical Center', 'Savannah', 'Georgia', 'United States', '31404'),
('SITE_165', 'Mercy Health Saint Mary\'s ', 'Grand Rapids', 'Michigan', 'United States', '49503'),
('SITE_166', 'MeritCare Bemidji', 'Bemidji', 'Minnesota', 'United States', '56601'),
('SITE_167', 'Methodist Estabrook Cancer Center', 'Omaha', 'Nebraska', 'United States', '68114'),
('SITE_168', 'Metro South Health', 'Brisbane', '', 'Australia', ' QLD 4113'),
('SITE_169', 'Michiana Hematology-Oncology  PC - South Bend', 'South Bend', 'Indiana', 'United States', '46601'),
('SITE_17', 'Azienda Ospedaliero Universitaria Di Modena', 'Modena', '', 'Italy', ''),
('SITE_170', 'Michigan Cancer Research Consortium CCOP', 'Ann Arbor', 'Michigan', 'United States', '48106'),
('SITE_171', 'Mountainview Medical', 'Berlin', 'Vermont', 'United States', '5602'),
('SITE_172', 'Nantucket Cottage Hospital', 'Nantucket', 'Massachusetts', 'United States', '2554'),
('SITE_173', 'National Cancer Center', 'Goyang Gyeonggi', '', 'Republic of Korea', ' 411-769'),
('SITE_174', 'National Taiwan University Hospital', 'Taipei', '', 'Taiwan', '100'),
('SITE_175', 'NEA Baptist Memorial Hospital', 'Jonesboro', 'Arkansas', 'United States', '72401'),
('SITE_176', 'New Hampshire Oncology - Hematology -  PA at Payson Center for Cancer Care', 'Concord', 'New Hampshire', 'United States', '3301'),
('SITE_177', 'New Hampshire Oncology - Hematology - PA - Hooksett', 'Hooksett', 'New Hampshire', 'United States', '3106'),
('SITE_178', 'NICCTU East Podium  C-Floor', 'Belfast', '', 'United Kingdom', ' BT9 7AB'),
('SITE_179', 'Nijmegen University Hospital', 'Nijmegen', '', 'Netherlands', ''),
('SITE_18', 'Azienda Ospedaliero-Universitaria Di Parma', 'Parma', '', 'Italy', ''),
('SITE_180', 'Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center', 'Lebanon', 'New Hampshire', 'United States', ' 03756-0002'),
('SITE_181', 'Oakwood Hospital and Medical Center', 'Dearborn', 'Michigan', 'United States', '48124'),
('SITE_182', 'Oncare Hawaii Inc-Kuakini ', 'Honolulu', 'Hawaii', 'United States', '96817'),
('SITE_183', 'Oncare Hawaii Inc-Pali Momi', 'Aiea', 'Hawaii', 'United States', '96701'),
('SITE_184', 'Oncare Hawaii Inc-POB II', 'Honolulu', 'Hawaii', 'United States', '96813'),
('SITE_185', 'OnCare Hawaii-Liliha', 'Honolulu', 'Hawaii', 'United States', ' 96817-3169'),
('SITE_186', 'Oregon Health Sciences Center', 'Portland', 'Oregon', 'United States', '97239'),
('SITE_187', 'Ospedale Civile Ss. Antonio E Biagio', 'Alessandria', '', 'Italy', ''),
('SITE_188', 'Ospedale S. Filippo Neri', 'Roma', '', 'Italy', ''),
('SITE_189', 'Ospedale S. Giacomo', 'Novi Ligure', '', 'Italy', ''),
('SITE_19', 'Azienda Provinciale Per I Servizi Sanitari (APSS)', 'Trento', '', 'Italy', ''),
('SITE_190', 'Ospedale S. Paolo', 'Savona', '', 'Italy', ''),
('SITE_191', 'Ospedale San Bortolo', 'Vicenza', '', 'Italy', '36100'),
('SITE_192', 'Pali Momi Medical Center', 'Aiea', 'Hawaii', 'United States', '96701'),
('SITE_193', 'Paul Scherrer Institute (PSI)', 'Villigen', '', 'Switzerland', ''),
('SITE_194', 'Policlinico S. Orsola-Malpighi', 'Bologna', '', 'Italy', ''),
('SITE_195', 'Poudre Valley Hospital', 'Fort Collins', 'Colorado', 'United States', '80524'),
('SITE_196', 'Princess Alexandra Hospital - University Of Queensland', 'Brisbane', '', 'Australia', ' QLD 4102'),
('SITE_197', 'Providence Hospital', 'Mobile', 'Alabama', 'United States', '36608'),
('SITE_198', 'Queen Elizabeth Hospital', 'Birmingham', '', 'United Kingdom', ' B15 2TH'),
('SITE_199', 'Queen\'s Medical Center', 'Honolulu', 'Hawaii', 'United States', '96813'),
('SITE_20', 'Azienda Sanitaria Ospedaliera Ordine Mauriziano', 'Turin', '', 'Italy', '10128'),
('SITE_200', 'Radboud University Medical Center Nijmegen', 'Nijmegen', '', 'Netherlands', ' 6500 H'),
('SITE_201', 'Rebecca and John Moores UCSD Cancer Center', 'La Jolla', 'California', 'United States', ' 92093-0658'),
('SITE_202', 'Reid Hospital and Health Care Services', 'Richmond', 'Indiana', 'United States', '47374'),
('SITE_203', 'Robert H. Lurie Comprehensive Cancer Center - Northwestern University', 'Chicago', 'Illinois', 'United States', '60611'),
('SITE_204', 'Rocky Mountain Oncology', 'Casper', 'Wyoming', 'United States', '82609'),
('SITE_205', 'Roswell Park Cancer Institute', 'Buffalo', 'New York', 'United States', ' 14263-0001'),
('SITE_206', 'Royal Blackburn Hospital', 'Blackburn', '', 'United Kingdom', ' BB2 3HH'),
('SITE_207', 'Royal Brisbane And Women\'s Hospital', 'Brisbane', '', 'Australia', ' QLD 4029'),
('SITE_208', 'Royal Devon University Health Care NHS Foundation Trust', 'Exeter', '', 'United Kingdom', ''),
('SITE_209', 'Royal Marsden - London', 'London', 'England', 'United Kingdom', ' SW3 6JJ'),
('SITE_21', 'BCCA-Vancouver Cancer Centre', 'Vancouver', 'British Columbia', 'Canada', ' V5Z 4E6'),
('SITE_210', 'Royal North Shore Hospital', 'St Leonards', '', 'Australia', ' NSW 2065'),
('SITE_211', 'Royal Surrey County Hospital', 'Guildford', '', 'United Kingdom', ' GU2 7XX'),
('SITE_212', 'Royal United Hospitals Bath NHS Foundation Trust', 'Bath', '', 'United Kingdom', ' BA1 3NH'),
('SITE_213', 'Rudolfstiftung', 'Vienna', '', 'Austria', '1030'),
('SITE_214', 'Saint Alphonsus Cancer Care Center-Boise', 'Boise', 'Idaho', 'United States', '83706'),
('SITE_215', 'Saint Anne\'s Hospital - Fall River', 'Fall River', 'Massachusetts', 'United States', '2721'),
('SITE_216', 'Saint Francis Hospital and Medical Center', 'Hartford', 'Connecticut', 'United States', '6105'),
('SITE_217', 'Saint Francis Hospital and Medical Center - Topeka', 'Topeka', 'Kansas', 'United States', '66606'),
('SITE_218', 'Saint John Hospital and Medical Center', 'Detroit', 'Michigan', 'United States', '48236'),
('SITE_219', 'Saint John Regional Hospital', 'Saint John', 'NewBrunswick', 'Canada', ' E2L 4L2'),
('SITE_22', 'Beatson Oncology Centre', 'Glasgow', '', 'United Kingdom', ' G11 6NT'),
('SITE_220', 'Saint John\'s Cancer Center at Saint John\'s Medical Center', 'Anderson', 'Indiana', 'United States', '46016'),
('SITE_221', 'Saint Joseph Mercy Cancer Center', 'Ann Arbor', 'Michigan', 'United States', ' 48106-0995'),
('SITE_222', 'Saint Joseph Mercy Hospital', 'Ann Arbor', 'Michigan', 'United States', ' 48106-0995'),
('SITE_223', 'Saint Joseph Regional Medical Center', 'Mishawaka', 'Indiana', 'United States', ' 46545-1470'),
('SITE_224', 'Saint Rose Ambulatory and Surgery Center', 'Great Bend', 'Kansas', 'United States', '67530'),
('SITE_225', 'Salina Regional Health Center', 'Salina', 'Kansas', 'United States', '67401'),
('SITE_226', 'Sanofi-Aventis Administrative Office-Spain', 'Barcelona', '', 'Spain', ''),
('SITE_227', 'Sanofi-Aventis Administrative Office-Hong Kong', 'Hong Kong', '', 'Hong Kong', ''),
('SITE_228', 'Sarah Cannon Research Institute', 'Nashville', 'Tennessee', 'United States', '37203'),
('SITE_229', 'Sinai Hospital of Baltimore', 'Baltimore', 'Maryland', 'United States', '21215'),
('SITE_23', 'Beth Israel Deaconess Medical Center', 'Boston', 'Massachusetts', 'United States', '2215'),
('SITE_230', 'Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis', 'Saint Louis', 'Missouri', 'United States', '63110'),
('SITE_231', 'SMZ OST', 'Vienna', '', 'Austria', ''),
('SITE_232', 'Spectrum Health Big Rapids Hospital', 'Big Rapids', 'Michigan', 'United States', '49307'),
('SITE_233', 'St James University Hospital', 'Leeds', '', 'United Kingdom', ' LS9 7TF'),
('SITE_234', 'Stichting Maastricht Radiation Oncology (MAASTRO)', 'Maastricht', '', 'Netherlands', ''),
('SITE_235', 'St-Luc University Hospital', 'Brussels', '', 'Belgium', ''),
('SITE_236', 'Straub Clinic and Hospital', 'Honolulu', 'Hawaii', 'United States', '96813'),
('SITE_237', 'SUNY Upstate Medical University Hospital', 'Syracuse', 'New York', 'United States', '13210'),
('SITE_238', 'Technische Universität Dresden (TUD)', 'Dresden', '', 'Germany', ''),
('SITE_239', 'The Christie NHS foundation trust', 'Manchester', '', 'United Kingdom', ''),
('SITE_24', 'Bethke Cancer Center at Emerson Hospital', 'Concord', 'Massachusetts', 'United States', '1742'),
('SITE_240', 'The Great Poland Cancer Centre', 'Poznan', '', 'Poland', ''),
('SITE_241', 'The Tisch Cancer Institute', 'New York', 'NewYork', 'United States', '10029'),
('SITE_242', 'The University of Arizona Cancer Center-North Campus', 'Tucson', 'Arizona', 'United States', '85719'),
('SITE_243', 'The University of Arizona Cancer Center-Orange Grove Campus', 'Tucson', 'Arizona', 'United States', '85704'),
('SITE_244', 'The University of Arizona Medical Center-University Campus', 'Tucson', 'Arizona', 'United States', '85724'),
('SITE_245', 'The University of Kansas Cancer Center-West', 'Kansas City', 'Kansas', 'United States', '66112'),
('SITE_246', 'U.Z. Leuven - Campus Gasthuisberg', 'Leuven', '', 'Belgium', '3000'),
('SITE_247', 'UC Irvine Health/Chao Family Comprehensive Cancer Center', 'Orange', 'California', 'United States', '92868'),
('SITE_248', 'UCI Medical Center', 'Orange', 'California', 'United States', '92868'),
('SITE_249', 'UF Cancer Center at Orlando Health', 'Orlando', 'Florida', 'United States', '32806'),
('SITE_25', 'Blumenthal Cancer Center at Carolinas Medical Center', 'Charlotte', 'North Carolina', 'United States', ' 28232-2861'),
('SITE_250', 'UMDNJ University Hospital', 'Newark', 'New Jersey', 'United States', '7103'),
('SITE_251', 'Unicancer', 'Paris', '', 'France', '75013'),
('SITE_252', 'Universita Degli Studi di Bari', 'Bari', '', 'Italy', '70124'),
('SITE_253', 'Universita Degli Studi di Florence - Policlinico di Careggi ', 'Florence', '', 'Italy', '50134'),
('SITE_254', 'Universita di Ferrara', 'Ferrara', '', 'Italy', '44100'),
('SITE_255', 'Universita di Torino', 'Turin', '', 'Italy', '10126'),
('SITE_256', 'UniversitaetsSpital Zurich', 'Zurich', '', 'Switzerland', '8091'),
('SITE_257', 'Universitat Leipzig', 'Leipzig', '', 'Germany', ''),
('SITE_258', 'Universitätsklinikum Gießen und Marburg', 'Marburg', '', 'Germany', '35043'),
('SITE_259', 'Universitätsklinikum Regensburg', 'Regensburg', '', 'Germany', '93053'),
('SITE_26', 'Brigham and Women\'s Hospital', 'Boston', 'Massachusetts', 'United States', '2115'),
('SITE_260', 'University College London Hospital (UCLH)', 'London', '', 'United Kingdom', ''),
('SITE_261', 'University College London Hospitals NHS Foundation Trust', 'London', '', 'United Kingdom', ' NW1 2BU'),
('SITE_262', 'University Hospital', 'Essen', '', 'Germany', '45147'),
('SITE_263', 'University Hospital Gasthuisberg', 'Leuven', '', 'Belgium', ''),
('SITE_264', 'University Hospitals Bristol NHS Foundation Trust', 'Bristol', '', 'United Kingdom', ' BS2 8ED'),
('SITE_265', 'University Hospitals Dorset NHS Foundation', 'Poole', 'Dorset', 'United Kingdom', ' BH15 2JB'),
('SITE_266', 'University Medical Center Hamburg - Eppendorf', 'Hamburg', '', 'Germany', '20246'),
('SITE_267', 'University of Arkansas for Medical Sciences', 'Little Rock', 'Arkansas', 'United States', '72205'),
('SITE_268', 'University of California Davis Cancer Center', 'Sacramento', 'California', 'United States', '95817'),
('SITE_269', 'University of Chicago Cancer Research Center', 'Chicago', 'Illinois', 'United States', '60637'),
('SITE_27', 'Bristol Haematology & Oncology Centre', 'Bristol', 'Avon', 'United Kingdom', ' BS2 8ED'),
('SITE_270', 'University of Colorado Denver', 'Denver', 'Colorado', 'United States', '80045'),
('SITE_271', 'University of Florida Shands Cancer Center', 'Gainesville', 'Florida', 'United States', ' 32610-0232'),
('SITE_272', 'University of Hawaii Cancer Center', 'Honolulu', 'Hawaii', 'United States', '96813'),
('SITE_273', 'University of Kansas Cancer Center', 'Kansas City', 'Kansas', 'United States', '66160'),
('SITE_274', 'University of Liverpool', 'Liverpool', '', 'United Kingdom', ' L69 3GB'),
('SITE_275', 'University of Michigan Cancer Center', 'Ann Arbor', 'Michigan', 'United States', '48109'),
('SITE_276', 'University of Pennsylvania Cancer Center', 'Philadelphia', 'Pennsylvania', 'United States', '19104'),
('SITE_278', 'University of Utah -  Huntsman Cancer Institute ', 'Salt Lake City', 'Utah', 'United States', '84112'),
('SITE_279', 'UPMC Cancer Centers', 'Pittsburgh', 'Pennsylvania', 'United States', '15232'),
('SITE_28', 'Bronson Battle Creek', 'Battle Creek', 'Michigan', 'United States', '49017'),
('SITE_280', 'USC/Norris Comprehensive Cancer Center and Hospital', 'Los Angeles', 'California', 'United States', ' 90033-0804'),
('SITE_281', 'Velindre NHS Trust', 'Cardiff', '', 'United Kingdom', ' CF142TL'),
('SITE_282', 'Veterans Affairs Medical Center - Buffalo', 'Buffalo', 'New York', 'United States', '14215'),
('SITE_283', 'Veterans Affairs Medical Center - Kansas City', 'Kansas City', 'Missouri', 'United States', '64128'),
('SITE_284', 'Via Christi Hospital-Pittsburg', 'Pittsburg', 'Kansas', 'United States', '66762'),
('SITE_285', 'Via Christi Regional Medical Center', 'Wichita', 'Kansas', 'United States', '67214'),
('SITE_286', 'Vrije Universiteit Medisch Centrum', 'Amsterdam', '', 'Netherlands', ' 7007MB'),
('SITE_287', 'Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support', 'Bethesda', 'Maryland', 'United States', ' 20892-1182'),
('SITE_288', 'Washington University Barnard Cancer Center', 'Saint Louis', 'Missouri', 'United States', '63110'),
('SITE_289', 'Washington University School of Medicine', 'Saint Louis', 'Missouri', 'United States', '63110'),
('SITE_29', 'Cadence Cancer Center at Delnor', 'Geneva', 'Illinois', 'United States', '60134'),
('SITE_290', 'Wayne Memorial Hospital Incorporated', 'Goldsboro', 'North Carolina', 'United States', '27534'),
('SITE_291', 'Welch Cancer Center', 'Sheridan', 'Wyoming', 'United States', '82801'),
('SITE_292', 'Wentworth Douglass Hospital', 'Dover', 'New Hampshire', 'United States', '3820'),
('SITE_293', 'Western General Hospital', 'Edinburgh', '', 'United Kingdom', ' EH4 2XU'),
('SITE_294', 'Wichita CCOP', 'Wichita', 'Kansas', 'United States', '67214'),
('SITE_295', 'Wilcox Memorial Hospital and Kauai Medical Clinic', 'Lihue', 'Hawaii', 'United States', '96766'),
('SITE_296', 'Wilhelminenspital', 'Vienna', '', 'Austria', ''),
('SITE_297', 'Winship Cancer Institute of Emory University', 'Atlanta', 'Georgia', 'United States', '30322'),
('SITE_298', 'Yale-New Haven Hospital', 'New Haven', 'Connecticut', 'United States', '6504'),
('SITE_299', 'Winship Cancer Institute', '', 'Georgia', 'United States', '31404'),
('SITE_30', 'Cadence Cancer Center in Warrenville', 'Warrenville', 'Illinois', 'United States', '60555'),
('SITE_31', 'Cambridge University Hospitals NHS Foundation Trust', 'Cambridge', '', 'United Kingdom', ' CB2 0QQ'),
('SITE_32', 'Cancer Center and Beckman Research Institute-City of Hope', 'Duarte', 'California', 'United States', ' 91010-3000'),
('SITE_33', 'Cancer Center of Kansas - Chanute', 'Chanute', 'Kansas', 'United States', '66720'),
('SITE_34', 'Cancer Center of Kansas - Dodge City', 'Dodge City', 'Kansas', 'United States', '67801'),
('SITE_35', 'Cancer Center of Kansas - Fort Scott', 'Fort Scott', 'Kansas', 'United States', '66701'),
('SITE_36', 'Cancer Center of Kansas - Main Office', 'Wichita', 'Kansas', 'United States', '67214'),
('SITE_37', 'Cancer Center of Kansas - Newton', 'Newton', 'Kansas', 'United States', '67114'),
('SITE_38', 'Cancer Center of Kansas - Parsons', 'Parsons', 'Kansas', 'United States', '67357'),
('SITE_39', 'Cancer Center of Kansas - Pratt', 'Pratt', 'Kansas', 'United States', '67124'),
('SITE_40', 'Cancer Center of Kansas - Salina', 'Salina', 'Kansas', 'United States', '67401'),
('SITE_41', 'Cancer Center of Kansas - Wellington', 'Wellington', 'Kansas', 'United States', '67152'),
('SITE_42', 'Cancer Center of Kansas - Winfield', 'Winfield', 'Kansas', 'United States', '67156'),
('SITE_43', 'Cancer Center of Kansas-Independence', 'Independence', 'Kansas', 'United States', '67301'),
('SITE_44', 'Cancer Center of Kansas-Kingman', 'Kingman', 'Kansas', 'United States', '67068'),
('SITE_45', 'Cancer Center of Kansas-Liberal', 'Liberal', 'Kansas', 'United States', '67901'),
('SITE_46', 'Cancer Center of Kansas-Wichita Medical Arts Tower', 'Wichita', 'Kansas', 'United States', '67208'),
('SITE_47', 'Cancer Research Center of Hawaii', 'Honolulu', 'Hawaii', 'United States', '96813'),
('SITE_48', 'Cancer Care of Maine at Eastern Maine Medical Center', 'Bangor', 'Maine', 'United States', '4401'),
('SITE_49', 'Cape Cod Health Care', 'Hyannis', 'Massachusetts', 'United States', '2601'),
('SITE_50', 'Cardiff and Vale University Local Health Board', 'Cardiff', '', 'United Kingdom', ' CF14 4XW'),
('SITE_51', 'Cardinal Bernardin Cancer Center at Loyola University Medical Center', 'Maywood', 'Illinois', 'United States', '60153'),
('SITE_52', 'Castle Hill Hospital', 'Cottingham', '', 'United Kingdom', ' HU16 5JQ'),
('SITE_53', 'Castle Medical Center', 'Kailua', 'Hawaii', 'United States', '96734'),
('SITE_54', 'Catholic University of Leuven', 'Leuven', '', 'Belgium', ''),
('SITE_55', 'Cattedra di Oncologia Medica - Universita degli Studi di Cagliari', 'Cagliari', '', 'Italy', '9042'),
('SITE_56', 'CCOP - Colorado Cancer Research Program', 'Denver', 'Colorado', 'United States', '80224'),
('SITE_57', 'CCOP - Northern Indiana CR Consortium', 'South Bend', 'Indiana', 'United States', '46601'),
('SITE_58', 'Center for Cancer Therapy at LaPorte Hospital and Health Services', 'La Porte', 'Indiana', 'United States', '46350'),
('SITE_59', 'Centre Antoine Lacassagne (CAL)', 'Nice', '', ' France', ''),
('SITE_60', 'Centre for Trials Research', 'Cardiff', '', 'United Kingdom', ' CF14 4YS'),
('SITE_61', 'Centre Georges-Francois Leclerc Hospital', 'Dijon', '', 'France', ''),
('SITE_62', 'Centre Georges-Francois-Leclerc', 'Dijon', '', 'France', '21079'),
('SITE_63', 'Centre Léon Bérard (CLB)', 'Lyon', '', 'France', ''),
('SITE_64', 'Centro Nazionale di Adroterapia Oncologica (CNAO)', 'Pavia', '', 'Italy', ''),
('SITE_65', 'Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum', 'Berlin', '', 'Germany', ''),
('SITE_66', 'Charité Universitaetsmedizin Berlin- CVK-CBF', 'Berlin', '', 'Germany', '13353'),
('SITE_67', 'Charité University Hospital', 'Berlin', '', 'Germany', '13353'),
('SITE_68', 'CHU de Tours - Hopital Bretonneau', 'Tours', '', 'France', '37044'),
('SITE_69', 'Clinique Saint Jean', 'Lyon', '', 'France', '69008'),
('SITE_70', 'Cliniques Universitaires Saint Luc', 'Brussels', '', 'Belgium', '1200'),
('SITE_71', 'Cookridge Hospital', 'Leeds', '', 'United Kingdom', ' LS16 6BB'),
('SITE_72', 'Copenhagen University Hospital', ' Herlev', 'Herlev', 'Denmark', '2730'),
('SITE_73', 'Dana-Farber Cancer Institute', 'Boston', 'Massachusetts', 'United States', '2115'),
('SITE_74', 'Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute', 'Boston', 'Massachusetts', 'United States', '2115'),
('SITE_75', 'Deanesly Centre', 'Wolverhampton', 'West Midlands', 'United Kingdom', ' WV10 0QP'),
('SITE_76', 'Dept Internal Medicine Gastrointestinal Oncology Unit B-3000', 'Leuven', '', 'Belgium', ''),
('SITE_77', 'Derby Teaching Hospitals NHS Foundation Trust', 'Derby', '', 'United Kingdom', ' DE22 3DT'),
('SITE_78', 'E.O. Ospedali Galliera', 'Genova', '', 'Italy', ''),
('SITE_79', 'Elkhart General Hospital', 'Elkhart', 'Indiana', 'United States', '46515'),
('SITE_80', 'Elliot Regional Cancer Center at Elliot Hospital', 'Manchester', 'New Hampshire', 'United States', '3103'),
('SITE_81', 'Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus', 'Boca Raton', 'Florida', 'United States', '33486'),
('SITE_82', 'Facoltà di Medicina e Chirurgia - Università Cattolica S.C. Istituto di Radiologia', 'Roma', '', 'Italy', '168'),
('SITE_83', 'Fairbanks Memorial Hospital', 'Fairbanks', 'Alaska', 'United States', '99701'),
('SITE_84', 'Fletcher Allen Health Care - University Health Center Campus', 'Burlington', 'Vermont', 'United States', '5401'),
('SITE_85', 'Fowler Family Center for Cancer Care', 'Jonesboro', 'Arkansas', 'United States', '72401'),
('SITE_86', 'Fox Chase Cancer Center', 'Philadelphia', 'Pennsylvania', 'United States', '19111'),
('SITE_87', 'Franciscan Saint Francis Health-Indianapolis', 'Indianapolis', 'Indiana', 'United States', '46237'),
('SITE_88', 'Franciscan St. Francis Health-Beech Grove', 'Beech Grove', 'Indiana', 'United States', '46107'),
('SITE_89', 'Front Range Cancer Specialists', 'Fort Collins', 'Colorado', 'United States', '80528'),
('SITE_90', 'Genesys Hurley Cancer Institute', 'Flint', 'Michigan', 'United States', '48503'),
('SITE_91', 'Genesys Regional Medical Center-West Flint Campus', 'Flint', 'Michigan', 'United States', '48532'),
('SITE_92', 'Goodall Hospital', 'Sanford', 'Maine', 'United States', '4703'),
('SITE_93', 'Grand Rapids Clinical Oncology Program', 'Grand Rapids', 'Michigan', 'United States', '49503'),
('SITE_94', 'Greenebaum Cancer Center at University of Maryland Medical Center', 'Baltimore', 'Maryland', 'United States', '21201'),
('SITE_96', 'Guys and St Thomas\'s NHS Foundation Trust', 'London', '', 'United Kingdom', ' SE1 9RT'),
('SITE_97', 'Hanusch Krankenhaus', 'Vienna', '', 'Austria', '1140'),
('SITE_98', 'Harvard Community Health Plan', 'Boston', 'Massachusetts', 'United States', ''),
('SITE_99', 'Harvard Pilgrim Health Care Institute', 'Boston', 'Massachusetts', 'United States', '2215'),
('SITE_UNDC', 'Undisclosed', '', '', '', ''),
('SITE_UNKW', ' ', '', '', '', '');

-- --------------------------------------------------------

--
-- Table structure for table `TREATMENTS`
--

DROP TABLE IF EXISTS `TREATMENTS`;
CREATE TABLE IF NOT EXISTS `TREATMENTS` (
  `TRT_ID` varchar(6) NOT NULL,
  `TREATMENT_NAME` varchar(32) DEFAULT NULL,
  `MODE_OF_ACTION` varchar(16) DEFAULT NULL,
  `SMALL_MOLECULE` varchar(14) DEFAULT NULL,
  `THERAPEUTIC_PROTEIN` varchar(19) DEFAULT NULL,
  PRIMARY KEY (`TRT_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `TREATMENTS`:
--

--
-- Dumping data for table `TREATMENTS`
--

INSERT INTO `TREATMENTS` (`TRT_ID`, `TREATMENT_NAME`, `MODE_OF_ACTION`, `SMALL_MOLECULE`, `THERAPEUTIC_PROTEIN`) VALUES
('TRT_01', 'docetaxel', 'Chemotherapeutic', 'Y', ''),
('TRT_02', 'Paclitaxel', 'Chemotherapeutic', '', ''),
('TRT_03', 'Cisplatin', 'Chemotherapeutic', 'Y', ''),
('TRT_04', 'FolicAcid', 'Adjuvant Therapy', '', ''),
('TRT_05', 'Fluorouracil', 'Chemotherapeutic', 'Y', ''),
('TRT_06', 'Decuprate', '', '', ''),
('TRT_07', 'gemcitabine', 'Chemotherapeutic', 'Y', ''),
('TRT_08', 'oxaliplatin', '', 'Y', ''),
('TRT_09', 'erlotinib', '', '', 'Y'),
('TRT_10', 'Cyclophosphamide', 'Chemotherapeutic', 'Y', ''),
('TRT_11', 'fludarabine', 'Chemotherapeutic', '', ''),
('TRT_12', 'cetuximab', 'Cell signalling', '', 'Y'),
('TRT_13', 'Methylphenidate', '', '', ''),
('TRT_14', 'patidegib', '', '', ''),
('TRT_15', 'Hydroxyurea', '', '', ''),
('TRT_16', 'Eniluracil', '', '', ''),
('TRT_17', 'capecitabine', 'Chemotherapeutic', '', ''),
('TRT_18', 'zalutumumab', 'Cell signalling', '', 'Y'),
('TRT_19', 'Doxorubicin', 'Chemotherapeutic', 'Y', ''),
('TRT_20', 'Ifosfamide', '', '', ''),
('TRT_21', 'Folfoxregimen', '', '', ''),
('TRT_22', 'alovudine', 'Chemotherapeutic', '', ''),
('TRT_23', 'tpfprotocol', 'Therapy', '', ''),
('TRT_24', 'MK2206', '', '', ''),
('TRT_25', 'aldesleukin', 'Cytokine', '', ''),
('TRT_26', 'OSI-7904L', '', '', ''),
('TRT_27', 'pegamotecan', '', '', ''),
('TRT_28', 'Methylprednisolone Hemisuccinate', '', '', 'Y'),
('TRT_29', 'D-Methionine', 'Cell signalling', 'Y', ''),
('TRT_30', 'Carboplatin', 'Chemotherapeutic', 'Y', ''),
('TRT_31', 'Amifostine', 'Chemotherapeutic', 'Y', ''),
('TRT_32', 'Edodekin alfa', '', '', ''),
('TRT_33', 'Leuprolide', '', '', ''),
('TRT_34', 'Goserelin', 'Cytokine', '', ''),
('TRT_35', 'terpene synthase', 'Cell signalling', '', ''),
('TRT_36', 'taxane', '', '', ''),
('TRT_37', 'trastuzumab emtansine', 'Cell signalling', '', 'Y'),
('TRT_38', 'eribulin', '', '', ''),
('TRT_39', 'nivolumab', 'Cell signalling', '', 'Y'),
('TRT_40', 'vandetanib', '', '', ''),
('TRT_41', 'trastuzumab', 'Cell signalling', '', 'Y'),
('TRT_42', 'irinotecan', 'Cell signalling', '', ''),
('TRT_43', 'bevacizumab', 'Cell signalling', '', 'Y'),
('TRT_44', 'edotecarin', '', '', ''),
('TRT_45', 'Nimorazole', 'Cell signalling', '', '');

-- --------------------------------------------------------

--
-- Table structure for table `TRIAL_COLLABORATORS`
--

DROP TABLE IF EXISTS `TRIAL_COLLABORATORS`;
CREATE TABLE IF NOT EXISTS `TRIAL_COLLABORATORS` (
  `TRIAL_ID` varchar(21) NOT NULL,
  `INS_ID` varchar(6) NOT NULL,
  `INS_IS_COLLABORATOR` varchar(19) DEFAULT NULL,
  PRIMARY KEY (`TRIAL_ID`,`INS_ID`),
  KEY `INS_IS_COLLABORATOR` (`INS_IS_COLLABORATOR`),
  KEY `INS_ID` (`INS_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `TRIAL_COLLABORATORS`:
--   `TRIAL_ID`
--       `TRIAL_SUMMARY` -> `TRIAL_ID`
--   `INS_IS_COLLABORATOR`
--       `INSTITUTIONS` -> `INS_IS_COLLABORATOR`
--   `INS_ID`
--       `INSTITUTIONS` -> `INS_ID`
--

--
-- Dumping data for table `TRIAL_COLLABORATORS`
--

INSERT INTO `TRIAL_COLLABORATORS` (`TRIAL_ID`, `INS_ID`, `INS_IS_COLLABORATOR`) VALUES
('NCT00002901', 'INS_61', 'Y'),
('NCT00003055', 'INS_61', 'Y'),
('NCT00003087', 'INS_61', 'Y'),
('NCT00003200', 'INS_61', 'Y'),
('NCT00003744', 'INS_61', 'Y'),
('NCT00004070', 'INS_61', 'Y'),
('NCT00004163', 'INS_61', 'Y'),
('NCT00004163', 'INS_70', 'Y'),
('NCT00004901', 'INS_61', 'Y'),
('NCT00005638', 'INS_61', 'Y'),
('NCT00016900', 'INS_61', 'Y'),
('NCT00030862', 'INS_61', 'Y'),
('NCT00072332', 'INS_61', 'Y'),
('NCT00095875', 'INS_61', 'Y'),
('NCT00095901', 'INS_61', 'Y'),
('NCT00095901', 'INS_70', 'Y'),
('NCT00095927', 'INS_12', 'Y'),
('NCT00095927', 'INS_57', 'Y'),
('NCT00095927', 'INS_61', 'Y'),
('NCT00101075', 'INS_61', 'Y'),
('NCT00101075', 'INS_72', 'Y'),
('NCT00316862', 'INS_61', 'Y'),
('NCT00354679', 'INS_61', 'Y'),
('NCT00375700', 'INS_28', 'Y'),
('NCT00389727', 'INS_35', 'Y'),
('NCT00397904', 'INS_61', 'Y'),
('NCT00402545', 'INS_14', 'Y'),
('NCT00402545', 'INS_15', 'Y'),
('NCT00459043', 'INS_12', 'Y'),
('NCT00459043', 'INS_14', 'Y'),
('NCT00459043', 'INS_52', 'Y'),
('NCT00459043', 'INS_54', 'Y'),
('NCT00525200 [PANCHO]', 'INS_13', 'Y'),
('NCT00578201 [FOLFOX]', 'INS_26', 'Y'),
('NCT00592501', 'INS_14', 'Y'),
('NCT00592501', 'INS_29', 'Y'),
('NCT00601692', 'INS_61', 'Y'),
('NCT00655876', 'INS_61', 'Y'),
('NCT00655876', 'INS_65', 'Y'),
('NCT01880359', 'INS_30', 'Y'),
('NCT02215265 [PATHOS]', 'INS_04', 'Y'),
('NCT02215265 [PATHOS]', 'INS_67', 'Y'),
('NCT02215265 [PATHOS]', 'INS_75', 'Y'),
('NCT02215265 [PATHOS]', 'INS_81', 'Y'),
('NCT02215265 [PATHOS]', 'INS_94', 'Y'),
('NCT03396718 [DELPHI]', 'INS_31', 'Y'),
('NCT03396718 [DELPHI]', 'INS_37', 'Y'),
('NCT03894891', 'INS_15', 'Y'),
('NCT05055648 [PROTECT]', 'INS_02', 'Y'),
('NCT05055648 [PROTECT]', 'INS_03', 'Y'),
('NCT05055648 [PROTECT]', 'INS_05', 'Y'),
('NCT05055648 [PROTECT]', 'INS_16', 'Y'),
('NCT05055648 [PROTECT]', 'INS_18', 'Y'),
('NCT05055648 [PROTECT]', 'INS_25', 'Y'),
('NCT05055648 [PROTECT]', 'INS_40', 'Y'),
('NCT05055648 [PROTECT]', 'INS_41', 'Y'),
('NCT05055648 [PROTECT]', 'INS_42', 'Y'),
('NCT05055648 [PROTECT]', 'INS_49', 'Y'),
('NCT05055648 [PROTECT]', 'INS_53', 'Y'),
('NCT05055648 [PROTECT]', 'INS_66', 'Y'),
('NCT05055648 [PROTECT]', 'INS_77', 'Y'),
('NCT05055648 [PROTECT]', 'INS_78', 'Y'),
('NCT05055648 [PROTECT]', 'INS_84', 'Y'),
('NCT05055648 [PROTECT]', 'INS_85', 'Y'),
('NCT05055648 [PROTECT]', 'INS_88', 'Y'),
('NCT05055648 [PROTECT]', 'INS_93', 'Y'),
('NCT05055648 [PROTECT]', 'INS_98', 'Y');

-- --------------------------------------------------------

--
-- Table structure for table `TRIAL_CTRY_ENROLL`
--

DROP TABLE IF EXISTS `TRIAL_CTRY_ENROLL`;
CREATE TABLE IF NOT EXISTS `TRIAL_CTRY_ENROLL` (
  `TRIAL_ID` varchar(25) DEFAULT NULL,
  `TRIALCTR_TOTAL_ENROLLMENT` int(25) DEFAULT NULL,
  `TRIALCTR_NR_SITES` int(17) DEFAULT NULL,
  `TRIAL_COUNTRY_ENROLLMENT` varchar(24) DEFAULT NULL,
  `TRIAL_COUNTRY_ENROLL_NO` int(23) DEFAULT NULL,
  KEY `TRIAL_ID` (`TRIAL_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `TRIAL_CTRY_ENROLL`:
--   `TRIAL_ID`
--       `TRIAL_SUMMARY` -> `TRIAL_ID`
--

--
-- Dumping data for table `TRIAL_CTRY_ENROLL`
--

INSERT INTO `TRIAL_CTRY_ENROLL` (`TRIAL_ID`, `TRIALCTR_TOTAL_ENROLLMENT`, `TRIALCTR_NR_SITES`, `TRIAL_COUNTRY_ENROLLMENT`, `TRIAL_COUNTRY_ENROLL_NO`) VALUES
('NCT00003200', 22, 4, 'United States', 22),
('NCT00016900', 1, 1, 'United States', 1),
('NCT00154700', 40, 1, 'Taiwan', 40),
('NCT00176800', 69, 1, 'United States', 69),
('NCT00375700', 35, 1, 'Canada', 35),
('NCT00436800', 41, 1, 'Hong Kong', 41),
('NCT00525200 [PANCHO]', 170, 13, 'Austria', 170),
('NCT00566800', 25, 1, 'United States', 25),
('NCT00937300', 6, 1, 'Denmark', 6),
('NCT00999700 [INTERCEPTOR]', 282, 20, 'Italy', 282),
('NCT01124500', 20, 1, 'United States', 20),
('NCT01216800', 84, 1, 'United Kingdom', 84),
('NCT01255800', 9, 1, 'United States', 9),
('NCT00002901', 3, 3, 'United States', 3),
('NCT00004901', 2, 2, 'United States', 2),
('NCT00019201', 1, 1, 'United States', 1),
('NCT00095901', 3, 3, 'United States', 3),
('NCT00401401', 30, 7, 'Belgium', 9),
('NCT00401401', 30, 7, 'UnitedStates', 4),
('NCT00401401', 30, 7, 'France', 9),
('NCT00401401', 30, 7, 'Netherlands', 4),
('NCT00401401', 30, 7, 'Sweden', 4),
('NCT00484601', 9, 2, 'Singapore', 5),
('NCT00484601', 9, 2, 'UnitedStates', 5),
('NCT00578201 [FOLFOX]', 80, 1, 'France', 80),
('NCT00592501', 25, 2, 'United States', 25),
('NCT00894101', 7, 1, 'United States', 7),
('NCT01024101', 36, 1, 'Japan', 36),
('NCT01181401 [ICRAT]', 94, 5, 'Germany', 94),
('NCT01186601', 30, 1, 'United States', 30),
('NCT01260701', 75, 170, 'Canada', 1),
('NCT01260701', 75, 170, 'UnitedStates', 169),
('NCT00002702', 260, 7, 'Italy', 260),
('NCT00073502', 43, 14, 'Belgium', 3),
('NCT00073502', 43, 14, 'UnitedKingdom', 31),
('NCT00073502', 43, 14, 'UnitedStates', 9),
('NCT00080002', 1, 1, 'United States', 1),
('NCT00259402', 41, 1, 'Spain', 41),
('NCT00290602', 40, 1, 'South Korea', 40),
('NCT00427102', 1, 1, 'United States', 1),
('NCT00402545', 29, 1, 'United States', 29),
('NCT00095927', 58, 10, 'United States', 58),
('NCT00095875', 145, 15, 'Germany', 10),
('NCT00095875', 145, 15, 'United States', 135),
('NCT00004070', 7, 2, 'United States', 7),
('NCT03894891', 70, 6, 'United States', 70),
('NCT01221753', 7, 1, 'United States', 7),
('NCT00459043', 30, 3, 'United States', 30),
('NCT00004163', 14, 10, 'United States', 14),
('NCT00003744', 16, 6, 'United States', 16),
('NCT00101075', 9, 1, 'United States', 9),
('NCT00601692', 27, 1, 'United States', 27),
('NCT00397904', 16, 1, 'United States', 16),
('NCT00354679', 34, 1, 'United States', 34),
('NCT00316862', 82, 24, 'United States', 82),
('NCT00003087', 25, 1, 'United States', 25),
('NCT00003055', 1, 1, 'United States', 1),
('NCT00072332', 1, 1, 'United States', 1),
('NCT00030862', 1, 1, 'United States', 1),
('NCT00005638', 2, 2, 'United States', 2),
('NCT00655876', 344, 171, 'Canada', 4),
('NCT00655876', 344, 171, 'United States', 340),
('NCT03396718 [DELPHI]', 384, 12, 'Germany', 384),
('NCT03865277 [INDIRA-MISO]', 345, 9, 'Austria', 38),
('NCT03865277 [INDIRA-MISO]', 345, 9, 'Germany', 230),
('NCT03865277 [INDIRA-MISO]', 345, 9, 'Italy', 38),
('NCT03865277 [INDIRA-MISO]', 345, 9, 'Poland', 38),
('NCT02336711', 10, 2, 'Belgium', 10),
('NCT01880359', 640, 31, 'Australia', 103),
('NCT01880359', 640, 31, 'Belgium', 103),
('NCT01880359', 640, 31, 'Canada', 21),
('NCT01880359', 640, 31, 'France', 103),
('NCT01880359', 640, 31, 'Germany', 83),
('NCT01880359', 640, 31, 'Netherlands', 62),
('NCT01880359', 640, 31, 'New Zealand', 21),
('NCT01880359', 640, 31, 'Poland', 103),
('NCT01880359', 640, 31, 'Switzerland', 41),
('NCT00389727', 22, 1, 'Belgium', 22),
('NCT05055648 [PROTECT]', 396, 13, 'Belgium', 30),
('NCT05055648 [PROTECT]', 396, 13, 'Denmark', 30),
('NCT05055648 [PROTECT]', 396, 13, 'France', 91),
('NCT05055648 [PROTECT]', 396, 13, 'Germany', 30),
('NCT05055648 [PROTECT]', 396, 13, 'Italy', 61),
('NCT05055648 [PROTECT]', 396, 13, 'Netherlands', 61),
('NCT05055648 [PROTECT]', 396, 13, 'Switzerland', 30),
('NCT05055648 [PROTECT]', 396, 13, 'United Kingdom', 61),
('NCT02215265 [PATHOS]', 1100, 53, 'Australia', 21),
('NCT02215265 [PATHOS]', 1100, 53, 'Austria', 21),
('NCT02215265 [PATHOS]', 1100, 53, 'Belgium', 21),
('NCT02215265 [PATHOS]', 1100, 53, 'France', 21),
('NCT02215265 [PATHOS]', 1100, 53, 'Germany', 21),
('NCT02215265 [PATHOS]', 1100, 53, 'Italy', 21),
('NCT02215265 [PATHOS]', 1100, 53, 'Netherlands', 21),
('NCT02215265 [PATHOS]', 1100, 53, 'Poland', 21),
('NCT02215265 [PATHOS]', 1100, 53, 'Portugal', 21),
('NCT02215265 [PATHOS]', 1100, 53, 'Spain', 42),
('NCT02215265 [PATHOS]', 1100, 53, 'Switzerland', 42),
('NCT02215265 [PATHOS]', 1100, 53, 'United Kingdom', 789),
('NCT02215265 [PATHOS]', 1100, 53, 'United States', 42);

-- --------------------------------------------------------

--
-- Table structure for table `TRIAL_HCP`
--

DROP TABLE IF EXISTS `TRIAL_HCP`;
CREATE TABLE IF NOT EXISTS `TRIAL_HCP` (
  `TRIAL_ID` varchar(25) NOT NULL,
  `HCP_ID` varchar(6) NOT NULL,
  PRIMARY KEY (`TRIAL_ID`,`HCP_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `TRIAL_HCP`:
--   `HCP_ID`
--       `HCP` -> `HCP_ID`
--

--
-- Dumping data for table `TRIAL_HCP`
--

INSERT INTO `TRIAL_HCP` (`TRIAL_ID`, `HCP_ID`) VALUES
('NCT00002702', 'HCP_19'),
('NCT00002901', 'HCP_27'),
('NCT00003055', 'HCP_14'),
('NCT00003087', 'HCP_14'),
('NCT00003200', 'HCP_37'),
('NCT00003200', 'HCP_46'),
('NCT00003744', 'HCP_37'),
('NCT00003744', 'HCP_46'),
('NCT00004070', 'HCP_01'),
('NCT00004070', 'HCP_46'),
('NCT00004163', 'HCP_37'),
('NCT00004163', 'HCP_46'),
('NCT00004901', 'HCP_16'),
('NCT00005638', 'HCP_14'),
('NCT00016900', 'HCP_14'),
('NCT00019201', 'HCP_25'),
('NCT00030862', 'HCP_14'),
('NCT00072332', 'HCP_14'),
('NCT00095875', 'HCP_46'),
('NCT00095901', 'HCP_34'),
('NCT00095927', 'HCP_46'),
('NCT00101075', 'HCP_46'),
('NCT00154700', 'HCP_05'),
('NCT00176800', 'HCP_49'),
('NCT00259402', 'HCP_31'),
('NCT00290602', 'HCP_26'),
('NCT00316862', 'HCP_14'),
('NCT00354679', 'HCP_14'),
('NCT00375700', 'HCP_08'),
('NCT00389727', 'HCP_51'),
('NCT00389728', 'HCP_44'),
('NCT00389729', 'HCP_47'),
('NCT00389730', 'HCP_18'),
('NCT00389731', 'HCP_06'),
('NCT00397904', 'HCP_14'),
('NCT00401401', 'HCP_51'),
('NCT00402545', 'HCP_46'),
('NCT00427102', 'HCP_20'),
('NCT00436800', 'HCP_23'),
('NCT00459043', 'HCP_46'),
('NCT00484601', 'HCP_02'),
('NCT00525200 [PANCHO]', 'HCP_13'),
('NCT00525200 [PANCHO]', 'HCP_30'),
('NCT00525200 [PANCHO]', 'HCP_41'),
('NCT00566800', 'HCP_29'),
('NCT00578201 [FOLFOX]', 'HCP_17'),
('NCT00578201 [FOLFOX]', 'HCP_24'),
('NCT00592501', 'HCP_04'),
('NCT00601692', 'HCP_14'),
('NCT00655876', 'HCP_14'),
('NCT00655876', 'HCP_42'),
('NCT00894101', 'HCP_15'),
('NCT00937300', 'HCP_22'),
('NCT00999700 [INTERCEPTOR]', 'HCP_35'),
('NCT01124500', 'HCP_43'),
('NCT01181401 [ICRAT]', 'HCP_52'),
('NCT01216800', 'HCP_09'),
('NCT01221753', 'HCP_46'),
('NCT01255800', 'HCP_07'),
('NCT01260701', 'HCP_45'),
('NCT01880359', 'HCP_28'),
('NCT01880359', 'HCP_51'),
('NCT02215265 [PATHOS]', 'HCP_40'),
('NCT02215265 [PATHOS]', 'HCP_50'),
('NCT02336711', 'HCP_51'),
('NCT03396718 [DELPHI]', 'HCP_03'),
('NCT03396718 [DELPHI]', 'HCP_10'),
('NCT03396718 [DELPHI]', 'HCP_11'),
('NCT03396718 [DELPHI]', 'HCP_12'),
('NCT03396718 [DELPHI]', 'HCP_21'),
('NCT03396718 [DELPHI]', 'HCP_32'),
('NCT03396718 [DELPHI]', 'HCP_38'),
('NCT03396718 [DELPHI]', 'HCP_39'),
('NCT03396718 [DELPHI]', 'HCP_48'),
('NCT03396718 [DELPHI]', 'HCP_52'),
('NCT03865277 [INDIRA-MISO]', 'HCP_39'),
('NCT03894891', 'HCP_46'),
('NCT05055648 [PROTECT]', 'HCP_33'),
('NCT05055648 [PROTECT]', 'HCP_36');

-- --------------------------------------------------------

--
-- Table structure for table `TRIAL_INS`
--

DROP TABLE IF EXISTS `TRIAL_INS`;
CREATE TABLE IF NOT EXISTS `TRIAL_INS` (
  `TRIAL_ID` varchar(25) NOT NULL,
  `INS_ID` varchar(6) NOT NULL,
  PRIMARY KEY (`TRIAL_ID`,`INS_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `TRIAL_INS`:
--   `TRIAL_ID`
--       `TRIAL_SUMMARY` -> `TRIAL_ID`
--   `INS_ID`
--       `INSTITUTIONS` -> `INS_ID`
--

--
-- Dumping data for table `TRIAL_INS`
--

INSERT INTO `TRIAL_INS` (`TRIAL_ID`, `INS_ID`) VALUES
('NCT00002702', 'INS_44'),
('NCT00002901', 'INS_23'),
('NCT00002901', 'INS_61'),
('NCT00003055', 'INS_58'),
('NCT00003055', 'INS_61'),
('NCT00003087', 'INS_58'),
('NCT00003087', 'INS_61'),
('NCT00003200', 'INS_29'),
('NCT00003200', 'INS_61'),
('NCT00003744', 'INS_29'),
('NCT00003744', 'INS_61'),
('NCT00004070', 'INS_29'),
('NCT00004070', 'INS_61'),
('NCT00004163', 'INS_29'),
('NCT00004163', 'INS_61'),
('NCT00004163', 'INS_70'),
('NCT00004901', 'INS_61'),
('NCT00004901', 'INS_69'),
('NCT00005638', 'INS_58'),
('NCT00005638', 'INS_61'),
('NCT00016900', 'INS_58'),
('NCT00016900', 'INS_61'),
('NCT00019201', 'INS_61'),
('NCT00030862', 'INS_58'),
('NCT00030862', 'INS_61'),
('NCT00072332', 'INS_58'),
('NCT00072332', 'INS_61'),
('NCT00073502', 'INS_11'),
('NCT00080002', 'INS_33'),
('NCT00095875', 'INS_29'),
('NCT00095875', 'INS_61'),
('NCT00095901', 'INS_29'),
('NCT00095901', 'INS_61'),
('NCT00095901', 'INS_70'),
('NCT00095927', 'INS_12'),
('NCT00095927', 'INS_29'),
('NCT00095927', 'INS_57'),
('NCT00095927', 'INS_61'),
('NCT00101075', 'INS_29'),
('NCT00101075', 'INS_61'),
('NCT00101075', 'INS_72'),
('NCT00154700', 'INS_01'),
('NCT00176800', 'INS_96'),
('NCT00259402', 'INS_72'),
('NCT00290602', 'INS_60'),
('NCT00316862', 'INS_08'),
('NCT00316862', 'INS_61'),
('NCT00354679', 'INS_58'),
('NCT00354679', 'INS_61'),
('NCT00375700', 'INS_06'),
('NCT00375700', 'INS_28'),
('NCT00389727', 'INS_24'),
('NCT00389727', 'INS_35'),
('NCT00397904', 'INS_58'),
('NCT00397904', 'INS_61'),
('NCT00401401', 'INS_36'),
('NCT00402545', 'INS_14'),
('NCT00402545', 'INS_15'),
('NCT00402545', 'INS_29'),
('NCT00427102', 'INS_73'),
('NCT00436800', 'INS_72'),
('NCT00459043', 'INS_12'),
('NCT00459043', 'INS_14'),
('NCT00459043', 'INS_29'),
('NCT00459043', 'INS_52'),
('NCT00459043', 'INS_54'),
('NCT00484601', 'INS_73'),
('NCT00525200 [PANCHO]', 'INS_13'),
('NCT00525200 [PANCHO]', 'INS_55'),
('NCT00566800', 'INS_48'),
('NCT00578201 [FOLFOX]', 'INS_10'),
('NCT00578201 [FOLFOX]', 'INS_26'),
('NCT00592501', 'INS_14'),
('NCT00592501', 'INS_29'),
('NCT00592501', 'INS_54'),
('NCT00601692', 'INS_58'),
('NCT00601692', 'INS_61'),
('NCT00655876', 'INS_61'),
('NCT00655876', 'INS_65'),
('NCT00655876', 'INS_68'),
('NCT00894101', 'INS_79'),
('NCT00937300', 'INS_39'),
('NCT00999700 [INTERCEPTOR]', 'INS_38'),
('NCT01024101', 'INS_15'),
('NCT01124500', 'INS_58'),
('NCT01181401 [ICRAT]', 'INS_20'),
('NCT01186601', 'INS_50'),
('NCT01216800', 'INS_43'),
('NCT01221753', 'INS_29'),
('NCT01255800', 'INS_92'),
('NCT01260701', 'INS_61'),
('NCT01880359', 'INS_30'),
('NCT01880359', 'INS_34'),
('NCT02215265 [PATHOS]', 'INS_04'),
('NCT02215265 [PATHOS]', 'INS_64'),
('NCT02215265 [PATHOS]', 'INS_67'),
('NCT02215265 [PATHOS]', 'INS_75'),
('NCT02215265 [PATHOS]', 'INS_81'),
('NCT02215265 [PATHOS]', 'INS_94'),
('NCT02336711', 'INS_24'),
('NCT03396718 [DELPHI]', 'INS_31'),
('NCT03396718 [DELPHI]', 'INS_32'),
('NCT03396718 [DELPHI]', 'INS_37'),
('NCT03865277 [INDIRA-MISO]', 'INS_32'),
('NCT03894891', 'INS_15'),
('NCT03894891', 'INS_29'),
('NCT05055648 [PROTECT]', 'INS_02'),
('NCT05055648 [PROTECT]', 'INS_03'),
('NCT05055648 [PROTECT]', 'INS_05'),
('NCT05055648 [PROTECT]', 'INS_16'),
('NCT05055648 [PROTECT]', 'INS_18'),
('NCT05055648 [PROTECT]', 'INS_25'),
('NCT05055648 [PROTECT]', 'INS_40'),
('NCT05055648 [PROTECT]', 'INS_41'),
('NCT05055648 [PROTECT]', 'INS_42'),
('NCT05055648 [PROTECT]', 'INS_49'),
('NCT05055648 [PROTECT]', 'INS_53'),
('NCT05055648 [PROTECT]', 'INS_66'),
('NCT05055648 [PROTECT]', 'INS_77'),
('NCT05055648 [PROTECT]', 'INS_78'),
('NCT05055648 [PROTECT]', 'INS_84'),
('NCT05055648 [PROTECT]', 'INS_85'),
('NCT05055648 [PROTECT]', 'INS_88'),
('NCT05055648 [PROTECT]', 'INS_93'),
('NCT05055648 [PROTECT]', 'INS_98');

-- --------------------------------------------------------

--
-- Table structure for table `TRIAL_LEADSPONSORS`
--

DROP TABLE IF EXISTS `TRIAL_LEADSPONSORS`;
CREATE TABLE IF NOT EXISTS `TRIAL_LEADSPONSORS` (
  `TRIAL_ID` varchar(25) NOT NULL,
  `INS_ID` varchar(6) NOT NULL,
  `INS_IS_SPONSOR` varchar(14) DEFAULT NULL,
  PRIMARY KEY (`TRIAL_ID`,`INS_ID`),
  KEY `INS_IS_SPONSOR` (`INS_IS_SPONSOR`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `TRIAL_LEADSPONSORS`:
--   `TRIAL_ID`
--       `TRIAL_SUMMARY` -> `TRIAL_ID`
--   `INS_IS_SPONSOR`
--       `INSTITUTIONS` -> `INS_IS_SPONSOR`
--

--
-- Dumping data for table `TRIAL_LEADSPONSORS`
--

INSERT INTO `TRIAL_LEADSPONSORS` (`TRIAL_ID`, `INS_ID`, `INS_IS_SPONSOR`) VALUES
('NCT00002702', 'INS_44', 'Y'),
('NCT00002901', 'INS_23', 'Y'),
('NCT00003055', 'INS_58', 'Y'),
('NCT00003087', 'INS_58', 'Y'),
('NCT00003200', 'INS_29', 'Y'),
('NCT00003744', 'INS_29', 'Y'),
('NCT00004070', 'INS_29', 'Y'),
('NCT00004163', 'INS_29', 'Y'),
('NCT00004901', 'INS_69', 'Y'),
('NCT00005638', 'INS_58', 'Y'),
('NCT00016900', 'INS_58', 'Y'),
('NCT00019201', 'INS_61', 'Y'),
('NCT00030862', 'INS_58', 'Y'),
('NCT00072332', 'INS_58', 'Y'),
('NCT00073502', 'INS_11', 'Y'),
('NCT00080002', 'INS_33', 'Y'),
('NCT00095875', 'INS_29', 'Y'),
('NCT00095901', 'INS_29', 'Y'),
('NCT00095927', 'INS_29', 'Y'),
('NCT00101075', 'INS_29', 'Y'),
('NCT00154700', 'INS_01', 'Y'),
('NCT00176800', 'INS_96', 'Y'),
('NCT00259402', 'INS_72', 'Y'),
('NCT00290602', 'INS_60', 'Y'),
('NCT00316862', 'INS_08', 'Y'),
('NCT00354679', 'INS_58', 'Y'),
('NCT00375700', 'INS_06', 'Y'),
('NCT00389727', 'INS_24', 'Y'),
('NCT00397904', 'INS_58', 'Y'),
('NCT00401401', 'INS_36', 'Y'),
('NCT00402545', 'INS_29', 'Y'),
('NCT00427102', 'INS_73', 'Y'),
('NCT00436800', 'INS_72', 'Y'),
('NCT00459043', 'INS_29', 'Y'),
('NCT00484601', 'INS_73', 'Y'),
('NCT00525200 [PANCHO]', 'INS_55', 'Y'),
('NCT00566800', 'INS_48', 'Y'),
('NCT00578201 [FOLFOX]', 'INS_10', 'Y'),
('NCT00592501', 'INS_54', 'Y'),
('NCT00601692', 'INS_58', 'Y'),
('NCT00655876', 'INS_68', 'Y'),
('NCT00894101', 'INS_79', 'Y'),
('NCT00937300', 'INS_39', 'Y'),
('NCT00999700 [INTERCEPTOR]', 'INS_38', 'Y'),
('NCT01024101', 'INS_15', 'Y'),
('NCT01124500', 'INS_58', 'Y'),
('NCT01181401 [ICRAT]', 'INS_20', 'Y'),
('NCT01186601', 'INS_50', 'Y'),
('NCT01216800', 'INS_43', 'Y'),
('NCT01221753', 'INS_29', 'Y'),
('NCT01255800', 'INS_92', 'Y'),
('NCT01260701', 'INS_61', 'Y'),
('NCT01880359', 'INS_34', 'Y'),
('NCT02215265 [PATHOS]', 'INS_64', 'Y'),
('NCT02336711', 'INS_24', 'Y'),
('NCT03396718 [DELPHI]', 'INS_32', 'Y'),
('NCT03865277 [INDIRA-MISO]', 'INS_32', 'Y'),
('NCT03894891', 'INS_29', 'Y'),
('NCT05055648 [PROTECT]', 'INS_02', 'Y');

-- --------------------------------------------------------

--
-- Table structure for table `TRIAL_MESH`
--

DROP TABLE IF EXISTS `TRIAL_MESH`;
CREATE TABLE IF NOT EXISTS `TRIAL_MESH` (
  `TRIAL_ID` varchar(25) NOT NULL,
  `MESH_ID` varchar(8) NOT NULL,
  PRIMARY KEY (`TRIAL_ID`,`MESH_ID`),
  KEY `MESH_ID` (`MESH_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `TRIAL_MESH`:
--   `TRIAL_ID`
--       `TRIAL_SUMMARY` -> `TRIAL_ID`
--   `MESH_ID`
--       `MESH_TERMS` -> `MESH_ID`
--

--
-- Dumping data for table `TRIAL_MESH`
--

INSERT INTO `TRIAL_MESH` (`TRIAL_ID`, `MESH_ID`) VALUES
('NCT00002702', 'MESH_001'),
('NCT00002702', 'MESH_002'),
('NCT00002702', 'MESH_003'),
('NCT00002702', 'MESH_005'),
('NCT00002702', 'MESH_185'),
('NCT00002702', 'MESH_186'),
('NCT00002702', 'MESH_187'),
('NCT00002901', 'MESH_001'),
('NCT00002901', 'MESH_002'),
('NCT00002901', 'MESH_108'),
('NCT00002901', 'MESH_109'),
('NCT00002901', 'MESH_110'),
('NCT00002901', 'MESH_111'),
('NCT00002901', 'MESH_112'),
('NCT00002901', 'MESH_113'),
('NCT00002901', 'MESH_114'),
('NCT00002901', 'MESH_115'),
('NCT00002901', 'MESH_116'),
('NCT00002901', 'MESH_117'),
('NCT00002901', 'MESH_118'),
('NCT00002901', 'MESH_119'),
('NCT00002901', 'MESH_120'),
('NCT00002901', 'MESH_121'),
('NCT00002901', 'MESH_122'),
('NCT00002901', 'MESH_123'),
('NCT00002901', 'MESH_124'),
('NCT00002901', 'MESH_125'),
('NCT00002901', 'MESH_126'),
('NCT00002901', 'MESH_127'),
('NCT00002901', 'MESH_128'),
('NCT00002901', 'MESH_129'),
('NCT00002901', 'MESH_130'),
('NCT00002901', 'MESH_131'),
('NCT00002901', 'MESH_132'),
('NCT00002901', 'MESH_133'),
('NCT00002901', 'MESH_134'),
('NCT00002901', 'MESH_135'),
('NCT00003055', 'MESH_226'),
('NCT00003055', 'MESH_229'),
('NCT00003055', 'MESH_230'),
('NCT00003055', 'MESH_231'),
('NCT00003055', 'MESH_232'),
('NCT00003055', 'MESH_234'),
('NCT00003055', 'MESH_235'),
('NCT00003087', 'MESH_226'),
('NCT00003087', 'MESH_227'),
('NCT00003087', 'MESH_228'),
('NCT00003087', 'MESH_229'),
('NCT00003200', 'MESH_001'),
('NCT00003200', 'MESH_002'),
('NCT00003200', 'MESH_003'),
('NCT00003200', 'MESH_004'),
('NCT00003200', 'MESH_005'),
('NCT00003200', 'MESH_006'),
('NCT00003200', 'MESH_007'),
('NCT00003200', 'MESH_008'),
('NCT00003200', 'MESH_009'),
('NCT00003200', 'MESH_010'),
('NCT00003200', 'MESH_011'),
('NCT00003200', 'MESH_012'),
('NCT00003200', 'MESH_013'),
('NCT00003200', 'MESH_014'),
('NCT00003200', 'MESH_015'),
('NCT00003200', 'MESH_016'),
('NCT00003744', 'MESH_214'),
('NCT00003744', 'MESH_215'),
('NCT00003744', 'MESH_217'),
('NCT00003744', 'MESH_218'),
('NCT00003744', 'MESH_219'),
('NCT00003744', 'MESH_220'),
('NCT00003744', 'MESH_221'),
('NCT00003744', 'MESH_222'),
('NCT00003744', 'MESH_223'),
('NCT00003744', 'MESH_224'),
('NCT00003744', 'MESH_225'),
('NCT00004070', 'MESH_001'),
('NCT00004070', 'MESH_002'),
('NCT00004070', 'MESH_003'),
('NCT00004070', 'MESH_005'),
('NCT00004070', 'MESH_007'),
('NCT00004070', 'MESH_009'),
('NCT00004070', 'MESH_011'),
('NCT00004070', 'MESH_012'),
('NCT00004070', 'MESH_013'),
('NCT00004070', 'MESH_014'),
('NCT00004070', 'MESH_015'),
('NCT00004070', 'MESH_016'),
('NCT00004070', 'MESH_121'),
('NCT00004070', 'MESH_134'),
('NCT00004070', 'MESH_141'),
('NCT00004070', 'MESH_143'),
('NCT00004070', 'MESH_145'),
('NCT00004070', 'MESH_147'),
('NCT00004070', 'MESH_207'),
('NCT00004070', 'MESH_208'),
('NCT00004163', 'MESH_214'),
('NCT00004163', 'MESH_215'),
('NCT00004163', 'MESH_216'),
('NCT00004163', 'MESH_217'),
('NCT00004163', 'MESH_218'),
('NCT00004163', 'MESH_219'),
('NCT00004163', 'MESH_220'),
('NCT00004163', 'MESH_221'),
('NCT00004163', 'MESH_222'),
('NCT00004163', 'MESH_223'),
('NCT00004163', 'MESH_224'),
('NCT00004901', 'MESH_002'),
('NCT00004901', 'MESH_005'),
('NCT00004901', 'MESH_006'),
('NCT00004901', 'MESH_009'),
('NCT00004901', 'MESH_010'),
('NCT00004901', 'MESH_012'),
('NCT00004901', 'MESH_014'),
('NCT00004901', 'MESH_131'),
('NCT00004901', 'MESH_132'),
('NCT00004901', 'MESH_133'),
('NCT00004901', 'MESH_134'),
('NCT00004901', 'MESH_136'),
('NCT00004901', 'MESH_137'),
('NCT00004901', 'MESH_138'),
('NCT00004901', 'MESH_139'),
('NCT00004901', 'MESH_140'),
('NCT00004901', 'MESH_141'),
('NCT00004901', 'MESH_142'),
('NCT00004901', 'MESH_143'),
('NCT00004901', 'MESH_144'),
('NCT00004901', 'MESH_145'),
('NCT00004901', 'MESH_146'),
('NCT00004901', 'MESH_147'),
('NCT00004901', 'MESH_148'),
('NCT00005638', 'MESH_017'),
('NCT00005638', 'MESH_018'),
('NCT00005638', 'MESH_019'),
('NCT00005638', 'MESH_020'),
('NCT00005638', 'MESH_021'),
('NCT00005638', 'MESH_022'),
('NCT00005638', 'MESH_023'),
('NCT00005638', 'MESH_024'),
('NCT00005638', 'MESH_025'),
('NCT00005638', 'MESH_028'),
('NCT00005638', 'MESH_032'),
('NCT00005638', 'MESH_034'),
('NCT00005638', 'MESH_046'),
('NCT00005638', 'MESH_177'),
('NCT00005638', 'MESH_183'),
('NCT00005638', 'MESH_184'),
('NCT00005638', 'MESH_226'),
('NCT00005638', 'MESH_227'),
('NCT00005638', 'MESH_228'),
('NCT00005638', 'MESH_229'),
('NCT00005638', 'MESH_233'),
('NCT00005638', 'MESH_235'),
('NCT00005638', 'MESH_236'),
('NCT00005638', 'MESH_237'),
('NCT00005638', 'MESH_238'),
('NCT00016900', 'MESH_017'),
('NCT00016900', 'MESH_018'),
('NCT00016900', 'MESH_019'),
('NCT00016900', 'MESH_020'),
('NCT00016900', 'MESH_021'),
('NCT00016900', 'MESH_022'),
('NCT00016900', 'MESH_023'),
('NCT00016900', 'MESH_024'),
('NCT00016900', 'MESH_025'),
('NCT00016900', 'MESH_026'),
('NCT00016900', 'MESH_027'),
('NCT00016900', 'MESH_028'),
('NCT00016900', 'MESH_029'),
('NCT00016900', 'MESH_030'),
('NCT00016900', 'MESH_031'),
('NCT00016900', 'MESH_032'),
('NCT00019201', 'MESH_149'),
('NCT00019201', 'MESH_150'),
('NCT00019201', 'MESH_151'),
('NCT00019201', 'MESH_152'),
('NCT00019201', 'MESH_153'),
('NCT00019201', 'MESH_154'),
('NCT00019201', 'MESH_155'),
('NCT00019201', 'MESH_156'),
('NCT00019201', 'MESH_157'),
('NCT00019201', 'MESH_158'),
('NCT00019201', 'MESH_159'),
('NCT00019201', 'MESH_160'),
('NCT00019201', 'MESH_161'),
('NCT00019201', 'MESH_162'),
('NCT00019201', 'MESH_163'),
('NCT00019201', 'MESH_164'),
('NCT00019201', 'MESH_165'),
('NCT00019201', 'MESH_166'),
('NCT00019201', 'MESH_167'),
('NCT00019201', 'MESH_168'),
('NCT00019201', 'MESH_169'),
('NCT00019201', 'MESH_170'),
('NCT00030862', 'MESH_017'),
('NCT00030862', 'MESH_018'),
('NCT00030862', 'MESH_019'),
('NCT00030862', 'MESH_020'),
('NCT00030862', 'MESH_021'),
('NCT00030862', 'MESH_022'),
('NCT00030862', 'MESH_023'),
('NCT00030862', 'MESH_024'),
('NCT00030862', 'MESH_025'),
('NCT00030862', 'MESH_028'),
('NCT00030862', 'MESH_032'),
('NCT00030862', 'MESH_034'),
('NCT00030862', 'MESH_046'),
('NCT00030862', 'MESH_177'),
('NCT00030862', 'MESH_226'),
('NCT00030862', 'MESH_227'),
('NCT00030862', 'MESH_228'),
('NCT00030862', 'MESH_229'),
('NCT00030862', 'MESH_230'),
('NCT00030862', 'MESH_236'),
('NCT00030862', 'MESH_237'),
('NCT00072332', 'MESH_017'),
('NCT00072332', 'MESH_018'),
('NCT00072332', 'MESH_019'),
('NCT00072332', 'MESH_020'),
('NCT00072332', 'MESH_021'),
('NCT00072332', 'MESH_022'),
('NCT00072332', 'MESH_023'),
('NCT00072332', 'MESH_024'),
('NCT00072332', 'MESH_025'),
('NCT00072332', 'MESH_028'),
('NCT00072332', 'MESH_034'),
('NCT00072332', 'MESH_120'),
('NCT00072332', 'MESH_183'),
('NCT00072332', 'MESH_184'),
('NCT00072332', 'MESH_230'),
('NCT00072332', 'MESH_234'),
('NCT00073502', 'MESH_021'),
('NCT00073502', 'MESH_040'),
('NCT00073502', 'MESH_041'),
('NCT00073502', 'MESH_042'),
('NCT00073502', 'MESH_182'),
('NCT00080002', 'MESH_021'),
('NCT00080002', 'MESH_188'),
('NCT00080002', 'MESH_189'),
('NCT00080002', 'MESH_190'),
('NCT00080002', 'MESH_191'),
('NCT00080002', 'MESH_192'),
('NCT00095875', 'MESH_001'),
('NCT00095875', 'MESH_002'),
('NCT00095875', 'MESH_003'),
('NCT00095875', 'MESH_005'),
('NCT00095875', 'MESH_011'),
('NCT00095875', 'MESH_012'),
('NCT00095875', 'MESH_013'),
('NCT00095875', 'MESH_014'),
('NCT00095901', 'MESH_020'),
('NCT00095901', 'MESH_021'),
('NCT00095901', 'MESH_022'),
('NCT00095901', 'MESH_028'),
('NCT00095901', 'MESH_032'),
('NCT00095901', 'MESH_061'),
('NCT00095901', 'MESH_062'),
('NCT00095901', 'MESH_171'),
('NCT00095927', 'MESH_001'),
('NCT00095927', 'MESH_002'),
('NCT00095927', 'MESH_003'),
('NCT00095927', 'MESH_005'),
('NCT00095927', 'MESH_011'),
('NCT00095927', 'MESH_012'),
('NCT00095927', 'MESH_013'),
('NCT00095927', 'MESH_014'),
('NCT00095927', 'MESH_015'),
('NCT00095927', 'MESH_016'),
('NCT00095927', 'MESH_185'),
('NCT00095927', 'MESH_186'),
('NCT00095927', 'MESH_197'),
('NCT00095927', 'MESH_200'),
('NCT00095927', 'MESH_201'),
('NCT00095927', 'MESH_202'),
('NCT00095927', 'MESH_203'),
('NCT00095927', 'MESH_204'),
('NCT00095927', 'MESH_205'),
('NCT00095927', 'MESH_206'),
('NCT00095927', 'MESH_207'),
('NCT00101075', 'MESH_214'),
('NCT00101075', 'MESH_215'),
('NCT00101075', 'MESH_216'),
('NCT00101075', 'MESH_217'),
('NCT00101075', 'MESH_218'),
('NCT00101075', 'MESH_219'),
('NCT00101075', 'MESH_220'),
('NCT00101075', 'MESH_221'),
('NCT00101075', 'MESH_222'),
('NCT00101075', 'MESH_223'),
('NCT00101075', 'MESH_224'),
('NCT00154700', 'MESH_017'),
('NCT00154700', 'MESH_018'),
('NCT00154700', 'MESH_019'),
('NCT00154700', 'MESH_020'),
('NCT00154700', 'MESH_021'),
('NCT00154700', 'MESH_022'),
('NCT00154700', 'MESH_023'),
('NCT00154700', 'MESH_024'),
('NCT00154700', 'MESH_025'),
('NCT00154700', 'MESH_026'),
('NCT00154700', 'MESH_027'),
('NCT00154700', 'MESH_028'),
('NCT00154700', 'MESH_029'),
('NCT00154700', 'MESH_030'),
('NCT00154700', 'MESH_031'),
('NCT00154700', 'MESH_032'),
('NCT00154700', 'MESH_033'),
('NCT00154700', 'MESH_034'),
('NCT00154700', 'MESH_035'),
('NCT00154700', 'MESH_036'),
('NCT00154700', 'MESH_037'),
('NCT00154700', 'MESH_038'),
('NCT00154700', 'MESH_039'),
('NCT00176800', 'MESH_017'),
('NCT00176800', 'MESH_018'),
('NCT00176800', 'MESH_019'),
('NCT00176800', 'MESH_020'),
('NCT00176800', 'MESH_021'),
('NCT00176800', 'MESH_022'),
('NCT00176800', 'MESH_023'),
('NCT00176800', 'MESH_024'),
('NCT00176800', 'MESH_025'),
('NCT00176800', 'MESH_028'),
('NCT00176800', 'MESH_032'),
('NCT00176800', 'MESH_039'),
('NCT00176800', 'MESH_040'),
('NCT00176800', 'MESH_041'),
('NCT00176800', 'MESH_042'),
('NCT00176800', 'MESH_043'),
('NCT00176800', 'MESH_044'),
('NCT00176800', 'MESH_045'),
('NCT00176800', 'MESH_046'),
('NCT00176800', 'MESH_047'),
('NCT00176800', 'MESH_048'),
('NCT00176800', 'MESH_049'),
('NCT00176800', 'MESH_050'),
('NCT00259402', 'MESH_017'),
('NCT00259402', 'MESH_018'),
('NCT00259402', 'MESH_019'),
('NCT00259402', 'MESH_020'),
('NCT00259402', 'MESH_021'),
('NCT00259402', 'MESH_022'),
('NCT00259402', 'MESH_023'),
('NCT00259402', 'MESH_024'),
('NCT00259402', 'MESH_025'),
('NCT00259402', 'MESH_028'),
('NCT00259402', 'MESH_032'),
('NCT00259402', 'MESH_034'),
('NCT00259402', 'MESH_039'),
('NCT00259402', 'MESH_060'),
('NCT00259402', 'MESH_061'),
('NCT00259402', 'MESH_062'),
('NCT00259402', 'MESH_065'),
('NCT00259402', 'MESH_066'),
('NCT00259402', 'MESH_068'),
('NCT00290602', 'MESH_193'),
('NCT00290602', 'MESH_194'),
('NCT00290602', 'MESH_195'),
('NCT00290602', 'MESH_196'),
('NCT00316862', 'MESH_227'),
('NCT00316862', 'MESH_228'),
('NCT00316862', 'MESH_229'),
('NCT00354679', 'MESH_227'),
('NCT00354679', 'MESH_228'),
('NCT00354679', 'MESH_229'),
('NCT00354679', 'MESH_231'),
('NCT00375700', 'MESH_020'),
('NCT00375700', 'MESH_021'),
('NCT00375700', 'MESH_022'),
('NCT00389727', 'MESH_021'),
('NCT00389727', 'MESH_040'),
('NCT00389727', 'MESH_041'),
('NCT00389727', 'MESH_042'),
('NCT00389727', 'MESH_073'),
('NCT00389727', 'MESH_074'),
('NCT00397904', 'MESH_226'),
('NCT00397904', 'MESH_227'),
('NCT00397904', 'MESH_230'),
('NCT00397904', 'MESH_231'),
('NCT00397904', 'MESH_232'),
('NCT00397904', 'MESH_233'),
('NCT00397904', 'MESH_234'),
('NCT00401401', 'MESH_020'),
('NCT00401401', 'MESH_021'),
('NCT00401401', 'MESH_022'),
('NCT00401401', 'MESH_028'),
('NCT00401401', 'MESH_034'),
('NCT00401401', 'MESH_040'),
('NCT00401401', 'MESH_041'),
('NCT00401401', 'MESH_042'),
('NCT00401401', 'MESH_073'),
('NCT00401401', 'MESH_074'),
('NCT00401401', 'MESH_090'),
('NCT00401401', 'MESH_172'),
('NCT00402545', 'MESH_020'),
('NCT00402545', 'MESH_021'),
('NCT00402545', 'MESH_022'),
('NCT00402545', 'MESH_028'),
('NCT00402545', 'MESH_029'),
('NCT00402545', 'MESH_030'),
('NCT00402545', 'MESH_031'),
('NCT00402545', 'MESH_032'),
('NCT00402545', 'MESH_034'),
('NCT00402545', 'MESH_039'),
('NCT00402545', 'MESH_040'),
('NCT00402545', 'MESH_041'),
('NCT00402545', 'MESH_042'),
('NCT00402545', 'MESH_061'),
('NCT00402545', 'MESH_062'),
('NCT00402545', 'MESH_065'),
('NCT00402545', 'MESH_066'),
('NCT00402545', 'MESH_067'),
('NCT00402545', 'MESH_068'),
('NCT00402545', 'MESH_073'),
('NCT00402545', 'MESH_074'),
('NCT00402545', 'MESH_088'),
('NCT00402545', 'MESH_089'),
('NCT00402545', 'MESH_090'),
('NCT00427102', 'MESH_020'),
('NCT00427102', 'MESH_021'),
('NCT00427102', 'MESH_022'),
('NCT00427102', 'MESH_023'),
('NCT00427102', 'MESH_025'),
('NCT00427102', 'MESH_028'),
('NCT00427102', 'MESH_034'),
('NCT00427102', 'MESH_040'),
('NCT00427102', 'MESH_041'),
('NCT00427102', 'MESH_042'),
('NCT00427102', 'MESH_057'),
('NCT00427102', 'MESH_073'),
('NCT00427102', 'MESH_074'),
('NCT00427102', 'MESH_088'),
('NCT00427102', 'MESH_197'),
('NCT00427102', 'MESH_198'),
('NCT00427102', 'MESH_199'),
('NCT00436800', 'MESH_020'),
('NCT00436800', 'MESH_021'),
('NCT00436800', 'MESH_022'),
('NCT00436800', 'MESH_028'),
('NCT00436800', 'MESH_032'),
('NCT00436800', 'MESH_039'),
('NCT00436800', 'MESH_040'),
('NCT00436800', 'MESH_041'),
('NCT00436800', 'MESH_042'),
('NCT00436800', 'MESH_046'),
('NCT00436800', 'MESH_051'),
('NCT00436800', 'MESH_052'),
('NCT00436800', 'MESH_053'),
('NCT00436800', 'MESH_054'),
('NCT00436800', 'MESH_055'),
('NCT00436800', 'MESH_056'),
('NCT00436800', 'MESH_057'),
('NCT00436800', 'MESH_058'),
('NCT00436800', 'MESH_059'),
('NCT00436800', 'MESH_060'),
('NCT00436800', 'MESH_061'),
('NCT00436800', 'MESH_062'),
('NCT00436800', 'MESH_063'),
('NCT00436800', 'MESH_064'),
('NCT00436800', 'MESH_065'),
('NCT00436800', 'MESH_066'),
('NCT00459043', 'MESH_020'),
('NCT00459043', 'MESH_021'),
('NCT00459043', 'MESH_022'),
('NCT00459043', 'MESH_028'),
('NCT00459043', 'MESH_029'),
('NCT00459043', 'MESH_030'),
('NCT00459043', 'MESH_031'),
('NCT00459043', 'MESH_032'),
('NCT00459043', 'MESH_040'),
('NCT00459043', 'MESH_041'),
('NCT00459043', 'MESH_042'),
('NCT00459043', 'MESH_067'),
('NCT00459043', 'MESH_073'),
('NCT00459043', 'MESH_074'),
('NCT00459043', 'MESH_088'),
('NCT00484601', 'MESH_020'),
('NCT00484601', 'MESH_021'),
('NCT00484601', 'MESH_022'),
('NCT00484601', 'MESH_028'),
('NCT00484601', 'MESH_032'),
('NCT00484601', 'MESH_040'),
('NCT00484601', 'MESH_041'),
('NCT00484601', 'MESH_042'),
('NCT00484601', 'MESH_046'),
('NCT00484601', 'MESH_051'),
('NCT00484601', 'MESH_052'),
('NCT00484601', 'MESH_053'),
('NCT00484601', 'MESH_054'),
('NCT00484601', 'MESH_055'),
('NCT00484601', 'MESH_056'),
('NCT00484601', 'MESH_057'),
('NCT00484601', 'MESH_058'),
('NCT00484601', 'MESH_081'),
('NCT00484601', 'MESH_082'),
('NCT00484601', 'MESH_173'),
('NCT00484601', 'MESH_174'),
('NCT00484601', 'MESH_175'),
('NCT00484601', 'MESH_176'),
('NCT00484601', 'MESH_177'),
('NCT00525200 [PANCHO]', 'MESH_017'),
('NCT00525200 [PANCHO]', 'MESH_018'),
('NCT00525200 [PANCHO]', 'MESH_019'),
('NCT00525200 [PANCHO]', 'MESH_020'),
('NCT00525200 [PANCHO]', 'MESH_021'),
('NCT00525200 [PANCHO]', 'MESH_022'),
('NCT00525200 [PANCHO]', 'MESH_023'),
('NCT00525200 [PANCHO]', 'MESH_024'),
('NCT00525200 [PANCHO]', 'MESH_025'),
('NCT00525200 [PANCHO]', 'MESH_028'),
('NCT00525200 [PANCHO]', 'MESH_029'),
('NCT00525200 [PANCHO]', 'MESH_030'),
('NCT00525200 [PANCHO]', 'MESH_031'),
('NCT00525200 [PANCHO]', 'MESH_032'),
('NCT00525200 [PANCHO]', 'MESH_034'),
('NCT00525200 [PANCHO]', 'MESH_039'),
('NCT00525200 [PANCHO]', 'MESH_061'),
('NCT00525200 [PANCHO]', 'MESH_062'),
('NCT00525200 [PANCHO]', 'MESH_065'),
('NCT00525200 [PANCHO]', 'MESH_066'),
('NCT00525200 [PANCHO]', 'MESH_067'),
('NCT00525200 [PANCHO]', 'MESH_068'),
('NCT00566800', 'MESH_017'),
('NCT00566800', 'MESH_018'),
('NCT00566800', 'MESH_019'),
('NCT00566800', 'MESH_020'),
('NCT00566800', 'MESH_021'),
('NCT00566800', 'MESH_022'),
('NCT00566800', 'MESH_023'),
('NCT00566800', 'MESH_024'),
('NCT00566800', 'MESH_025'),
('NCT00566800', 'MESH_028'),
('NCT00566800', 'MESH_032'),
('NCT00566800', 'MESH_046'),
('NCT00566800', 'MESH_069'),
('NCT00566800', 'MESH_070'),
('NCT00566800', 'MESH_071'),
('NCT00566800', 'MESH_072'),
('NCT00578201 [FOLFOX]', 'MESH_017'),
('NCT00578201 [FOLFOX]', 'MESH_018'),
('NCT00578201 [FOLFOX]', 'MESH_019'),
('NCT00578201 [FOLFOX]', 'MESH_020'),
('NCT00578201 [FOLFOX]', 'MESH_021'),
('NCT00578201 [FOLFOX]', 'MESH_022'),
('NCT00578201 [FOLFOX]', 'MESH_023'),
('NCT00578201 [FOLFOX]', 'MESH_024'),
('NCT00578201 [FOLFOX]', 'MESH_025'),
('NCT00578201 [FOLFOX]', 'MESH_028'),
('NCT00578201 [FOLFOX]', 'MESH_089'),
('NCT00578201 [FOLFOX]', 'MESH_090'),
('NCT00592501', 'MESH_020'),
('NCT00592501', 'MESH_021'),
('NCT00592501', 'MESH_022'),
('NCT00592501', 'MESH_028'),
('NCT00592501', 'MESH_032'),
('NCT00592501', 'MESH_034'),
('NCT00592501', 'MESH_039'),
('NCT00592501', 'MESH_040'),
('NCT00592501', 'MESH_041'),
('NCT00592501', 'MESH_042'),
('NCT00592501', 'MESH_051'),
('NCT00592501', 'MESH_052'),
('NCT00592501', 'MESH_053'),
('NCT00592501', 'MESH_054'),
('NCT00592501', 'MESH_055'),
('NCT00592501', 'MESH_056'),
('NCT00592501', 'MESH_057'),
('NCT00592501', 'MESH_058'),
('NCT00592501', 'MESH_061'),
('NCT00592501', 'MESH_062'),
('NCT00592501', 'MESH_065'),
('NCT00592501', 'MESH_066'),
('NCT00592501', 'MESH_068'),
('NCT00601692', 'MESH_226'),
('NCT00601692', 'MESH_227'),
('NCT00601692', 'MESH_228'),
('NCT00601692', 'MESH_229'),
('NCT00601692', 'MESH_230'),
('NCT00655876', 'MESH_017'),
('NCT00655876', 'MESH_018'),
('NCT00655876', 'MESH_019'),
('NCT00655876', 'MESH_020'),
('NCT00655876', 'MESH_021'),
('NCT00655876', 'MESH_022'),
('NCT00655876', 'MESH_023'),
('NCT00655876', 'MESH_024'),
('NCT00655876', 'MESH_025'),
('NCT00655876', 'MESH_026'),
('NCT00655876', 'MESH_027'),
('NCT00655876', 'MESH_028'),
('NCT00655876', 'MESH_029'),
('NCT00655876', 'MESH_030'),
('NCT00655876', 'MESH_031'),
('NCT00655876', 'MESH_032'),
('NCT00655876', 'MESH_034'),
('NCT00655876', 'MESH_089'),
('NCT00655876', 'MESH_090'),
('NCT00655876', 'MESH_226'),
('NCT00655876', 'MESH_230'),
('NCT00655876', 'MESH_239'),
('NCT00655876', 'MESH_240'),
('NCT00655876', 'MESH_241'),
('NCT00655876', 'MESH_242'),
('NCT00655876', 'MESH_243'),
('NCT00894101', 'MESH_020'),
('NCT00894101', 'MESH_021'),
('NCT00894101', 'MESH_022'),
('NCT00937300', 'MESH_020'),
('NCT00937300', 'MESH_021'),
('NCT00937300', 'MESH_022'),
('NCT00937300', 'MESH_028'),
('NCT00937300', 'MESH_032'),
('NCT00937300', 'MESH_039'),
('NCT00937300', 'MESH_040'),
('NCT00937300', 'MESH_041'),
('NCT00937300', 'MESH_042'),
('NCT00937300', 'MESH_061'),
('NCT00937300', 'MESH_062'),
('NCT00937300', 'MESH_063'),
('NCT00937300', 'MESH_064'),
('NCT00937300', 'MESH_065'),
('NCT00937300', 'MESH_066'),
('NCT00937300', 'MESH_073'),
('NCT00937300', 'MESH_074'),
('NCT00937300', 'MESH_075'),
('NCT00937300', 'MESH_076'),
('NCT00937300', 'MESH_077'),
('NCT00937300', 'MESH_078'),
('NCT00937300', 'MESH_079'),
('NCT00937300', 'MESH_080'),
('NCT00937300', 'MESH_081'),
('NCT00937300', 'MESH_082'),
('NCT00937300', 'MESH_083'),
('NCT00937300', 'MESH_084'),
('NCT00937300', 'MESH_085'),
('NCT00937300', 'MESH_086'),
('NCT00937300', 'MESH_087'),
('NCT00999700 [INTERCEPTOR]', 'MESH_020'),
('NCT00999700 [INTERCEPTOR]', 'MESH_021'),
('NCT00999700 [INTERCEPTOR]', 'MESH_022'),
('NCT00999700 [INTERCEPTOR]', 'MESH_028'),
('NCT00999700 [INTERCEPTOR]', 'MESH_029'),
('NCT00999700 [INTERCEPTOR]', 'MESH_030'),
('NCT00999700 [INTERCEPTOR]', 'MESH_031'),
('NCT00999700 [INTERCEPTOR]', 'MESH_032'),
('NCT00999700 [INTERCEPTOR]', 'MESH_034'),
('NCT00999700 [INTERCEPTOR]', 'MESH_039'),
('NCT00999700 [INTERCEPTOR]', 'MESH_040'),
('NCT00999700 [INTERCEPTOR]', 'MESH_041'),
('NCT00999700 [INTERCEPTOR]', 'MESH_042'),
('NCT00999700 [INTERCEPTOR]', 'MESH_061'),
('NCT00999700 [INTERCEPTOR]', 'MESH_062'),
('NCT00999700 [INTERCEPTOR]', 'MESH_065'),
('NCT00999700 [INTERCEPTOR]', 'MESH_066'),
('NCT00999700 [INTERCEPTOR]', 'MESH_067'),
('NCT00999700 [INTERCEPTOR]', 'MESH_068'),
('NCT00999700 [INTERCEPTOR]', 'MESH_073'),
('NCT00999700 [INTERCEPTOR]', 'MESH_088'),
('NCT00999700 [INTERCEPTOR]', 'MESH_089'),
('NCT00999700 [INTERCEPTOR]', 'MESH_090'),
('NCT01024101', 'MESH_020'),
('NCT01024101', 'MESH_021'),
('NCT01024101', 'MESH_022'),
('NCT01024101', 'MESH_026'),
('NCT01024101', 'MESH_027'),
('NCT01024101', 'MESH_028'),
('NCT01024101', 'MESH_029'),
('NCT01024101', 'MESH_030'),
('NCT01024101', 'MESH_031'),
('NCT01024101', 'MESH_032'),
('NCT01124500', 'MESH_032'),
('NCT01124500', 'MESH_039'),
('NCT01124500', 'MESH_091'),
('NCT01124500', 'MESH_092'),
('NCT01124500', 'MESH_093'),
('NCT01124500', 'MESH_094'),
('NCT01124500', 'MESH_095'),
('NCT01124500', 'MESH_096'),
('NCT01124500', 'MESH_097'),
('NCT01124500', 'MESH_098'),
('NCT01181401 [ICRAT]', 'MESH_021'),
('NCT01181401 [ICRAT]', 'MESH_028'),
('NCT01181401 [ICRAT]', 'MESH_029'),
('NCT01181401 [ICRAT]', 'MESH_030'),
('NCT01181401 [ICRAT]', 'MESH_031'),
('NCT01181401 [ICRAT]', 'MESH_032'),
('NCT01181401 [ICRAT]', 'MESH_034'),
('NCT01181401 [ICRAT]', 'MESH_040'),
('NCT01181401 [ICRAT]', 'MESH_041'),
('NCT01181401 [ICRAT]', 'MESH_042'),
('NCT01181401 [ICRAT]', 'MESH_067'),
('NCT01181401 [ICRAT]', 'MESH_073'),
('NCT01181401 [ICRAT]', 'MESH_074'),
('NCT01181401 [ICRAT]', 'MESH_089'),
('NCT01181401 [ICRAT]', 'MESH_090'),
('NCT01186601', 'MESH_022'),
('NCT01186601', 'MESH_178'),
('NCT01186601', 'MESH_179'),
('NCT01186601', 'MESH_180'),
('NCT01186601', 'MESH_181'),
('NCT01216800', 'MESH_058'),
('NCT01216800', 'MESH_099'),
('NCT01216800', 'MESH_100'),
('NCT01216800', 'MESH_101'),
('NCT01216800', 'MESH_102'),
('NCT01216800', 'MESH_103'),
('NCT01216800', 'MESH_104'),
('NCT01216800', 'MESH_105'),
('NCT01221753', 'MESH_020'),
('NCT01221753', 'MESH_021'),
('NCT01221753', 'MESH_022'),
('NCT01221753', 'MESH_028'),
('NCT01221753', 'MESH_029'),
('NCT01221753', 'MESH_030'),
('NCT01221753', 'MESH_031'),
('NCT01221753', 'MESH_032'),
('NCT01221753', 'MESH_034'),
('NCT01221753', 'MESH_039'),
('NCT01221753', 'MESH_040'),
('NCT01221753', 'MESH_041'),
('NCT01221753', 'MESH_042'),
('NCT01221753', 'MESH_061'),
('NCT01221753', 'MESH_062'),
('NCT01221753', 'MESH_065'),
('NCT01221753', 'MESH_066'),
('NCT01221753', 'MESH_067'),
('NCT01221753', 'MESH_068'),
('NCT01221753', 'MESH_073'),
('NCT01221753', 'MESH_074'),
('NCT01221753', 'MESH_088'),
('NCT01221753', 'MESH_089'),
('NCT01221753', 'MESH_090'),
('NCT01221753', 'MESH_212'),
('NCT01221753', 'MESH_213'),
('NCT01255800', 'MESH_020'),
('NCT01255800', 'MESH_021'),
('NCT01255800', 'MESH_022'),
('NCT01255800', 'MESH_028'),
('NCT01255800', 'MESH_089'),
('NCT01255800', 'MESH_090'),
('NCT01255800', 'MESH_103'),
('NCT01255800', 'MESH_106'),
('NCT01255800', 'MESH_107'),
('NCT01260701', 'MESH_018'),
('NCT01260701', 'MESH_019'),
('NCT01260701', 'MESH_020'),
('NCT01260701', 'MESH_021'),
('NCT01260701', 'MESH_023'),
('NCT01260701', 'MESH_025'),
('NCT01260701', 'MESH_040'),
('NCT01260701', 'MESH_041'),
('NCT01260701', 'MESH_042'),
('NCT01260701', 'MESH_182'),
('NCT01260701', 'MESH_183'),
('NCT01260701', 'MESH_184'),
('NCT01880359', 'MESH_021'),
('NCT01880359', 'MESH_028'),
('NCT01880359', 'MESH_034'),
('NCT01880359', 'MESH_040'),
('NCT01880359', 'MESH_041'),
('NCT01880359', 'MESH_042'),
('NCT01880359', 'MESH_064'),
('NCT01880359', 'MESH_073'),
('NCT01880359', 'MESH_074'),
('NCT01880359', 'MESH_254'),
('NCT01880359', 'MESH_255'),
('NCT01880359', 'MESH_256'),
('NCT01880359', 'MESH_257'),
('NCT02215265 [PATHOS]', 'MESH_020'),
('NCT02215265 [PATHOS]', 'MESH_021'),
('NCT02215265 [PATHOS]', 'MESH_022'),
('NCT02215265 [PATHOS]', 'MESH_028'),
('NCT02215265 [PATHOS]', 'MESH_034'),
('NCT02215265 [PATHOS]', 'MESH_053'),
('NCT02215265 [PATHOS]', 'MESH_054'),
('NCT02215265 [PATHOS]', 'MESH_056'),
('NCT02215265 [PATHOS]', 'MESH_057'),
('NCT02215265 [PATHOS]', 'MESH_058'),
('NCT02215265 [PATHOS]', 'MESH_258'),
('NCT02336711', 'MESH_020'),
('NCT02336711', 'MESH_021'),
('NCT02336711', 'MESH_022'),
('NCT03396718 [DELPHI]', 'MESH_020'),
('NCT03396718 [DELPHI]', 'MESH_021'),
('NCT03396718 [DELPHI]', 'MESH_022'),
('NCT03396718 [DELPHI]', 'MESH_040'),
('NCT03396718 [DELPHI]', 'MESH_041'),
('NCT03396718 [DELPHI]', 'MESH_042'),
('NCT03396718 [DELPHI]', 'MESH_073'),
('NCT03396718 [DELPHI]', 'MESH_074'),
('NCT03396718 [DELPHI]', 'MESH_088'),
('NCT03396718 [DELPHI]', 'MESH_244'),
('NCT03396718 [DELPHI]', 'MESH_245'),
('NCT03396718 [DELPHI]', 'MESH_246'),
('NCT03396718 [DELPHI]', 'MESH_247'),
('NCT03396718 [DELPHI]', 'MESH_248'),
('NCT03396718 [DELPHI]', 'MESH_249'),
('NCT03396718 [DELPHI]', 'MESH_250'),
('NCT03865277 [INDIRA-MISO]', 'MESH_020'),
('NCT03865277 [INDIRA-MISO]', 'MESH_021'),
('NCT03865277 [INDIRA-MISO]', 'MESH_022'),
('NCT03865277 [INDIRA-MISO]', 'MESH_040'),
('NCT03865277 [INDIRA-MISO]', 'MESH_041'),
('NCT03865277 [INDIRA-MISO]', 'MESH_042'),
('NCT03865277 [INDIRA-MISO]', 'MESH_073'),
('NCT03865277 [INDIRA-MISO]', 'MESH_088'),
('NCT03865277 [INDIRA-MISO]', 'MESH_244'),
('NCT03865277 [INDIRA-MISO]', 'MESH_248'),
('NCT03865277 [INDIRA-MISO]', 'MESH_250'),
('NCT03865277 [INDIRA-MISO]', 'MESH_252'),
('NCT03865277 [INDIRA-MISO]', 'MESH_253'),
('NCT03894891', 'MESH_020'),
('NCT03894891', 'MESH_021'),
('NCT03894891', 'MESH_022'),
('NCT03894891', 'MESH_028'),
('NCT03894891', 'MESH_029'),
('NCT03894891', 'MESH_030'),
('NCT03894891', 'MESH_031'),
('NCT03894891', 'MESH_032'),
('NCT03894891', 'MESH_034'),
('NCT03894891', 'MESH_053'),
('NCT03894891', 'MESH_054'),
('NCT03894891', 'MESH_056'),
('NCT03894891', 'MESH_057'),
('NCT03894891', 'MESH_058'),
('NCT03894891', 'MESH_067'),
('NCT03894891', 'MESH_090'),
('NCT03894891', 'MESH_209'),
('NCT03894891', 'MESH_210'),
('NCT03894891', 'MESH_211'),
('NCT05055648 [PROTECT]', 'MESH_017'),
('NCT05055648 [PROTECT]', 'MESH_018'),
('NCT05055648 [PROTECT]', 'MESH_019'),
('NCT05055648 [PROTECT]', 'MESH_020'),
('NCT05055648 [PROTECT]', 'MESH_021'),
('NCT05055648 [PROTECT]', 'MESH_022'),
('NCT05055648 [PROTECT]', 'MESH_023'),
('NCT05055648 [PROTECT]', 'MESH_024'),
('NCT05055648 [PROTECT]', 'MESH_025');

-- --------------------------------------------------------

--
-- Table structure for table `TRIAL_PATIENT_ENROLL`
--

DROP TABLE IF EXISTS `TRIAL_PATIENT_ENROLL`;
CREATE TABLE IF NOT EXISTS `TRIAL_PATIENT_ENROLL` (
  `TRIAL_ID` varchar(25) NOT NULL,
  `TRIALPTN_RECRUITMENT_END_ESTIMATED` varchar(34) DEFAULT NULL,
  `TRIAL_PATIENT_PER_SITE_PER_MONTH` float DEFAULT NULL,
  `TRIAL_PATIENT_PER_SITE_PER_MONTH_ESTIMATED` varchar(42) DEFAULT NULL,
  `TRIALPTN_AGE_RANGE` varchar(18) DEFAULT NULL,
  PRIMARY KEY (`TRIAL_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `TRIAL_PATIENT_ENROLL`:
--   `TRIAL_ID`
--       `TRIAL_SUMMARY` -> `TRIAL_ID`
--

--
-- Dumping data for table `TRIAL_PATIENT_ENROLL`
--

INSERT INTO `TRIAL_PATIENT_ENROLL` (`TRIAL_ID`, `TRIALPTN_RECRUITMENT_END_ESTIMATED`, `TRIAL_PATIENT_PER_SITE_PER_MONTH`, `TRIAL_PATIENT_PER_SITE_PER_MONTH_ESTIMATED`, `TRIALPTN_AGE_RANGE`) VALUES
('NCT00002702', 'Yes', 0.48, 'Yes', 'up to 75 years'),
('NCT00002901', 'Yes', NULL, 'No target enrollment', 'from 18 years'),
('NCT00003055', 'Yes', NULL, 'No target enrollment', 'from 18 years'),
('NCT00003087', 'Yes', NULL, 'Not enough sites', 'from 18 years'),
('NCT00003200', 'Insufficient reference data', NULL, 'No recruitment period', 'from 18 years'),
('NCT00003744', 'Yes', 0.049, 'Yes', 'from 18 years'),
('NCT00004070', 'Yes', NULL, 'Not enough sites', 'from 18 years'),
('NCT00004163', 'Yes', 0.1, 'Yes', 'from 18 years'),
('NCT00004901', 'Yes', NULL, 'No target enrollment', 'from 18 years'),
('NCT00005638', 'Yes', NULL, 'No target enrollment', 'from 18 years'),
('NCT00016900', 'Yes', NULL, 'No target enrollment', 'from 18 years'),
('NCT00019201', 'Yes', NULL, 'No target enrollment', 'from 18 years'),
('NCT00030862', 'Yes', NULL, 'No target enrollment', 'from 18 years'),
('NCT00072332', 'No', NULL, 'No target enrollment', 'from 18 years'),
('NCT00073502', 'No', 0.15, 'No', 'from 18 years'),
('NCT00080002', 'Yes', NULL, 'No target enrollment', 'from 18 years'),
('NCT00095875', 'Yes', 0.16, 'Yes', 'from 18 years'),
('NCT00095901', 'No', 0.053, 'No', 'from 18 years'),
('NCT00095927', 'Yes', 0.18, 'Yes', 'from 18 years'),
('NCT00101075', 'No', NULL, 'Not enough sites', 'from 18 years'),
('NCT00154700', 'Yes', NULL, 'Not enough sites', 'from 18 years'),
('NCT00176800', 'No', NULL, 'Not enough sites', 'from 18 years'),
('NCT00259402', 'No', NULL, 'Not enough sites', '18 to 75 years'),
('NCT00290602', 'Yes', NULL, 'Not enough sites', 'from 18 years'),
('NCT00316862', 'No', 0.043, 'No', 'from 18 years'),
('NCT00354679', 'No', NULL, 'Not enough sites', 'from 18 years'),
('NCT00375700', 'Yes', NULL, 'Not enough sites', 'from 18 years'),
('NCT00389727', 'Yes', NULL, 'Not enough sites', 'from 18 years'),
('NCT00397904', 'No', NULL, 'Not enough sites', 'from 18 years'),
('NCT00401401', 'No', 0.12, 'No', 'from 18 years'),
('NCT00402545', 'No', NULL, 'Not enough sites', 'from 18 years'),
('NCT00427102', 'Yes', NULL, 'No target enrollment', 'from 18 years'),
('NCT00436800', 'No', NULL, 'Not enough sites', 'from 18 years'),
('NCT00459043', 'No', 0.31, 'No', 'from 18 years'),
('NCT00484601', 'Yes', NULL, 'Not enough sites', 'from 18 years'),
('NCT00525200 [PANCHO]', 'Yes', 0.31, 'Yes', 'from 18 years'),
('NCT00566800', 'Yes', NULL, 'Not enough sites', 'from 18 years'),
('NCT00578201 [FOLFOX]', 'Yes', NULL, 'Not enough sites', '18 to 80 years'),
('NCT00592501', 'No', NULL, 'Not enough sites', 'from 18 years'),
('NCT00601692', 'No', NULL, 'Not enough sites', 'from 18 years'),
('NCT00655876', 'No', 0.034, 'No', '18 to 74 years'),
('NCT00894101', 'Yes', NULL, 'Not enough sites', 'from 18 years'),
('NCT00937300', 'Yes', NULL, 'Not enough sites', '18 to 70 years'),
('NCT00999700 [INTERCEPTOR]', 'No', 0.15, 'No', 'from 18 years'),
('NCT01024101', 'Yes', NULL, 'Not enough sites', '20 to 74 years'),
('NCT01124500', 'Yes', NULL, 'Not enough sites', 'from 21 years'),
('NCT01181401 [ICRAT]', 'Yes', 0.51, 'Yes', 'from 18 years'),
('NCT01186601', 'Yes', NULL, 'Not enough sites', '18 to 90 years'),
('NCT01216800', 'Yes', NULL, 'Not enough sites', 'from 18 years'),
('NCT01221753', 'Yes', NULL, 'Not enough sites', 'from 18 years'),
('NCT01255800', 'No', NULL, 'Not enough sites', 'from 18 years'),
('NCT01260701', 'No', 0.016, 'No', 'from 18 years'),
('NCT01880359', 'No', 0.48, 'No', 'from 18 years'),
('NCT02215265 [PATHOS]', 'Yes', 0.2, 'Yes', 'from 18 years'),
('NCT02336711', 'Yes', NULL, 'Not enough sites', 'from 18 years'),
('NCT03396718 [DELPHI]', 'Yes', 0.39, 'Yes', 'from 18 years'),
('NCT03865277 [INDIRA-MISO]', 'Yes', 0.85, 'Yes', 'from 18 years'),
('NCT03894891', 'No', 5.83, 'No', 'from 18 years'),
('NCT05055648 [PROTECT]', 'Yes', 0.48, 'Yes', 'from 18 years');

-- --------------------------------------------------------

--
-- Table structure for table `TRIAL_PHASE`
--

DROP TABLE IF EXISTS `TRIAL_PHASE`;
CREATE TABLE IF NOT EXISTS `TRIAL_PHASE` (
  `TRIAL_ID` varchar(25) NOT NULL,
  `TRIAL_STATUS` varchar(21) DEFAULT NULL,
  `TRIAL_PHASE` varchar(13) DEFAULT NULL,
  `TRIAL_STUDY_START` varchar(11) DEFAULT NULL,
  `TRIAL_STUDY_END` varchar(11) DEFAULT NULL,
  `TRIAL_RESULT_SINCE` varchar(11) DEFAULT NULL,
  PRIMARY KEY (`TRIAL_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `TRIAL_PHASE`:
--   `TRIAL_ID`
--       `TRIAL_SUMMARY` -> `TRIAL_ID`
--

--
-- Dumping data for table `TRIAL_PHASE`
--

INSERT INTO `TRIAL_PHASE` (`TRIAL_ID`, `TRIAL_STATUS`, `TRIAL_PHASE`, `TRIAL_STUDY_START`, `TRIAL_STUDY_END`, `TRIAL_RESULT_SINCE`) VALUES
('NCT00002702', 'no information', 'phase 3', '01-Sep-1992', '11-Jun-2001', ''),
('NCT00002901', 'completed', 'phase 1', '01-Dec-1996', '04-Dec-1999', ''),
('NCT00003055', 'completed', 'phase 2', '01-Jun-1997', '01-Apr-2001', ''),
('NCT00003087', 'completed', 'phase 2', '01-Aug-1997', '01-Feb-2005', ''),
('NCT00003200', 'completed', 'phase 1', '01-Oct-1995', '01-Jun-2008', ''),
('NCT00003744', 'completed', 'phase 2', '01-Nov-1998', '01-May-2004', ''),
('NCT00004070', 'completed', 'phase 1/2', '01-Jul-1999', '01-Dec-2000', ''),
('NCT00004163', 'completed', 'phase 2', '01-Oct-1999', '01-Sep-2001', ''),
('NCT00004901', 'completed', 'phase 1/2', '01-Oct-1999', '01-Jul-2004', ''),
('NCT00005638', 'completed', 'phase 1', '01-Oct-1999', '01-Apr-2004', ''),
('NCT00016900', 'completed', 'phase 2', '01-Dec-2000', '01-Jun-2001', ''),
('NCT00019201', 'completed', 'unknown phase', '01-Aug-1996', '15-Feb-1999', ''),
('NCT00030862', 'completed', 'phase 2', '01-Oct-2001', '01-Dec-2003', ''),
('NCT00072332', 'completed', 'phase 1', '01-Aug-2003', '01-Dec-2009', ''),
('NCT00073502', 'completed', 'phase 2', '01-Oct-2003', '26-Aug-2005', ''),
('NCT00080002', 'terminated', 'phase 2', '01-Dec-2003', '09-Jun-2006', ''),
('NCT00095875', 'completed', 'phase 3', '01-Aug-2004', '01-Apr-2012', '15-May-2013'),
('NCT00095901', 'completed', 'phase 2', '01-Jun-2004', '01-May-2007', ''),
('NCT00095927', 'completed', 'phase 2', '01-May-2003', '01-Jun-2008', ''),
('NCT00101075', 'terminated', 'phase 2', '01-Oct-2004', '01-Mar-2008', ''),
('NCT00154700', 'completed', 'phase 2', '01-Jan-2001', '01-Jul-2005', ''),
('NCT00176800', 'completed', 'phase 2', '01-Nov-2001', '01-May-2013', '14-Apr-16'),
('NCT00259402', 'completed', 'phase 2', '01-Feb-2000', '01-Oct-2008', ''),
('NCT00290602', 'completed', 'phase 2', '01-Feb-2004', '01-Dec-2006', ''),
('NCT00316862', 'completed', 'phase 2', '01-Feb-2006', '15-Oct-2014', '26-Jan-2017'),
('NCT00354679', 'completed', 'phase 2', '01-Apr-2006', '01-Jun-2015', '14-Jan-2016'),
('NCT00375700', 'withdrawn', 'unknown phase', '01-Nov-2006', '01-Jan-2010', ''),
('NCT00389727', 'completed', 'phase 2', '24-Sep-2004', '26-May-2008', ''),
('NCT00397904', 'completed', 'phase 2', '01-Oct-2006', '01-Sep-2010', '22-Oct-2015'),
('NCT00401401', 'terminated', 'phase 1/2', '01-Dec-2006', '01-Oct-2010', '07-Oct-2011'),
('NCT00402545', 'completed', 'phase 1', '01-Jan-2007', '01-Jul-2009', ''),
('NCT00427102', 'terminated', 'phase 1', '01-Jan-2007', '01-Jul-2007', ''),
('NCT00436800', 'completed', 'phase 2', '01-Mar-2005', '01-Oct-2008', ''),
('NCT00459043', 'completed', 'phase 2', '01-Mar-2007', '01-Feb-2012', '28-Feb-2013'),
('NCT00484601', 'terminated', 'phase 2', '15-Apr-2004', '07-Nov-2007', ''),
('NCT00525200 [PANCHO]', 'completed', 'phase 3', '01-Jun-2007', '01-Dec-2012', ''),
('NCT00566800', 'no information', 'phase 1', '01-Jul-2007', '06-Feb-2013', ''),
('NCT00578201 [FOLFOX]', 'completed', 'phase 2', '01-Nov-2007', '01-Feb-2011', ''),
('NCT00592501', 'completed', 'phase 2', '01-Oct-2006', '01-Apr-2019', '02-Jun-2021'),
('NCT00601692', 'completed', 'phase 1', '01-Apr-2003', '01-Dec-2009', ''),
('NCT00655876', 'completed', 'phase 3', '01-Jun-2008', '01-Apr-2015', '20-Dec-2017'),
('NCT00894101', 'withdrawn', 'phase 2/3', '01-May-2009', '01-Apr-2010', ''),
('NCT00937300', 'withdrawn', 'phase 1', '01-Jun-2009', '01-Jun-2011', ''),
('NCT00999700 [INTERCEPTOR]', 'completed', 'phase 3', '01-Sep-2009', '01-Dec-2021', ''),
('NCT01024101', 'completed', 'phase 2', '01-Jan-2004', '01-Dec-2005', ''),
('NCT01124500', 'withdrawn', 'unknown phase', '01-May-2010', '01-May-2012', ''),
('NCT01181401 [ICRAT]', 'completed', 'phase 2', '01-Aug-2010', '15-Jul-2015', ''),
('NCT01186601', 'completed', 'phase 1', '01-Dec-2010', '01-Oct-2011', ''),
('NCT01216800', 'completed', 'phase 3', '01-Aug-2008', '01-Aug-2016', ''),
('NCT01221753', 'terminated', 'phase 2', '01-Jul-2011', '01-Jul-2017', '15-Aug-2016'),
('NCT01255800', 'completed', 'phase 1', '01-Apr-2011', '01-Dec-2013', ''),
('NCT01260701', 'completed', 'phase 2', '01-Jan-2011', '01-Jul-2015', '07-Jul-2014'),
('NCT01880359', 'completed', 'phase 3', '01-Jul-2014', '04-Nov-2020', ''),
('NCT02215265 [PATHOS]', 'recruiting', 'phase 3', '01-Oct-2015', '25-Aug-2027', ''),
('NCT02336711', 'completed', 'unknown phase', '01-Nov-2014', '01-Sep-2016', ''),
('NCT03396718 [DELPHI]', 'recruiting', 'unknown phase', '04-Sep-2018', '01-Jan-2029', ''),
('NCT03865277 [INDIRA-MISO]', 'not yet recruiting', 'phase 2', '01-Feb-2022', '30-Sep-2027', ''),
('NCT03894891', 'active not recruiting', 'phase 2', '11-Jun-2019', '30-Nov-2024', ''),
('NCT05055648 [PROTECT]', 'not yet recruiting', 'unknown phase', '01-Oct-2021', '01-Oct-2029', '');

-- --------------------------------------------------------

--
-- Table structure for table `TRIAL_PUB`
--

DROP TABLE IF EXISTS `TRIAL_PUB`;
CREATE TABLE IF NOT EXISTS `TRIAL_PUB` (
  `TRIAL_ID` varchar(25) NOT NULL,
  `PUB_ID` varchar(7) NOT NULL,
  PRIMARY KEY (`TRIAL_ID`,`PUB_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `TRIAL_PUB`:
--   `TRIAL_ID`
--       `TRIAL_STUDY_DETAILS` -> `TRIAL_ID`
--   `PUB_ID`
--       `PUBLICATION` -> `PUB_ID`
--

--
-- Dumping data for table `TRIAL_PUB`
--

INSERT INTO `TRIAL_PUB` (`TRIAL_ID`, `PUB_ID`) VALUES
('NCT00003087', 'PUB_018'),
('NCT00003087', 'PUB_019'),
('NCT00005638', 'PUB_020'),
('NCT00095875', 'PUB_017'),
('NCT00095927', 'PUB_016'),
('NCT00290602', 'PUB_014'),
('NCT00290602', 'PUB_015'),
('NCT00525200 [PANCHO]', 'PUB_001'),
('NCT00655876', 'PUB_021'),
('NCT00999700 [INTERCEPTOR]', 'PUB_002'),
('NCT00999700 [INTERCEPTOR]', 'PUB_003'),
('NCT00999700 [INTERCEPTOR]', 'PUB_004'),
('NCT00999700 [INTERCEPTOR]', 'PUB_005'),
('NCT00999700 [INTERCEPTOR]', 'PUB_006'),
('NCT00999700 [INTERCEPTOR]', 'PUB_007'),
('NCT00999700 [INTERCEPTOR]', 'PUB_008'),
('NCT00999700 [INTERCEPTOR]', 'PUB_009'),
('NCT01181401 [ICRAT]', 'PUB_006'),
('NCT01181401 [ICRAT]', 'PUB_007'),
('NCT01181401 [ICRAT]', 'PUB_010'),
('NCT01181401 [ICRAT]', 'PUB_011'),
('NCT01186601', 'PUB_012'),
('NCT01186601', 'PUB_023'),
('NCT01260701', 'PUB_013'),
('NCT02215265 [PATHOS]', 'PUB_022');

-- --------------------------------------------------------

--
-- Table structure for table `TRIAL_SITE`
--

DROP TABLE IF EXISTS `TRIAL_SITE`;
CREATE TABLE IF NOT EXISTS `TRIAL_SITE` (
  `TRIAL_ID` varchar(25) NOT NULL,
  `SITE_ID` varchar(9) NOT NULL,
  PRIMARY KEY (`TRIAL_ID`,`SITE_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `TRIAL_SITE`:
--   `TRIAL_ID`
--       `TRIAL_SUMMARY` -> `TRIAL_ID`
--

--
-- Dumping data for table `TRIAL_SITE`
--

INSERT INTO `TRIAL_SITE` (`TRIAL_ID`, `SITE_ID`) VALUES
('NCT00002702', 'SITE_155'),
('NCT00002702', 'SITE_156'),
('NCT00002702', 'SITE_157'),
('NCT00002702', 'SITE_158'),
('NCT00002702', 'SITE_159'),
('NCT00002702', 'SITE_160'),
('NCT00002702', 'SITE_161'),
('NCT00002901', 'SITE_49'),
('NCT00002901', 'SITE_50'),
('NCT00002901', 'SITE_51'),
('NCT00003055', 'SITE_256'),
('NCT00003087', 'SITE_255'),
('NCT00003200', 'SITE_01'),
('NCT00003200', 'SITE_02'),
('NCT00003200', 'SITE_03'),
('NCT00003200', 'SITE_04'),
('NCT00003744', 'SITE_221'),
('NCT00003744', 'SITE_222'),
('NCT00003744', 'SITE_223'),
('NCT00003744', 'SITE_224'),
('NCT00003744', 'SITE_225'),
('NCT00003744', 'SITE_226'),
('NCT00004070', 'SITE_201'),
('NCT00004070', 'SITE_202'),
('NCT00004163', 'SITE_211'),
('NCT00004163', 'SITE_212'),
('NCT00004163', 'SITE_213'),
('NCT00004163', 'SITE_214'),
('NCT00004163', 'SITE_215'),
('NCT00004163', 'SITE_216'),
('NCT00004163', 'SITE_217'),
('NCT00004163', 'SITE_218'),
('NCT00004163', 'SITE_219'),
('NCT00004163', 'SITE_220'),
('NCT00004901', 'SITE_52'),
('NCT00004901', 'SITE_53'),
('NCT00005638', 'SITE_259'),
('NCT00005638', 'SITE_260'),
('NCT00016900', 'SITE_05'),
('NCT00019201', 'SITE_54'),
('NCT00030862', 'SITE_258'),
('NCT00072332', 'SITE_257'),
('NCT00073502', 'SITE_162'),
('NCT00073502', 'SITE_163'),
('NCT00073502', 'SITE_164'),
('NCT00073502', 'SITE_165'),
('NCT00073502', 'SITE_166'),
('NCT00073502', 'SITE_167'),
('NCT00073502', 'SITE_168'),
('NCT00073502', 'SITE_169'),
('NCT00073502', 'SITE_170'),
('NCT00073502', 'SITE_171'),
('NCT00080002', 'SITE_172'),
('NCT00095875', 'SITE_186'),
('NCT00095875', 'SITE_187'),
('NCT00095875', 'SITE_188'),
('NCT00095875', 'SITE_189'),
('NCT00095875', 'SITE_190'),
('NCT00095875', 'SITE_191'),
('NCT00095875', 'SITE_192'),
('NCT00095875', 'SITE_193'),
('NCT00095875', 'SITE_194'),
('NCT00095875', 'SITE_195'),
('NCT00095875', 'SITE_196'),
('NCT00095875', 'SITE_197'),
('NCT00095875', 'SITE_198'),
('NCT00095875', 'SITE_199'),
('NCT00095875', 'SITE_200'),
('NCT00095901', 'SITE_55'),
('NCT00095901', 'SITE_56'),
('NCT00095901', 'SITE_57'),
('NCT00095927', 'SITE_177'),
('NCT00095927', 'SITE_178'),
('NCT00095927', 'SITE_179'),
('NCT00095927', 'SITE_180'),
('NCT00095927', 'SITE_181'),
('NCT00095927', 'SITE_182'),
('NCT00095927', 'SITE_183'),
('NCT00095927', 'SITE_184'),
('NCT00095927', 'SITE_185'),
('NCT00101075', 'SITE_227'),
('NCT00154700', 'SITE_06'),
('NCT00176800', 'SITE_07'),
('NCT00259402', 'SITE_173'),
('NCT00290602', 'SITE_174'),
('NCT00316862', 'SITE_231'),
('NCT00316862', 'SITE_232'),
('NCT00316862', 'SITE_233'),
('NCT00316862', 'SITE_234'),
('NCT00316862', 'SITE_235'),
('NCT00316862', 'SITE_236'),
('NCT00316862', 'SITE_237'),
('NCT00316862', 'SITE_238'),
('NCT00316862', 'SITE_239'),
('NCT00316862', 'SITE_240'),
('NCT00316862', 'SITE_241'),
('NCT00316862', 'SITE_242'),
('NCT00316862', 'SITE_243'),
('NCT00316862', 'SITE_244'),
('NCT00316862', 'SITE_245'),
('NCT00316862', 'SITE_246'),
('NCT00316862', 'SITE_247'),
('NCT00316862', 'SITE_248'),
('NCT00316862', 'SITE_249'),
('NCT00316862', 'SITE_250'),
('NCT00316862', 'SITE_251'),
('NCT00316862', 'SITE_252'),
('NCT00316862', 'SITE_253'),
('NCT00316862', 'SITE_254'),
('NCT00354679', 'SITE_230'),
('NCT00375700', 'SITE_08'),
('NCT00389727', 'SITE_UNKW'),
('NCT00397904', 'SITE_229'),
('NCT00401401', 'SITE_58'),
('NCT00401401', 'SITE_59'),
('NCT00401401', 'SITE_60'),
('NCT00401401', 'SITE_61'),
('NCT00401401', 'SITE_62'),
('NCT00401401', 'SITE_63'),
('NCT00401401', 'SITE_64'),
('NCT00402545', 'SITE_176'),
('NCT00427102', 'SITE_175'),
('NCT00436800', 'SITE_09'),
('NCT00459043', 'SITE_208'),
('NCT00459043', 'SITE_209'),
('NCT00459043', 'SITE_210'),
('NCT00484601', 'SITE_65'),
('NCT00525200 [PANCHO]', 'SITE_10'),
('NCT00525200 [PANCHO]', 'SITE_11'),
('NCT00525200 [PANCHO]', 'SITE_12'),
('NCT00525200 [PANCHO]', 'SITE_13'),
('NCT00525200 [PANCHO]', 'SITE_14'),
('NCT00525200 [PANCHO]', 'SITE_15'),
('NCT00525200 [PANCHO]', 'SITE_16'),
('NCT00525200 [PANCHO]', 'SITE_17'),
('NCT00525200 [PANCHO]', 'SITE_18'),
('NCT00525200 [PANCHO]', 'SITE_19'),
('NCT00525200 [PANCHO]', 'SITE_20'),
('NCT00525200 [PANCHO]', 'SITE_21'),
('NCT00525200 [PANCHO]', 'SITE_22'),
('NCT00566800', 'SITE_23'),
('NCT00578201 [FOLFOX]', 'SITE_66'),
('NCT00592501', 'SITE_67'),
('NCT00592501', 'SITE_68'),
('NCT00601692', 'SITE_228'),
('NCT00655876', 'SITE_261'),
('NCT00655876', 'SITE_262'),
('NCT00655876', 'SITE_263'),
('NCT00655876', 'SITE_264'),
('NCT00655876', 'SITE_265'),
('NCT00655876', 'SITE_266'),
('NCT00655876', 'SITE_267'),
('NCT00655876', 'SITE_268'),
('NCT00655876', 'SITE_269'),
('NCT00655876', 'SITE_270'),
('NCT00655876', 'SITE_271'),
('NCT00655876', 'SITE_272'),
('NCT00655876', 'SITE_273'),
('NCT00655876', 'SITE_274'),
('NCT00655876', 'SITE_275'),
('NCT00894101', 'SITE_69'),
('NCT00937300', 'SITE_24'),
('NCT00999700 [INTERCEPTOR]', 'SITE_25'),
('NCT00999700 [INTERCEPTOR]', 'SITE_26'),
('NCT00999700 [INTERCEPTOR]', 'SITE_27'),
('NCT00999700 [INTERCEPTOR]', 'SITE_28'),
('NCT00999700 [INTERCEPTOR]', 'SITE_29'),
('NCT00999700 [INTERCEPTOR]', 'SITE_30'),
('NCT00999700 [INTERCEPTOR]', 'SITE_31'),
('NCT00999700 [INTERCEPTOR]', 'SITE_32'),
('NCT00999700 [INTERCEPTOR]', 'SITE_33'),
('NCT00999700 [INTERCEPTOR]', 'SITE_34'),
('NCT00999700 [INTERCEPTOR]', 'SITE_35'),
('NCT00999700 [INTERCEPTOR]', 'SITE_36'),
('NCT00999700 [INTERCEPTOR]', 'SITE_37'),
('NCT00999700 [INTERCEPTOR]', 'SITE_38'),
('NCT00999700 [INTERCEPTOR]', 'SITE_39'),
('NCT00999700 [INTERCEPTOR]', 'SITE_40'),
('NCT00999700 [INTERCEPTOR]', 'SITE_41'),
('NCT00999700 [INTERCEPTOR]', 'SITE_42'),
('NCT00999700 [INTERCEPTOR]', 'SITE_43'),
('NCT00999700 [INTERCEPTOR]', 'SITE_44'),
('NCT00999700 [INTERCEPTOR]', 'SITE_45'),
('NCT01024101', 'SITE_70'),
('NCT01124500', 'SITE_46'),
('NCT01181401 [ICRAT]', 'SITE_71'),
('NCT01181401 [ICRAT]', 'SITE_72'),
('NCT01181401 [ICRAT]', 'SITE_73'),
('NCT01181401 [ICRAT]', 'SITE_74'),
('NCT01181401 [ICRAT]', 'SITE_75'),
('NCT01186601', 'SITE_76'),
('NCT01216800', 'SITE_47'),
('NCT01221753', 'SITE_207'),
('NCT01255800', 'SITE_48'),
('NCT01260701', 'SITE_100'),
('NCT01260701', 'SITE_101'),
('NCT01260701', 'SITE_102'),
('NCT01260701', 'SITE_103'),
('NCT01260701', 'SITE_104'),
('NCT01260701', 'SITE_105'),
('NCT01260701', 'SITE_106'),
('NCT01260701', 'SITE_107'),
('NCT01260701', 'SITE_108'),
('NCT01260701', 'SITE_109'),
('NCT01260701', 'SITE_110'),
('NCT01260701', 'SITE_111'),
('NCT01260701', 'SITE_112'),
('NCT01260701', 'SITE_113'),
('NCT01260701', 'SITE_114'),
('NCT01260701', 'SITE_115'),
('NCT01260701', 'SITE_116'),
('NCT01260701', 'SITE_117'),
('NCT01260701', 'SITE_118'),
('NCT01260701', 'SITE_119'),
('NCT01260701', 'SITE_120'),
('NCT01260701', 'SITE_121'),
('NCT01260701', 'SITE_122'),
('NCT01260701', 'SITE_123'),
('NCT01260701', 'SITE_124'),
('NCT01260701', 'SITE_125'),
('NCT01260701', 'SITE_126'),
('NCT01260701', 'SITE_127'),
('NCT01260701', 'SITE_128'),
('NCT01260701', 'SITE_129'),
('NCT01260701', 'SITE_130'),
('NCT01260701', 'SITE_131'),
('NCT01260701', 'SITE_132'),
('NCT01260701', 'SITE_133'),
('NCT01260701', 'SITE_134'),
('NCT01260701', 'SITE_135'),
('NCT01260701', 'SITE_136'),
('NCT01260701', 'SITE_137'),
('NCT01260701', 'SITE_138'),
('NCT01260701', 'SITE_139'),
('NCT01260701', 'SITE_140'),
('NCT01260701', 'SITE_141'),
('NCT01260701', 'SITE_142'),
('NCT01260701', 'SITE_143'),
('NCT01260701', 'SITE_144'),
('NCT01260701', 'SITE_145'),
('NCT01260701', 'SITE_146'),
('NCT01260701', 'SITE_147'),
('NCT01260701', 'SITE_148'),
('NCT01260701', 'SITE_149'),
('NCT01260701', 'SITE_150'),
('NCT01260701', 'SITE_151'),
('NCT01260701', 'SITE_152'),
('NCT01260701', 'SITE_153'),
('NCT01260701', 'SITE_154'),
('NCT01260701', 'SITE_77'),
('NCT01260701', 'SITE_78'),
('NCT01260701', 'SITE_79'),
('NCT01260701', 'SITE_80'),
('NCT01260701', 'SITE_81'),
('NCT01260701', 'SITE_82'),
('NCT01260701', 'SITE_83'),
('NCT01260701', 'SITE_84'),
('NCT01260701', 'SITE_85'),
('NCT01260701', 'SITE_86'),
('NCT01260701', 'SITE_87'),
('NCT01260701', 'SITE_88'),
('NCT01260701', 'SITE_89'),
('NCT01260701', 'SITE_90'),
('NCT01260701', 'SITE_91'),
('NCT01260701', 'SITE_92'),
('NCT01260701', 'SITE_93'),
('NCT01260701', 'SITE_94'),
('NCT01260701', 'SITE_96'),
('NCT01260701', 'SITE_97'),
('NCT01260701', 'SITE_98'),
('NCT01260701', 'SITE_99'),
('NCT01880359', 'SITE_163'),
('NCT01880359', 'SITE_164'),
('NCT01880359', 'SITE_297'),
('NCT01880359', 'SITE_298'),
('NCT01880359', 'SITE_UNDC'),
('NCT01880359', 'SITE_UNKW'),
('NCT02215265 [PATHOS]', 'SITE_UNKW'),
('NCT02336711', 'SITE_295'),
('NCT02336711', 'SITE_296'),
('NCT03396718 [DELPHI]', 'SITE_276'),
('NCT03396718 [DELPHI]', 'SITE_277'),
('NCT03396718 [DELPHI]', 'SITE_278'),
('NCT03396718 [DELPHI]', 'SITE_279'),
('NCT03396718 [DELPHI]', 'SITE_280'),
('NCT03396718 [DELPHI]', 'SITE_281'),
('NCT03396718 [DELPHI]', 'SITE_282'),
('NCT03396718 [DELPHI]', 'SITE_283'),
('NCT03396718 [DELPHI]', 'SITE_284'),
('NCT03396718 [DELPHI]', 'SITE_285'),
('NCT03865277 [INDIRA-MISO]', 'SITE_286'),
('NCT03865277 [INDIRA-MISO]', 'SITE_287'),
('NCT03865277 [INDIRA-MISO]', 'SITE_288'),
('NCT03865277 [INDIRA-MISO]', 'SITE_289'),
('NCT03865277 [INDIRA-MISO]', 'SITE_290'),
('NCT03865277 [INDIRA-MISO]', 'SITE_291'),
('NCT03865277 [INDIRA-MISO]', 'SITE_292'),
('NCT03865277 [INDIRA-MISO]', 'SITE_293'),
('NCT03865277 [INDIRA-MISO]', 'SITE_294'),
('NCT03894891', 'SITE_203'),
('NCT03894891', 'SITE_204'),
('NCT03894891', 'SITE_205'),
('NCT03894891', 'SITE_206'),
('NCT05055648 [PROTECT]', 'SITE_UNKW');

-- --------------------------------------------------------

--
-- Table structure for table `TRIAL_STUDY_DETAILS`
--

DROP TABLE IF EXISTS `TRIAL_STUDY_DETAILS`;
CREATE TABLE IF NOT EXISTS `TRIAL_STUDY_DETAILS` (
  `TRIAL_ID` varchar(25) NOT NULL,
  `TRIAL_PRIMARY_COMPLETION_DATE` varchar(11) DEFAULT NULL,
  `TRIAL_STUDY_END_ESTIMATED` varchar(24) DEFAULT NULL,
  `TRIAL_RECRUITMENT_START` varchar(11) DEFAULT NULL,
  `TRIAL_RECRUITMENT_END` varchar(11) DEFAULT NULL,
  `TRIAL_RECRUITMENT_END_ESTIMATED` varchar(27) DEFAULT NULL,
  PRIMARY KEY (`TRIAL_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `TRIAL_STUDY_DETAILS`:
--   `TRIAL_ID`
--       `TRIAL_SUMMARY` -> `TRIAL_ID`
--

--
-- Dumping data for table `TRIAL_STUDY_DETAILS`
--

INSERT INTO `TRIAL_STUDY_DETAILS` (`TRIAL_ID`, `TRIAL_PRIMARY_COMPLETION_DATE`, `TRIAL_STUDY_END_ESTIMATED`, `TRIAL_RECRUITMENT_START`, `TRIAL_RECRUITMENT_END`, `TRIAL_RECRUITMENT_END_ESTIMATED`) VALUES
('NCT00002702', '', 'Yes, average: 105 months', '01-Sep-1992', '27-Jan-1999', 'Yes'),
('NCT00002901', '', 'Yes, average: 36 months', '01-Dec-1996', '11-Jun-1999', 'Yes'),
('NCT00003055', '01-Apr-2001', 'No', '01-Jun-1997', '19-Mar-2000', 'Yes'),
('NCT00003087', '01-Feb-2005', 'No', '01-Aug-1997', '23-Jul-2001', 'Yes'),
('NCT00003200', '01-Oct-2006', 'No', '', '', 'Insufficient reference data'),
('NCT00003744', '01-May-2004', 'No', '01-Nov-1998', '15-Apr-2003', 'Yes'),
('NCT00004070', '01-Nov-2000', 'No', '01-Jul-1999', '07-Jun-2000', 'Yes'),
('NCT00004163', '01-Sep-2001', 'No', '01-Oct-1999', '24-Nov-2000', 'Yes'),
('NCT00004901', '', 'No', '01-Oct-1999', '23-Dec-2002', 'Yes'),
('NCT00005638', '01-Apr-2004', 'No', '01-Oct-1999', '27-Dec-2002', 'Yes'),
('NCT00016900', '01-Jun-2001', 'No', '01-Dec-2000', '07-Mar-2001', 'Yes'),
('NCT00019201', '', 'Yes, average: 30 months', '01-Aug-1996', '05-Apr-1998', 'Yes'),
('NCT00030862', '01-Dec-2003', 'No', '01-Oct-2001', '01-May-2003', 'Yes'),
('NCT00072332', '01-Dec-2005', 'No', '01-Aug-2003', '21-Sep-2005', 'No'),
('NCT00073502', '', 'No', '01-Oct-2003', '23-Jun-2005', 'No'),
('NCT00080002', '', 'Yes, average: 30 months', '01-Dec-2003', '30-Jul-2005', 'Yes'),
('NCT00095875', '01-Apr-2012', 'No', '01-Aug-2004', '31-May-2009', 'Yes'),
('NCT00095901', '01-May-2007', 'No', '01-Jun-2004', '14-Dec-2005', 'No'),
('NCT00095927', '01-Jun-2007', 'No', '01-May-2003', '09-Jan-2006', 'Yes'),
('NCT00101075', '01-Mar-2007', 'No', '01-Oct-2004', '26-Apr-2007', 'No'),
('NCT00154700', '', 'No', '01-Jan-2001', '21-May-2003', 'Yes'),
('NCT00176800', '01-Feb-2006', 'No', '01-Nov-2001', '16-Dec-2007', 'No'),
('NCT00259402', '01-Oct-2008', 'No', '11-Jul-2007', '15-Apr-2008', 'No'),
('NCT00290602', '', 'No', '01-Feb-2004', '08-Jun-2006', 'Yes'),
('NCT00316862', '01-Dec-2012', 'No', '01-Feb-2006', '06-Sep-2012', 'No'),
('NCT00354679', '01-Jun-2015', 'No', '01-Apr-2006', '12-Mar-2013', 'No'),
('NCT00375700', '01-Jan-2010', 'No', '30-Jan-2007', '03-Jan-2009', 'Yes'),
('NCT00389727', '26-May-2008', 'No', '24-Sep-2004', '25-Feb-2007', 'Yes'),
('NCT00397904', '01-Sep-2010', 'No', '01-Oct-2006', '16-Feb-2010', 'No'),
('NCT00401401', '01-Oct-2010', 'No', '01-Dec-2006', '11-Dec-2009', 'No'),
('NCT00402545', '01-Jul-2009', 'No', '01-Jan-2007', '17-Sep-2008', 'No'),
('NCT00427102', '', 'No', '25-Jan-2007', '30-Apr-2007', 'Yes'),
('NCT00436800', '01-Oct-2008', 'No', '01-Mar-2005', '18-Jun-2007', 'No'),
('NCT00459043', '01-Mar-2010', 'No', '01-Mar-2007', '30-Oct-2009', 'No'),
('NCT00484601', '07-Nov-2007', 'No', '15-Apr-2004', '21-Aug-2006', 'Yes'),
('NCT00525200 [PANCHO]', '01-May-2012', 'No', '01-Jun-2007', '18-Nov-2010', 'Yes'),
('NCT00566800', '', 'Yes, average: 67 months', '01-Jul-2007', '22-Apr-2011', 'Yes'),
('NCT00578201 [FOLFOX]', '01-Feb-2011', 'No', '01-Nov-2007', '08-Sep-2009', 'Yes'),
('NCT00592501', '01-Apr-2019', 'No', '01-Oct-2006', '01-Apr-2013', 'No'),
('NCT00601692', '01-Dec-2009', 'No', '01-Apr-2003', '13-May-2009', 'No'),
('NCT00655876', '01-Apr-2015', 'No', '17-Jul-2008', '30-Jul-2013', 'No'),
('NCT00894101', '01-Apr-2010', 'No', '01-May-2009', '08-Dec-2009', 'Yes'),
('NCT00937300', '01-Jun-2011', 'No', '01-Jun-2009', '01-Nov-2010', 'Yes'),
('NCT00999700 [INTERCEPTOR]', '31-Dec-2016', 'No', '01-Sep-2009', '27-Feb-2017', 'No'),
('NCT01024101', '01-Dec-2005', 'No', '01-Jan-2004', '06-Jan-2005', 'Yes'),
('NCT01124500', '01-May-2012', 'No', '01-May-2010', '26-Aug-2011', 'Yes'),
('NCT01181401 [ICRAT]', '01-Apr-2015', 'No', '01-Aug-2010', '18-Aug-2013', 'Yes'),
('NCT01186601', '01-Oct-2011', 'No', '14-Dec-2010', '24-Jun-2011', 'Yes'),
('NCT01216800', '01-Aug-2016', 'No', '01-Aug-2008', '11-Nov-2013', 'Yes'),
('NCT01221753', '01-Jul-2012', 'No', '01-Jul-2011', '30-Jul-2015', 'Yes'),
('NCT01255800', '01-Dec-2013', 'No', '18-Apr-2011', '18-Oct-2013', 'No'),
('NCT01260701', '01-May-2014', 'No', '10-Feb-2011', '28-May-2013', 'No'),
('NCT01880359', '06-Sep-2019', 'No', '01-Jul-2014', '25-Feb-2018', 'No'),
('NCT02215265 [PATHOS]', '01-Oct-2026', 'No', '01-Oct-2015', '22-Feb-2024', 'Yes'),
('NCT02336711', '01-Sep-2016', 'No', '01-Nov-2014', '17-Jan-2016', 'Yes'),
('NCT03396718 [DELPHI]', '01-Jan-2026', 'No', '04-Sep-2018', '28-Jun-2025', 'Yes'),
('NCT03865277 [INDIRA-MISO]', '30-Sep-2025', 'No', '01-Feb-2022', '27-Oct-2025', 'Yes'),
('NCT03894891', '30-Mar-2022', 'No', '26-Jun-2019', '07-Sep-2019', 'No'),
('NCT05055648 [PROTECT]', '01-Oct-2024', 'No', '01-Oct-2021', '11-Jan-2027', 'Yes');

-- --------------------------------------------------------

--
-- Table structure for table `TRIAL_SUMMARY`
--

DROP TABLE IF EXISTS `TRIAL_SUMMARY`;
CREATE TABLE IF NOT EXISTS `TRIAL_SUMMARY` (
  `TRIAL_ID` varchar(25) NOT NULL,
  `TRIAL_ALT_ID` varchar(148) DEFAULT NULL,
  `TRIAL_NAME` varchar(202) DEFAULT NULL,
  `TRIAL_TREATMENTS` varchar(113) DEFAULT NULL,
  `TRIAL_CTR_ENROLL` varchar(186) DEFAULT NULL,
  `TRIAL_STATUS` varchar(21) DEFAULT NULL,
  `TRIAL_PHASE` varchar(13) DEFAULT NULL,
  `TRIAL_URL` varchar(46) DEFAULT NULL,
  PRIMARY KEY (`TRIAL_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `TRIAL_SUMMARY`:
--

--
-- Dumping data for table `TRIAL_SUMMARY`
--

INSERT INTO `TRIAL_SUMMARY` (`TRIAL_ID`, `TRIAL_ALT_ID`, `TRIAL_NAME`, `TRIAL_TREATMENTS`, `TRIAL_CTR_ENROLL`, `TRIAL_STATUS`, `TRIAL_PHASE`, `TRIAL_URL`) VALUES
('NCT00002702', 'CDR0000064500, CNR-9506, EU-95024', 'Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx', 'aldesleukin', 'Italy: 260', 'no information', 'phase 3', 'http://clinicaltrials.gov/ct2/show/NCT00002702'),
('NCT00002901', 'CDR0000065241, CHNMC-IRB-96118, NCI-T96-0028H, P30CA033572, U01CA062505', 'Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function', 'docetaxel', 'United States: 3', 'completed', 'phase 1', 'http://clinicaltrials.gov/ct2/show/NCT00002901'),
('NCT00003055', 'CDR0000065703, NCI-G97-1306', 'Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer', 'Cisplatin, irinotecan', 'United States: 1', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00003055'),
('NCT00003087', 'CDR0000065787, NCI-T97-0066', 'Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus', 'Cisplatin, Paclitaxel', 'United States: 25', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00003087'),
('NCT00003200', 'NCI-G98-1382, P30CA006516', 'Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck', 'docetaxel', 'United States: 22', 'completed', 'phase 1', 'http://clinicaltrials.gov/ct2/show/NCT00003200'),
('NCT00003744', 'DFCI-98168, LILLY-DFCI-98168, NCI-G99-1496, P30CA006516', 'Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery', 'gemcitabine', 'United States: 16', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00003744'),
('NCT00004070', 'CDR0000067274, NCI-G99-1578, VALENTIS-DFCI-99081, P30CA006516', 'Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer', 'Edodekin alfa', 'United States: 7', 'completed', 'phase 1/2', 'http://clinicaltrials.gov/ct2/show/NCT00004070'),
('NCT00004163', 'CDR0000067405, NCI-G99-1628, P30CA006516', 'Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer', 'trastuzumab', 'United States: 14', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00004163'),
('NCT00004901', 'CDR0000067580, NCI-G00-1680', 'Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer', 'Hydroxyurea, Fluorouracil, Eniluracil', 'United States: 2', 'completed', 'phase 1/2', 'http://clinicaltrials.gov/ct2/show/NCT00004901'),
('NCT00005638', 'CDR0000067794, NCI-G00-1766', 'Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer', 'Cisplatin, irinotecan', 'United States: 2', 'completed', 'phase 1', 'http://clinicaltrials.gov/ct2/show/NCT00005638'),
('NCT00016900', 'CDR0000068614, NCI-G01-1946, P-UPJOHN-914-ONC-0355-009', 'PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus', 'Paclitaxel', 'United States: 1', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00016900'),
('NCT00019201', 'CDR0000065062, NCI-96-C-0128, NCT00001511', 'Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer', '', 'United States: 1', 'completed', 'unknown phase', 'http://clinicaltrials.gov/ct2/show/NCT00019201'),
('NCT00030862', 'CDR0000069204, NCI-G01-2050, PHARMACIA-440E-ONC-0020-319', 'Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus', 'Cisplatin, irinotecan', 'United States: 1', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00030862'),
('NCT00072332', 'CDR0000339607, MSKCC-03070, PHARMACIA-EDOAES-2730-001', 'Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors', 'Cisplatin, edotecarin', 'United States: 1', 'completed', 'phase 1', 'http://clinicaltrials.gov/ct2/show/NCT00072332'),
('NCT00073502', 'OSI-904-201, UKCTG17306', 'Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer', 'OSI-7904L', 'Belgium: 3, United Kingdom: 31, United States: 9', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00073502'),
('NCT00080002', 'CAM-9011', 'Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction', 'pegamotecan', 'United States: 1', 'terminated', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00080002'),
('NCT00095875', 'CDR0000393548, DFCI 04-006, NCT00705068, P30CA006516', 'Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)', 'Cisplatin, Carboplatin, Fluorouracil, docetaxel', 'Germany: 10, United States: 135', 'completed', 'phase 3', 'http://clinicaltrials.gov/ct2/show/NCT00095875'),
('NCT00095901', 'P30CA006516', 'Capecitabine For Nasopharyngeal Cancer', 'capecitabine', 'United States: 3', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00095901'),
('NCT00095927', 'P30CA006516', 'Randomized Amifostine For SCCHN', 'Carboplatin, Paclitaxel, Amifostine', 'United States: 58', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00095927'),
('NCT00101075', 'SANOFI-DFCI-04149, P30CA006516', 'Title XELOX FOR SALIVARY GLAND CANCERS', 'oxaliplatin, capecitabine', 'United States: 9', 'terminated', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00101075'),
('NCT00154700', '159I9', 'Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer', 'Cisplatin, Folic Acid, Paclitaxel, Fluorouracil', 'Taiwan: 40', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00154700'),
('NCT00176800', 'UMCC 2001-007, HUM 49005 Legacy 2001-0623', 'Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma', 'Decuprate', 'United States: 69', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00176800'),
('NCT00259402', 'EFC_7127', 'Oxaliplatin in Esophagus Cancer (Advanced) 1st Line', 'Cisplatin, oxaliplatin', 'Spain: 41', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00259402'),
('NCT00290602', 'NCCCTS-04-087', 'Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome', 'Methylprednisolone Hemisuccinate', 'South Korea: 40', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00290602'),
('NCT00316862', 'CALGB-80302, CDR0000468495, NCI-2009-00491, U10CA180821', 'Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery', 'Cisplatin, irinotecan', 'United States: 82', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00316862'),
('NCT00354679', 'MSKCC-06013, P30CA008748', 'Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer', 'Cisplatin, bevacizumab, irinotecan', 'United States: 34', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00354679'),
('NCT00375700', 'HN-4-0029', 'Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy', '', 'Canada: 35', 'withdrawn', 'unknown phase', 'http://clinicaltrials.gov/ct2/show/NCT00375700'),
('NCT00389727', '2004-01avr-074', 'Simultaneous Integrated Boost (SIB)- IMRT', '', 'Belgium: 22', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00389727'),
('NCT00397904', 'MSKCC-06095, P30CA008748', 'Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin', 'Cisplatin, cetuximab, irinotecan', 'United States: 16', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00397904'),
('NCT00401401', 'Hx-EGFr-203', 'Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer', 'Cisplatin, zalutumumab', 'Belgium: 9, France: 9, Netherlands: 4, Sweden: 4, United States: 4', 'terminated', 'phase 1/2', 'http://clinicaltrials.gov/ct2/show/NCT00401401'),
('NCT00402545', 'CA225249', 'C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck', 'Cisplatin, Fluorouracil, docetaxel, cetuximab', 'United States: 29', 'completed', 'phase 1', 'http://clinicaltrials.gov/ct2/show/NCT00402545'),
('NCT00427102', 'J-0657', 'MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck', 'Cisplatin, D-Methionine', 'United States: 1', 'terminated', 'phase 1', 'http://clinicaltrials.gov/ct2/show/NCT00427102'),
('NCT00436800', 'L_9281', 'Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma', 'gemcitabine, oxaliplatin', 'Hong Kong: 41', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00436800'),
('NCT00459043', '', 'Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck', 'docetaxel, vandetanib', 'United States: 30', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00459043'),
('NCT00484601', '03-09-11-08, JS0327', 'Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma', 'Doxorubicin, Ifosfamide', 'Singapore: 5, United States: 5', 'terminated', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00484601'),
('NCT00525200 [PANCHO]', 'EudraCT 2006-006647-31', 'p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer', 'Cisplatin, Fluorouracil, docetaxel', 'Austria: 170', 'completed', 'phase 3', 'http://clinicaltrials.gov/ct2/show/NCT00525200'),
('NCT00566800', 'CDR0000576425, GENENTECH-OSI3717s, VAMCK-JB0027', 'Erlotinib in Treating Patients With Barrett Esophagus', 'erlotinib', 'United States: 25', 'no information', 'phase 1', 'http://clinicaltrials.gov/ct2/show/NCT00566800'),
('NCT00578201 [FOLFOX]', 'P060503, 2006-005550-72', 'FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer', 'cetuximab, Folfox regimen', 'France: 80', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00578201'),
('NCT00592501', '', 'Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma', 'Cisplatin, Fluorouracil', 'United States: 25', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT00592501'),
('NCT00601692', 'MSKCC-02061, SANOFI-AVENTIS-MSKCC-02061, P30CA008748', 'Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer', 'Cisplatin, docetaxel, irinotecan', 'United States: 27', 'completed', 'phase 1', 'http://clinicaltrials.gov/ct2/show/NCT00601692'),
('NCT00655876', 'CDR0000538085, RTOG 0436', 'Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer', 'Cisplatin, Paclitaxel, cetuximab', 'Canada: 4, United States: 340', 'completed', 'phase 3', 'http://clinicaltrials.gov/ct2/show/NCT00655876'),
('NCT00894101', 'HS# 2009-6857', 'Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation', 'alovudine', 'United States: 7', 'withdrawn', 'phase 2/3', 'http://clinicaltrials.gov/ct2/show/NCT00894101'),
('NCT00937300', 'HH0908', 'T-cell Based Immunotherapy for Head and Neck Cancer', 'Cyclophosphamide, fludarabine', 'Denmark: 6', 'withdrawn', 'phase 1', 'http://clinicaltrials.gov/ct2/show/NCT00937300'),
('NCT00999700 [INTERCEPTOR]', '2009-013402-14, EUDRACT NUMBER 2009-013402-14', 'Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin', 'Cisplatin, Fluorouracil, docetaxel, cetuximab', 'Italy: 282', 'completed', 'phase 3', 'http://clinicaltrials.gov/ct2/show/NCT00999700'),
('NCT01024101', 'CA139-372, JPRN-JP-JapicCTI-090965, JPRN-JapicCTI-090965, JapicCTI-090965', 'Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck Cancer', 'Paclitaxel', 'Japan: 36', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT01024101'),
('NCT01124500', '', 'Transdermal Methylphenidate for Cancer-Related Fatigue', 'Methylphenidate', 'United States: 20', 'withdrawn', 'unknown phase', 'http://clinicaltrials.gov/ct2/show/NCT01124500'),
('NCT01181401 [ICRAT]', '2010-019347-18, DRKS00005568, EudraCT No. 2010-019347-18, ICRAT-0210', 'InductionChemo-Radio-Antibody-Treatment', 'Cisplatin, Fluorouracil, docetaxel, cetuximab, tpf protocol', 'Germany: 94', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT01181401'),
('NCT01186601', '', 'Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer', '', 'United States: 30', 'completed', 'phase 1', 'http://clinicaltrials.gov/ct2/show/NCT01186601'),
('NCT01216800', 'CDR0000686212, CRUK-08/004, EU-21073, ICR-CTSU/2007/10012, ICR-RMH-2708, ISRCTN-81772291, ISRCTN81772291, MREC-05/Q0801/183, N0258171463, UKCTG13122', 'Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors', '', 'United Kingdom: 84', 'completed', 'phase 3', 'http://clinicaltrials.gov/ct2/show/NCT01216800'),
('NCT01221753', '', 'Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study', 'Cisplatin, Carboplatin, Fluorouracil, docetaxel, cetuximab', 'United States: 7', 'terminated', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT01221753'),
('NCT01255800', '11-0109.cc', 'Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck Cancer', 'cetuximab, patidegib', 'United States: 9', 'completed', 'phase 1', 'http://clinicaltrials.gov/ct2/show/NCT01255800'),
('NCT01260701', 'NCI-2011-02619, U10CA032102, S1005, CDR0000689602, SWOG-S1005, U10CA180888', 'Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer', 'MK2206', 'Canada: 1, United States: 169', 'completed', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT01260701'),
('NCT01880359', '2013-002441-12, EORTC-1219', 'AF CRT +/- Nimorazole in HNSCC', 'Cisplatin, Nimorazole', 'Australia: 103, Belgium: 103, Canada: 21, France: 103, Germany: 83, Netherlands: 62, New Zealand: 21, Poland: 103, Switzerland: 41', 'completed', 'phase 3', 'http://clinicaltrials.gov/ct2/show/NCT01880359'),
('NCT02215265 [PATHOS]', '2014-003392-32, 2014/VCC/0014, EORTC-1701, NCI-2020-08056, PATHOS-2014/VVC/0014, SPON1610-17, UKCTG18140', 'Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)', 'Cisplatin, Carboplatin', 'Australia: 21, Austria: 21, Belgium: 21, France: 21, Germany: 21, Italy: 21, Netherlands: 21, Poland: 21, Portugal: 21, Spain: 42, Switzerland: 42, United Kingdom: 789, United States: 42', 'recruiting', 'phase 3', 'http://clinicaltrials.gov/ct2/show/NCT02215265'),
('NCT02336711', '2013/13MAR/117', 'Molecular Imaging-based Dose Escalation in HPV Negative Patients With Locally Advanced SCC of the Oropharynx', '', 'Belgium: 10', 'completed', 'unknown phase', 'http://clinicaltrials.gov/ct2/show/NCT02336711'),
('NCT03396718 [DELPHI]', 'STR-DELPHI-2016', 'De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas', '', 'Germany: 384', 'recruiting', 'unknown phase', 'http://clinicaltrials.gov/ct2/show/NCT03396718'),
('NCT03865277 [INDIRA-MISO]', 'STR-INDIRA-MISO-2014', 'Individualized Radiation Dose Prescription in HNSCC Based on F-MISO-PET Hypoxia-Imaging', '', 'Austria: 38, Germany: 230, Italy: 38, Poland: 38', 'not yet recruiting', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT03865277'),
('NCT03894891', '18-652, NCI-2019-04114', 'Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer', 'Cisplatin, Goserelin, Leuprolide, docetaxel, terpene synthase, taxane, trastuzumab emtansine, eribulin, nivolumab', 'United States: 70', 'active not recruiting', 'phase 2', 'http://clinicaltrials.gov/ct2/show/NCT03894891'),
('NCT05055648 [PROTECT]', 'DCPT101008134', 'PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy', '', 'Belgium: 30, Denmark: 30, France: 91, Germany: 30, Italy: 61, Netherlands: 61, Switzerland: 30, United Kingdom: 61', 'not yet recruiting', 'unknown phase', 'http://clinicaltrials.gov/ct2/show/NCT05055648');

-- --------------------------------------------------------

--
-- Table structure for table `TRIAL_TREATMENT`
--

DROP TABLE IF EXISTS `TRIAL_TREATMENT`;
CREATE TABLE IF NOT EXISTS `TRIAL_TREATMENT` (
  `TRIAL_ID` varchar(25) NOT NULL,
  `TREATMENT_NAME` varchar(32) DEFAULT NULL,
  `TRT_ID` varchar(6) NOT NULL,
  PRIMARY KEY (`TRIAL_ID`,`TRT_ID`),
  KEY `TRT_ID` (`TRT_ID`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_general_ci;

--
-- RELATIONSHIPS FOR TABLE `TRIAL_TREATMENT`:
--   `TRIAL_ID`
--       `TRIAL_SUMMARY` -> `TRIAL_ID`
--   `TRT_ID`
--       `TREATMENTS` -> `TRT_ID`
--

--
-- Dumping data for table `TRIAL_TREATMENT`
--

INSERT INTO `TRIAL_TREATMENT` (`TRIAL_ID`, `TREATMENT_NAME`, `TRT_ID`) VALUES
('NCT00002702', 'aldesleukin', 'TRT_25'),
('NCT00002901', 'docetaxel', 'TRT_01'),
('NCT00003055', 'Cisplatin', 'TRT_03'),
('NCT00003055', 'irinotecan', 'TRT_42'),
('NCT00003087', 'Paclitaxel', 'TRT_02'),
('NCT00003087', 'Cisplatin', 'TRT_03'),
('NCT00003200', 'docetaxel', 'TRT_01'),
('NCT00003744', 'gemcitabine', 'TRT_07'),
('NCT00004070', 'Edodekin alfa', 'TRT_32'),
('NCT00004163', 'trastuzumab', 'TRT_41'),
('NCT00004901', 'Fluorouracil', 'TRT_05'),
('NCT00004901', 'Hydroxyurea', 'TRT_15'),
('NCT00004901', 'Eniluracil', 'TRT_16'),
('NCT00005638', 'Cisplatin', 'TRT_03'),
('NCT00005638', 'irinotecan', 'TRT_42'),
('NCT00016900', 'Paclitaxel', 'TRT_02'),
('NCT00030862', 'Cisplatin', 'TRT_03'),
('NCT00030862', 'irinotecan', 'TRT_42'),
('NCT00072332', 'Cisplatin', 'TRT_03'),
('NCT00072332', 'edotecarin', 'TRT_44'),
('NCT00073502', 'OSI-7904L', 'TRT_26'),
('NCT00080002', 'pegamotecan', 'TRT_27'),
('NCT00095875', 'docetaxel', 'TRT_01'),
('NCT00095875', 'Cisplatin', 'TRT_03'),
('NCT00095875', 'Fluorouracil', 'TRT_05'),
('NCT00095875', 'Carboplatin', 'TRT_30'),
('NCT00095901', 'capecitabine', 'TRT_17'),
('NCT00095927', 'Paclitaxel', 'TRT_02'),
('NCT00095927', 'Carboplatin', 'TRT_30'),
('NCT00095927', 'Amifostine', 'TRT_31'),
('NCT00101075', 'oxaliplatin', 'TRT_08'),
('NCT00101075', 'capecitabine', 'TRT_17'),
('NCT00154700', 'Paclitaxel', 'TRT_02'),
('NCT00154700', 'Cisplatin', 'TRT_03'),
('NCT00154700', 'FolicAcid', 'TRT_04'),
('NCT00154700', 'Fluorouracil', 'TRT_05'),
('NCT00176800', 'Decuprate', 'TRT_06'),
('NCT00259402', 'Cisplatin', 'TRT_03'),
('NCT00259402', 'oxaliplatin', 'TRT_08'),
('NCT00290602', 'Methylprednisolone Hemisuccinate', 'TRT_28'),
('NCT00316862', 'Cisplatin', 'TRT_03'),
('NCT00316862', 'irinotecan', 'TRT_42'),
('NCT00354679', 'Cisplatin', 'TRT_03'),
('NCT00354679', 'irinotecan', 'TRT_42'),
('NCT00354679', 'bevacizumab', 'TRT_43'),
('NCT00397904', 'Cisplatin', 'TRT_03'),
('NCT00397904', 'cetuximab', 'TRT_12'),
('NCT00397904', 'irinotecan', 'TRT_42'),
('NCT00401401', 'Cisplatin', 'TRT_03'),
('NCT00401401', 'zalutumumab', 'TRT_18'),
('NCT00402545', 'docetaxel', 'TRT_01'),
('NCT00402545', 'Cisplatin', 'TRT_03'),
('NCT00402545', 'Fluorouracil', 'TRT_05'),
('NCT00402545', 'cetuximab', 'TRT_12'),
('NCT00427102', 'Cisplatin', 'TRT_03'),
('NCT00427102', 'D-Methionine', 'TRT_29'),
('NCT00436800', 'gemcitabine', 'TRT_07'),
('NCT00436800', 'oxaliplatin', 'TRT_08'),
('NCT00459043', 'docetaxel', 'TRT_01'),
('NCT00459043', 'vandetanib', 'TRT_40'),
('NCT00484601', 'Doxorubicin', 'TRT_19'),
('NCT00484601', 'Ifosfamide', 'TRT_20'),
('NCT00525200 [PANCHO]', 'docetaxel', 'TRT_01'),
('NCT00525200 [PANCHO]', 'Cisplatin', 'TRT_03'),
('NCT00525200 [PANCHO]', 'Fluorouracil', 'TRT_05'),
('NCT00566800', 'erlotinib', 'TRT_09'),
('NCT00578201 [FOLFOX]', 'cetuximab', 'TRT_12'),
('NCT00578201 [FOLFOX]', 'Folfoxregimen', 'TRT_21'),
('NCT00592501', 'Cisplatin', 'TRT_03'),
('NCT00592501', 'Fluorouracil', 'TRT_05'),
('NCT00601692', 'docetaxel', 'TRT_01'),
('NCT00601692', 'Cisplatin', 'TRT_03'),
('NCT00601692', 'irinotecan', 'TRT_42'),
('NCT00655876', 'Paclitaxel', 'TRT_02'),
('NCT00655876', 'Cisplatin', 'TRT_03'),
('NCT00655876', 'cetuximab', 'TRT_12'),
('NCT00894101', 'alovudine', 'TRT_22'),
('NCT00937300', 'Cyclophosphamide', 'TRT_10'),
('NCT00937300', 'fludarabine', 'TRT_11'),
('NCT00999700 [INTERCEPTOR]', 'docetaxel', 'TRT_01'),
('NCT00999700 [INTERCEPTOR]', 'Cisplatin', 'TRT_03'),
('NCT00999700 [INTERCEPTOR]', 'Fluorouracil', 'TRT_05'),
('NCT00999700 [INTERCEPTOR]', 'cetuximab', 'TRT_12'),
('NCT01024101', 'Paclitaxel', 'TRT_02'),
('NCT01124500', 'Methylphenidate', 'TRT_13'),
('NCT01181401 [ICRAT]', 'docetaxel', 'TRT_01'),
('NCT01181401 [ICRAT]', 'Cisplatin', 'TRT_03'),
('NCT01181401 [ICRAT]', 'Fluorouracil', 'TRT_05'),
('NCT01181401 [ICRAT]', 'cetuximab', 'TRT_12'),
('NCT01181401 [ICRAT]', 'tpfprotocol', 'TRT_23'),
('NCT01221753', 'docetaxel', 'TRT_01'),
('NCT01221753', 'Cisplatin', 'TRT_03'),
('NCT01221753', 'Fluorouracil', 'TRT_05'),
('NCT01221753', 'cetuximab', 'TRT_12'),
('NCT01221753', 'Carboplatin', 'TRT_30'),
('NCT01255800', 'cetuximab', 'TRT_12'),
('NCT01255800', 'patidegib', 'TRT_14'),
('NCT01260701', 'MK2206', 'TRT_24'),
('NCT01880359', 'Cisplatin', 'TRT_03'),
('NCT01880359', 'Nimorazole', 'TRT_45'),
('NCT02215265 [PATHOS]', 'Cisplatin', 'TRT_03'),
('NCT02215265 [PATHOS]', 'Carboplatin', 'TRT_30'),
('NCT03894891', 'docetaxel', 'TRT_01'),
('NCT03894891', 'Cisplatin', 'TRT_03'),
('NCT03894891', 'Leuprolide', 'TRT_33'),
('NCT03894891', 'Goserelin', 'TRT_34'),
('NCT03894891', 'terpene synthase', 'TRT_35'),
('NCT03894891', 'taxane', 'TRT_36'),
('NCT03894891', 'trastuzumab emtansine', 'TRT_37'),
('NCT03894891', 'eribulin', 'TRT_38'),
('NCT03894891', 'nivolumab', 'TRT_39');

-- --------------------------------------------------------

--
-- Table structure for table `users`
--

DROP TABLE IF EXISTS `users`;
CREATE TABLE IF NOT EXISTS `users` (
  `u_id` int(5) NOT NULL AUTO_INCREMENT,
  `u_email` varchar(128) NOT NULL,
  `u_PWD` varchar(128) NOT NULL,
  PRIMARY KEY (`u_id`)
) ENGINE=InnoDB AUTO_INCREMENT=17 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;

--
-- RELATIONSHIPS FOR TABLE `users`:
--

--
-- Dumping data for table `users`
--

INSERT INTO `users` (`u_id`, `u_email`, `u_PWD`) VALUES
(1, 'aldenjettpace@gmail.com', '$2y$10$25QTeA1H9aZlvYbwOGZnkengq/lEt.GrsOZeSXz//wx8i819yUerO'),
(2, 'ajettpac@gmail.com', '$2y$10$E3Bn1vw2f4uP2TkBJbag7.PBxZl8Pc7Rkz1LREI./l/XcdN/KuxFy'),
(3, 'bardolynno@yahoo.com', '$2y$10$pCYT9dTWrYoXcLlpNGn2o.hTuuTUVjGBQ9bE1YSfd8nhncejtxoNq'),
(4, 'ajettpac@gmail.com', '$2y$10$Ni5cUCa58Pmfe8/qvC27XunKvLqR7HMURRawCKv.s6jzF8p6gV.cS'),
(5, 'wiley@gmail.com', '$2y$10$JdSde9UDjG4Hg2QmvDbBce/ETXUf0QDEwou.X3x02A3dogX8IXq6m'),
(6, 'andersau@iu.edu', '$2y$10$mxkioB0W9pFN3Ugr4uv/9OWL3FukuNiXaIw8Za5uAwrTjLNlRkVIu'),
(7, 'austin.anderson538@gmail.com', '$2y$10$aM2gefAazZCU22HA5xDq2OaPhxebXsJhR0IJGkcBkRfFGSuO0mchm'),
(8, 'will@gmail.com', '$2y$10$SuRnFfoGHbU5T7XS/Br7Pu5JpabDnsu9NmJcf6HOzRFCQ5TJTSUwe'),
(9, 'nic86@gmail.com', '$2y$10$uW/jYnqXYUNSBvvrqYF0J.oZTlJBNzgClafQf0TFpD3GQMzSnxa4e'),
(10, 'nk286@gmail.com', '$2y$10$oiq7tWi0luIebkmNFCnVduj2Jz6H9x3nFcpaJ8F6U60vjjisgaQgq'),
(11, 'billy@gmail.com', '$2y$10$tTfyG8Z.QwJx4feOb00GFOBPiBnDWcqaZbnHc1nH0qIoup0pimM7m'),
(12, 'njettpace@gmail.com', '$2y$10$g/IOIGQxbLPmkCqZx2nIAurWQjc3NcksNj6KkMj0YFoHAv4PmFeJW'),
(13, 'lynn@gmail.com', '$2y$10$L1lKAWucdpubjKT2UsJEK.onRABPRt8/p38zVne0Z5VTfBiLbKnw6'),
(14, 'ruddy@yahoo.com', '$2y$10$BPWqaAVHceBQRYgjiSKOq.3lUhYpvEDrXvoptdh9i4E3IpQ7a3uB2'),
(15, 'nicky@gmail.com', '$2y$10$0myTS6.KAk5YKvBmVFsx3eTn9BfND.Lwmx327nVhTAyIvXDftWQoS'),
(16, 'Fred@gmail.com', '$2y$10$rANuOUxOFvJmsefPjI6Pcea9IuMTgA14R3zQewpds3WOdSMSihaNG');

--
-- Constraints for dumped tables
--

--
-- Constraints for table `HCP_INS`
--
ALTER TABLE `HCP_INS`
  ADD CONSTRAINT `HCP_INS_ibfk_1` FOREIGN KEY (`HCP_ID`) REFERENCES `HCP` (`HCP_ID`) ON DELETE CASCADE ON UPDATE CASCADE,
  ADD CONSTRAINT `HCP_INS_ibfk_2` FOREIGN KEY (`INS_ID`) REFERENCES `INSTITUTIONS` (`INS_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `TRIAL_COLLABORATORS`
--
ALTER TABLE `TRIAL_COLLABORATORS`
  ADD CONSTRAINT `TRIAL_COLLABORATORS_ibfk_1` FOREIGN KEY (`TRIAL_ID`) REFERENCES `TRIAL_SUMMARY` (`TRIAL_ID`) ON DELETE CASCADE ON UPDATE CASCADE,
  ADD CONSTRAINT `TRIAL_COLLABORATORS_ibfk_2` FOREIGN KEY (`INS_IS_COLLABORATOR`) REFERENCES `INSTITUTIONS` (`INS_IS_COLLABORATOR`),
  ADD CONSTRAINT `TRIAL_COLLABORATORS_ibfk_3` FOREIGN KEY (`INS_ID`) REFERENCES `INSTITUTIONS` (`INS_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `TRIAL_CTRY_ENROLL`
--
ALTER TABLE `TRIAL_CTRY_ENROLL`
  ADD CONSTRAINT `TRIAL_CTRY_ENROLL_ibfk_1` FOREIGN KEY (`TRIAL_ID`) REFERENCES `TRIAL_SUMMARY` (`TRIAL_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `TRIAL_HCP`
--
ALTER TABLE `TRIAL_HCP`
  ADD CONSTRAINT `TRIAL_HCP_ibfk_1` FOREIGN KEY (`HCP_ID`) REFERENCES `HCP` (`HCP_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `TRIAL_INS`
--
ALTER TABLE `TRIAL_INS`
  ADD CONSTRAINT `TRIAL_INS_ibfk_1` FOREIGN KEY (`TRIAL_ID`) REFERENCES `TRIAL_SUMMARY` (`TRIAL_ID`) ON DELETE CASCADE ON UPDATE CASCADE,
  ADD CONSTRAINT `TRIAL_INS_ibfk_2` FOREIGN KEY (`INS_ID`) REFERENCES `INSTITUTIONS` (`INS_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `TRIAL_LEADSPONSORS`
--
ALTER TABLE `TRIAL_LEADSPONSORS`
  ADD CONSTRAINT `TRIAL_LEADSPONSORS_ibfk_1` FOREIGN KEY (`TRIAL_ID`) REFERENCES `TRIAL_SUMMARY` (`TRIAL_ID`) ON DELETE CASCADE ON UPDATE CASCADE,
  ADD CONSTRAINT `TRIAL_LEADSPONSORS_ibfk_2` FOREIGN KEY (`INS_IS_SPONSOR`) REFERENCES `INSTITUTIONS` (`INS_IS_SPONSOR`);

--
-- Constraints for table `TRIAL_MESH`
--
ALTER TABLE `TRIAL_MESH`
  ADD CONSTRAINT `TRIAL_MESH_ibfk_1` FOREIGN KEY (`TRIAL_ID`) REFERENCES `TRIAL_SUMMARY` (`TRIAL_ID`) ON DELETE CASCADE ON UPDATE CASCADE,
  ADD CONSTRAINT `TRIAL_MESH_ibfk_2` FOREIGN KEY (`MESH_ID`) REFERENCES `MESH_TERMS` (`MESH_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `TRIAL_PATIENT_ENROLL`
--
ALTER TABLE `TRIAL_PATIENT_ENROLL`
  ADD CONSTRAINT `TRIAL_PATIENT_ENROLL_ibfk_1` FOREIGN KEY (`TRIAL_ID`) REFERENCES `TRIAL_SUMMARY` (`TRIAL_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `TRIAL_PHASE`
--
ALTER TABLE `TRIAL_PHASE`
  ADD CONSTRAINT `TRIAL_PHASE_ibfk_1` FOREIGN KEY (`TRIAL_ID`) REFERENCES `TRIAL_SUMMARY` (`TRIAL_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `TRIAL_PUB`
--
ALTER TABLE `TRIAL_PUB`
  ADD CONSTRAINT `TRIAL_PUB_ibfk_1` FOREIGN KEY (`TRIAL_ID`) REFERENCES `TRIAL_STUDY_DETAILS` (`TRIAL_ID`) ON DELETE CASCADE ON UPDATE CASCADE,
  ADD CONSTRAINT `TRIAL_PUB_ibfk_2` FOREIGN KEY (`PUB_ID`) REFERENCES `PUBLICATION` (`PUB_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `TRIAL_SITE`
--
ALTER TABLE `TRIAL_SITE`
  ADD CONSTRAINT `TRIAL_SITE_ibfk_1` FOREIGN KEY (`TRIAL_ID`) REFERENCES `TRIAL_SUMMARY` (`TRIAL_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `TRIAL_STUDY_DETAILS`
--
ALTER TABLE `TRIAL_STUDY_DETAILS`
  ADD CONSTRAINT `TRIAL_STUDY_DETAILS_ibfk_1` FOREIGN KEY (`TRIAL_ID`) REFERENCES `TRIAL_SUMMARY` (`TRIAL_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `TRIAL_TREATMENT`
--
ALTER TABLE `TRIAL_TREATMENT`
  ADD CONSTRAINT `TRIAL_TREATMENT_ibfk_1` FOREIGN KEY (`TRIAL_ID`) REFERENCES `TRIAL_SUMMARY` (`TRIAL_ID`) ON DELETE CASCADE ON UPDATE CASCADE,
  ADD CONSTRAINT `TRIAL_TREATMENT_ibfk_2` FOREIGN KEY (`TRT_ID`) REFERENCES `TREATMENTS` (`TRT_ID`) ON DELETE CASCADE ON UPDATE CASCADE;
COMMIT;

/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
